id	sid	tid	token	lemma	pos
easat-2814	1	1	edelweiss	edelweiss	PROPN
easat-2814	1	2	applied	apply	VERB
easat-2814	1	3	science	science	NOUN
easat-2814	1	4	and	and	CCONJ
easat-2814	1	5	technology	technology	NOUN
easat-2814	1	6	issn	issn	PROPN
easat-2814	1	7	:	:	PUNCT
easat-2814	1	8	2576	2576	NUM
easat-2814	1	9	-	-	SYM
easat-2814	1	10	8484	8484	NUM
easat-2814	1	11	vol	vol	NOUN
easat-2814	1	12	.	.	PROPN
easat-2814	1	13	8	8	NUM
easat-2814	1	14	,	,	PUNCT
easat-2814	1	15	no	no	INTJ
easat-2814	1	16	.	.	NOUN
easat-2814	1	17	6	6	NUM
easat-2814	1	18	,	,	PUNCT
easat-2814	1	19	3722	3722	NUM
easat-2814	1	20	-	-	SYM
easat-2814	1	21	3733	3733	NUM
easat-2814	1	22	2024	2024	NUM
easat-2814	1	23	publisher	publisher	NOUN
easat-2814	1	24	:	:	PUNCT
easat-2814	1	25	learning	learn	VERB
easat-2814	1	26	gate	gate	NOUN
easat-2814	1	27	doi	doi	PROPN
easat-2814	1	28	:	:	PUNCT
easat-2814	1	29	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	1	30	©	©	ADP
easat-2814	1	31	2024	2024	NUM
easat-2814	1	32	by	by	ADP
easat-2814	1	33	the	the	DET
easat-2814	1	34	authors	author	NOUN
easat-2814	1	35	;	;	PUNCT
easat-2814	1	36	licensee	licensee	PROPN
easat-2814	1	37	learning	learning	NOUN
easat-2814	1	38	gate	gate	NOUN
easat-2814	1	39	©	©	PROPN
easat-2814	1	40	2024	2024	NUM
easat-2814	1	41	by	by	ADP
easat-2814	1	42	the	the	DET
easat-2814	1	43	authors	author	NOUN
easat-2814	1	44	;	;	PUNCT
easat-2814	1	45	licensee	licensee	PROPN
easat-2814	1	46	learning	learn	VERB
easat-2814	1	47	gate	gate	NOUN
easat-2814	1	48	*	*	PUNCT
easat-2814	1	49	correspondence	correspondence	NOUN
easat-2814	1	50	:	:	PUNCT
easat-2814	1	51	wimbo2005@yahoo.co.id	wimbo2005@yahoo.co.id	PROPN
easat-2814	1	52	the	the	DET
easat-2814	1	53	effects	effect	NOUN
easat-2814	1	54	of	of	ADP
easat-2814	1	55	sod	sod	NOUN
easat-2814	1	56	melon	melon	NOUN
easat-2814	1	57	gliadin	gliadin	NOUN
easat-2814	1	58	as	as	ADP
easat-2814	1	59	an	an	DET
easat-2814	1	60	antioxidant	antioxidant	NOUN
easat-2814	1	61	on	on	ADP
easat-2814	1	62	vegf	vegf	PROPN
easat-2814	1	63	and	and	CCONJ
easat-2814	1	64	tgf	tgf	PROPN
easat-2814	1	65	β	β	PROPN
easat-2814	1	66	blood	blood	NOUN
easat-2814	1	67	serum	serum	NOUN
easat-2814	1	68	and	and	CCONJ
easat-2814	1	69	vitreoretina	vitreoretina	NOUN
easat-2814	1	70	in	in	ADP
easat-2814	1	71	hyperglycemia	hyperglycemia	NOUN
easat-2814	1	72	rat	rat	NOUN
easat-2814	1	73	model	model	NOUN
easat-2814	1	74	a	a	DET
easat-2814	1	75	literature	literature	NOUN
easat-2814	1	76	review	review	PROPN
easat-2814	1	77	windya	windya	PROPN
easat-2814	1	78	tri	tri	PROPN
easat-2814	1	79	hapsari1	hapsari1	NOUN
easat-2814	1	80	,	,	PUNCT
easat-2814	1	81	wimbo	wimbo	NOUN
easat-2814	1	82	sasono2	sasono2	NOUN
easat-2814	1	83	*	*	PUNCT
easat-2814	1	84	,	,	PUNCT
easat-2814	1	85	sauli	sauli	PROPN
easat-2814	1	86	ari	ari	PROPN
easat-2814	1	87	widjaja3	widjaja3	PROPN
easat-2814	2	1	1,2,3department	1,2,3department	NUM
easat-2814	2	2	of	of	ADP
easat-2814	2	3	opthalmology	opthalmology	NOUN
easat-2814	2	4	,	,	PUNCT
easat-2814	2	5	faculty	faculty	NOUN
easat-2814	2	6	of	of	ADP
easat-2814	2	7	medicine	medicine	NOUN
easat-2814	2	8	,	,	PUNCT
easat-2814	2	9	universitas	universita	NOUN
easat-2814	2	10	airlangga	airlangga	NOUN
easat-2814	2	11	,	,	PUNCT
easat-2814	2	12	soetomo	soetomo	PROPN
easat-2814	2	13	general	general	ADJ
easat-2814	2	14	academic	academic	ADJ
easat-2814	2	15	hospital	hospital	NOUN
easat-2814	2	16	,	,	PUNCT
easat-2814	2	17	surabaya	surabaya	PROPN
easat-2814	2	18	indonesia	indonesia	PROPN
easat-2814	2	19	;	;	PUNCT
easat-2814	2	20	windya.tri.hapsari-2019@fk.unair.ac.id	windya.tri.hapsari-2019@fk.unair.ac.id	PROPN
easat-2814	2	21	(	(	PUNCT
easat-2814	2	22	w.t.h	w.t.h	NOUN
easat-2814	2	23	.	.	PUNCT
easat-2814	2	24	)	)	PUNCT
easat-2814	3	1	wimbo2005@yahoo.co.id	wimbo2005@yahoo.co.id	PROPN
easat-2814	3	2	(	(	PUNCT
easat-2814	3	3	w.s	w.s	PROPN
easat-2814	3	4	.	.	PUNCT
easat-2814	3	5	)	)	PUNCT
easat-2814	4	1	sauliawidjaja@gmail.com	sauliawidjaja@gmail.com	X
easat-2814	4	2	(	(	PUNCT
easat-2814	4	3	s.a.w	s.a.w	NOUN
easat-2814	4	4	.	.	PUNCT
easat-2814	4	5	)	)	PUNCT
easat-2814	4	6	.	.	PUNCT
easat-2814	5	1	abstract	abstract	ADJ
easat-2814	5	2	:	:	PUNCT
easat-2814	5	3	diabetes	diabetes	NOUN
easat-2814	5	4	mellitus	mellitus	NOUN
easat-2814	5	5	is	be	AUX
easat-2814	5	6	a	a	DET
easat-2814	5	7	chronic	chronic	ADJ
easat-2814	5	8	metabolic	metabolic	NOUN
easat-2814	5	9	disorder	disorder	NOUN
easat-2814	5	10	characterized	characterize	VERB
easat-2814	5	11	by	by	ADP
easat-2814	5	12	hyperglycemia	hyperglycemia	NOUN
easat-2814	5	13	resulting	result	VERB
easat-2814	5	14	from	from	ADP
easat-2814	5	15	impaired	impaired	ADJ
easat-2814	5	16	insulin	insulin	NOUN
easat-2814	5	17	secretion	secretion	NOUN
easat-2814	5	18	,	,	PUNCT
easat-2814	5	19	action	action	NOUN
easat-2814	5	20	,	,	PUNCT
easat-2814	5	21	or	or	CCONJ
easat-2814	5	22	both	both	PRON
easat-2814	5	23	.	.	PUNCT
easat-2814	6	1	persistent	persistent	ADJ
easat-2814	6	2	hyperglycemia	hyperglycemia	NOUN
easat-2814	6	3	can	can	AUX
easat-2814	6	4	lead	lead	VERB
easat-2814	6	5	to	to	ADP
easat-2814	6	6	organ	organ	NOUN
easat-2814	6	7	damage	damage	NOUN
easat-2814	6	8	,	,	PUNCT
easat-2814	6	9	including	include	VERB
easat-2814	6	10	ocular	ocular	ADJ
easat-2814	6	11	complications	complication	NOUN
easat-2814	6	12	such	such	ADJ
easat-2814	6	13	as	as	ADP
easat-2814	6	14	diabetic	diabetic	ADJ
easat-2814	6	15	retinopathy	retinopathy	NOUN
easat-2814	6	16	.	.	PUNCT
easat-2814	7	1	diabetic	diabetic	ADJ
easat-2814	7	2	retinopathy	retinopathy	NOUN
easat-2814	7	3	is	be	AUX
easat-2814	7	4	a	a	DET
easat-2814	7	5	primary	primary	ADJ
easat-2814	7	6	cause	cause	NOUN
easat-2814	7	7	of	of	ADP
easat-2814	7	8	preventable	preventable	ADJ
easat-2814	7	9	blindness	blindness	NOUN
easat-2814	7	10	and	and	CCONJ
easat-2814	7	11	can	can	AUX
easat-2814	7	12	become	become	VERB
easat-2814	7	13	vision	vision	NOUN
easat-2814	7	14	-	-	PUNCT
easat-2814	7	15	threatening	threaten	VERB
easat-2814	7	16	if	if	SCONJ
easat-2814	7	17	complications	complication	NOUN
easat-2814	7	18	are	be	AUX
easat-2814	7	19	persistent	persistent	ADJ
easat-2814	7	20	.	.	PUNCT
easat-2814	8	1	over	over	ADP
easat-2814	8	2	one	one	NUM
easat-2814	8	3	-	-	PUNCT
easat-2814	8	4	third	third	NOUN
easat-2814	8	5	of	of	ADP
easat-2814	8	6	individuals	individual	NOUN
easat-2814	8	7	with	with	ADP
easat-2814	8	8	diabetes	diabetes	NOUN
easat-2814	8	9	exhibit	exhibit	VERB
easat-2814	8	10	signs	sign	NOUN
easat-2814	8	11	of	of	ADP
easat-2814	8	12	diabetic	diabetic	ADJ
easat-2814	8	13	retinopathy	retinopathy	NOUN
easat-2814	8	14	,	,	PUNCT
easat-2814	8	15	and	and	CCONJ
easat-2814	8	16	among	among	ADP
easat-2814	8	17	them	they	PRON
easat-2814	8	18	,	,	PUNCT
easat-2814	8	19	approximately	approximately	ADV
easat-2814	8	20	onethird	onethird	PROPN
easat-2814	8	21	experience	experience	PROPN
easat-2814	8	22	vision	vision	NOUN
easat-2814	8	23	-	-	PUNCT
easat-2814	8	24	threatening	threaten	VERB
easat-2814	8	25	diabetic	diabetic	ADJ
easat-2814	8	26	retinopathy	retinopathy	ADJ
easat-2814	8	27	(	(	PUNCT
easat-2814	8	28	vtdr	vtdr	NOUN
easat-2814	8	29	)	)	PUNCT
easat-2814	8	30	,	,	PUNCT
easat-2814	8	31	defined	define	VERB
easat-2814	8	32	as	as	ADP
easat-2814	8	33	severe	severe	ADJ
easat-2814	8	34	non	non	ADJ
easat-2814	8	35	-	-	ADJ
easat-2814	8	36	proliferative	proliferative	ADJ
easat-2814	8	37	diabetic	diabetic	ADJ
easat-2814	8	38	retinopathy	retinopathy	ADJ
easat-2814	8	39	(	(	PUNCT
easat-2814	8	40	npdr	npdr	NOUN
easat-2814	8	41	)	)	PUNCT
easat-2814	8	42	,	,	PUNCT
easat-2814	8	43	proliferative	proliferative	ADJ
easat-2814	8	44	diabetic	diabetic	ADJ
easat-2814	8	45	retinopathy	retinopathy	ADJ
easat-2814	8	46	(	(	PUNCT
easat-2814	8	47	pdr	pdr	NOUN
easat-2814	8	48	)	)	PUNCT
easat-2814	8	49	,	,	PUNCT
easat-2814	8	50	or	or	CCONJ
easat-2814	8	51	the	the	DET
easat-2814	8	52	presence	presence	NOUN
easat-2814	8	53	of	of	ADP
easat-2814	8	54	diabetic	diabetic	ADJ
easat-2814	8	55	macular	macular	ADJ
easat-2814	8	56	edema	edema	NOUN
easat-2814	8	57	(	(	PUNCT
easat-2814	8	58	dme	dme	PROPN
easat-2814	8	59	)	)	PUNCT
easat-2814	8	60	.	.	PUNCT
easat-2814	9	1	diabetic	diabetic	ADJ
easat-2814	9	2	retinopathy	retinopathy	ADJ
easat-2814	9	3	triggers	trigger	VERB
easat-2814	9	4	the	the	DET
easat-2814	9	5	production	production	NOUN
easat-2814	9	6	of	of	ADP
easat-2814	9	7	reactive	reactive	ADJ
easat-2814	9	8	oxygen	oxygen	NOUN
easat-2814	9	9	species	specie	NOUN
easat-2814	9	10	(	(	PUNCT
easat-2814	9	11	ros	ros	PROPN
easat-2814	9	12	)	)	PUNCT
easat-2814	9	13	.	.	PUNCT
easat-2814	10	1	excessive	excessive	ADJ
easat-2814	10	2	accumulation	accumulation	NOUN
easat-2814	10	3	of	of	ADP
easat-2814	10	4	ros	ros	PROPN
easat-2814	10	5	can	can	AUX
easat-2814	10	6	damage	damage	VERB
easat-2814	10	7	tissues	tissue	NOUN
easat-2814	10	8	surrounding	surround	VERB
easat-2814	10	9	retinal	retinal	ADJ
easat-2814	10	10	blood	blood	NOUN
easat-2814	10	11	vessels	vessel	NOUN
easat-2814	10	12	,	,	PUNCT
easat-2814	10	13	leading	lead	VERB
easat-2814	10	14	to	to	ADP
easat-2814	10	15	oxidative	oxidative	ADJ
easat-2814	10	16	stress	stress	NOUN
easat-2814	10	17	that	that	PRON
easat-2814	10	18	compromises	compromise	VERB
easat-2814	10	19	the	the	DET
easat-2814	10	20	blood	blood	NOUN
easat-2814	10	21	-	-	PUNCT
easat-2814	10	22	retina	retina	NOUN
easat-2814	10	23	barrier	barrier	NOUN
easat-2814	10	24	(	(	PUNCT
easat-2814	10	25	brb	brb	PROPN
easat-2814	10	26	)	)	PUNCT
easat-2814	10	27	.	.	PUNCT
easat-2814	11	1	vascular	vascular	ADJ
easat-2814	11	2	endothelial	endothelial	ADJ
easat-2814	11	3	growth	growth	NOUN
easat-2814	11	4	factor	factor	NOUN
easat-2814	11	5	(	(	PUNCT
easat-2814	11	6	vegf	vegf	PROPN
easat-2814	11	7	)	)	PUNCT
easat-2814	11	8	and	and	CCONJ
easat-2814	11	9	transforming	transform	VERB
easat-2814	11	10	growth	growth	NOUN
easat-2814	11	11	factor	factor	NOUN
easat-2814	11	12	-	-	PUNCT
easat-2814	11	13	beta	beta	NOUN
easat-2814	11	14	(	(	PUNCT
easat-2814	11	15	tgf	tgf	PROPN
easat-2814	11	16	-	-	PUNCT
easat-2814	11	17	β	β	NOUN
easat-2814	11	18	)	)	PUNCT
easat-2814	11	19	are	be	AUX
easat-2814	11	20	two	two	NUM
easat-2814	11	21	markers	marker	NOUN
easat-2814	11	22	that	that	PRON
easat-2814	11	23	indicate	indicate	VERB
easat-2814	11	24	retinal	retinal	ADJ
easat-2814	11	25	dysfunction	dysfunction	NOUN
easat-2814	11	26	.	.	PUNCT
easat-2814	12	1	cells	cell	NOUN
easat-2814	12	2	possess	possess	VERB
easat-2814	12	3	an	an	DET
easat-2814	12	4	intrinsic	intrinsic	ADJ
easat-2814	12	5	defense	defense	NOUN
easat-2814	12	6	system	system	NOUN
easat-2814	12	7	against	against	ADP
easat-2814	12	8	ros	ros	PROPN
easat-2814	12	9	,	,	PUNCT
easat-2814	12	10	comprising	comprise	VERB
easat-2814	12	11	antioxidants	antioxidant	NOUN
easat-2814	12	12	such	such	ADJ
easat-2814	12	13	as	as	ADP
easat-2814	12	14	superoxide	superoxide	NOUN
easat-2814	12	15	dismutase	dismutase	NOUN
easat-2814	12	16	(	(	PUNCT
easat-2814	12	17	sod	sod	NOUN
easat-2814	12	18	)	)	PUNCT
easat-2814	12	19	,	,	PUNCT
easat-2814	12	20	glutathione	glutathione	NOUN
easat-2814	12	21	reductase	reductase	NOUN
easat-2814	12	22	,	,	PUNCT
easat-2814	12	23	glutathione	glutathione	NOUN
easat-2814	12	24	peroxidase	peroxidase	NOUN
easat-2814	12	25	,	,	PUNCT
easat-2814	12	26	and	and	CCONJ
easat-2814	12	27	catalase	catalase	NOUN
easat-2814	12	28	.	.	PUNCT
easat-2814	13	1	sod	sod	NOUN
easat-2814	13	2	melon	melon	NOUN
easat-2814	13	3	gliadin	gliadin	NOUN
easat-2814	13	4	(	(	PUNCT
easat-2814	13	5	glisodin	glisodin	NOUN
easat-2814	13	6	®	®	NOUN
easat-2814	13	7	)	)	PUNCT
easat-2814	13	8	is	be	AUX
easat-2814	13	9	a	a	DET
easat-2814	13	10	potent	potent	ADJ
easat-2814	13	11	antioxidant	antioxidant	NOUN
easat-2814	13	12	that	that	PRON
easat-2814	13	13	elevates	elevate	VERB
easat-2814	13	14	endogenous	endogenous	ADJ
easat-2814	13	15	sod	sod	NOUN
easat-2814	13	16	levels	level	NOUN
easat-2814	13	17	,	,	PUNCT
easat-2814	13	18	reduces	reduce	VERB
easat-2814	13	19	ros	ros	PROPN
easat-2814	13	20	,	,	PUNCT
easat-2814	13	21	and	and	CCONJ
easat-2814	13	22	protects	protect	VERB
easat-2814	13	23	retinal	retinal	ADJ
easat-2814	13	24	tissues	tissue	NOUN
easat-2814	13	25	from	from	ADP
easat-2814	13	26	damage	damage	NOUN
easat-2814	13	27	and	and	CCONJ
easat-2814	13	28	cell	cell	NOUN
easat-2814	13	29	death	death	NOUN
easat-2814	13	30	.	.	PUNCT
easat-2814	14	1	research	research	NOUN
easat-2814	14	2	on	on	ADP
easat-2814	14	3	sod	sod	NOUN
easat-2814	14	4	melon	melon	NOUN
easat-2814	14	5	gliadin	gliadin	NOUN
easat-2814	14	6	(	(	PUNCT
easat-2814	14	7	glisodin	glisodin	NOUN
easat-2814	14	8	®	®	NOUN
easat-2814	14	9	)	)	PUNCT
easat-2814	14	10	shows	show	VERB
easat-2814	14	11	its	its	PRON
easat-2814	14	12	potential	potential	NOUN
easat-2814	14	13	as	as	ADP
easat-2814	14	14	an	an	DET
easat-2814	14	15	antioxidant	antioxidant	NOUN
easat-2814	14	16	for	for	ADP
easat-2814	14	17	preventing	prevent	VERB
easat-2814	14	18	diabetic	diabetic	ADJ
easat-2814	14	19	complications	complication	NOUN
easat-2814	14	20	in	in	ADP
easat-2814	14	21	the	the	DET
easat-2814	14	22	retina	retina	NOUN
easat-2814	14	23	,	,	PUNCT
easat-2814	14	24	specifically	specifically	ADV
easat-2814	14	25	diabetic	diabetic	ADJ
easat-2814	14	26	retinopathy	retinopathy	NOUN
easat-2814	14	27	.	.	PUNCT
easat-2814	15	1	keywords	keyword	NOUN
easat-2814	15	2	:	:	PUNCT
easat-2814	15	3	blood	blood	NOUN
easat-2814	15	4	serum	serum	NOUN
easat-2814	15	5	,	,	PUNCT
easat-2814	15	6	diabetes	diabetes	NOUN
easat-2814	15	7	mellitus	mellitus	NOUN
easat-2814	15	8	,	,	PUNCT
easat-2814	15	9	glisodin	glisodin	PROPN
easat-2814	15	10	,	,	PUNCT
easat-2814	15	11	tgf	tgf	PROPN
easat-2814	15	12	β	β	PROPN
easat-2814	15	13	,	,	PUNCT
easat-2814	15	14	vegf	vegf	PROPN
easat-2814	15	15	,	,	PUNCT
easat-2814	15	16	vitreoretina	vitreoretina	PROPN
easat-2814	15	17	.	.	PUNCT
easat-2814	16	1	1	1	X
easat-2814	16	2	.	.	X
easat-2814	16	3	introduction	introduction	NOUN
easat-2814	16	4	diabetes	diabetes	NOUN
easat-2814	16	5	mellitus	mellitus	NOUN
easat-2814	16	6	is	be	AUX
easat-2814	16	7	a	a	DET
easat-2814	16	8	chronic	chronic	ADJ
easat-2814	16	9	metabolic	metabolic	NOUN
easat-2814	16	10	disease	disease	NOUN
easat-2814	16	11	characterized	characterize	VERB
easat-2814	16	12	by	by	ADP
easat-2814	16	13	hyperglycemia	hyperglycemia	NOUN
easat-2814	16	14	due	due	ADP
easat-2814	16	15	to	to	ADP
easat-2814	16	16	impaired	impaired	ADJ
easat-2814	16	17	insulin	insulin	NOUN
easat-2814	16	18	secretion	secretion	NOUN
easat-2814	16	19	,	,	PUNCT
easat-2814	16	20	action	action	NOUN
easat-2814	16	21	,	,	PUNCT
easat-2814	16	22	or	or	CCONJ
easat-2814	16	23	both	both	PRON
easat-2814	16	24	.	.	PUNCT
easat-2814	17	1	diabetes	diabetes	NOUN
easat-2814	17	2	-	-	PUNCT
easat-2814	17	3	related	relate	VERB
easat-2814	17	4	complications	complication	NOUN
easat-2814	17	5	can	can	AUX
easat-2814	17	6	affect	affect	VERB
easat-2814	17	7	both	both	DET
easat-2814	17	8	macrovascular	macrovascular	ADJ
easat-2814	17	9	and	and	CCONJ
easat-2814	17	10	microvascular	microvascular	ADJ
easat-2814	17	11	systems	system	NOUN
easat-2814	17	12	.	.	PUNCT
easat-2814	18	1	diabetic	diabetic	ADJ
easat-2814	18	2	retinopathy	retinopathy	NOUN
easat-2814	18	3	is	be	AUX
easat-2814	18	4	a	a	DET
easat-2814	18	5	microvascular	microvascular	ADJ
easat-2814	18	6	complication	complication	NOUN
easat-2814	18	7	of	of	ADP
easat-2814	18	8	diabetes	diabetes	NOUN
easat-2814	18	9	mellitus	mellitus	NOUN
easat-2814	18	10	,	,	PUNCT
easat-2814	18	11	contributing	contribute	VERB
easat-2814	18	12	significantly	significantly	ADV
easat-2814	18	13	to	to	ADP
easat-2814	18	14	morbidity	morbidity	NOUN
easat-2814	18	15	associated	associate	VERB
easat-2814	18	16	with	with	ADP
easat-2814	18	17	the	the	DET
easat-2814	18	18	disease	disease	NOUN
easat-2814	18	19	.	.	PUNCT
easat-2814	19	1	the	the	DET
easat-2814	19	2	global	global	ADJ
easat-2814	19	3	prevalence	prevalence	NOUN
easat-2814	19	4	of	of	ADP
easat-2814	19	5	diabetes	diabetes	NOUN
easat-2814	19	6	in	in	ADP
easat-2814	19	7	adults	adult	NOUN
easat-2814	19	8	has	have	AUX
easat-2814	19	9	been	be	AUX
easat-2814	19	10	rising	rise	VERB
easat-2814	19	11	over	over	ADP
easat-2814	19	12	recent	recent	ADJ
easat-2814	19	13	decades	decade	NOUN
easat-2814	19	14	.	.	PUNCT
easat-2814	20	1	according	accord	VERB
easat-2814	20	2	to	to	ADP
easat-2814	20	3	the	the	DET
easat-2814	20	4	international	international	ADJ
easat-2814	20	5	diabetes	diabetes	PROPN
easat-2814	20	6	federation	federation	PROPN
easat-2814	20	7	(	(	PUNCT
easat-2814	20	8	idf	idf	PROPN
easat-2814	20	9	)	)	PUNCT
easat-2814	20	10	,	,	PUNCT
easat-2814	20	11	1	1	NUM
easat-2814	20	12	in	in	ADP
easat-2814	20	13	11	11	NUM
easat-2814	20	14	adults	adult	NOUN
easat-2814	20	15	aged	age	VERB
easat-2814	20	16	20	20	NUM
easat-2814	20	17	to	to	PART
easat-2814	20	18	79	79	NUM
easat-2814	20	19	years	year	NOUN
easat-2814	20	20	had	have	VERB
easat-2814	20	21	diabetes	diabetes	NOUN
easat-2814	20	22	mellitus	mellitus	NOUN
easat-2814	20	23	globally	globally	ADV
easat-2814	20	24	in	in	ADP
easat-2814	20	25	2015	2015	NUM
easat-2814	20	26	.	.	PUNCT
easat-2814	21	1	by	by	ADP
easat-2814	21	2	2021	2021	NUM
easat-2814	21	3	,	,	PUNCT
easat-2814	21	4	this	this	DET
easat-2814	21	5	number	number	NOUN
easat-2814	21	6	will	will	AUX
easat-2814	21	7	increase	increase	VERB
easat-2814	21	8	to	to	ADP
easat-2814	21	9	an	an	DET
easat-2814	21	10	estimated	estimate	VERB
easat-2814	21	11	537	537	NUM
easat-2814	21	12	million	million	NUM
easat-2814	21	13	people	people	NOUN
easat-2814	21	14	,	,	PUNCT
easat-2814	21	15	with	with	ADP
easat-2814	21	16	projections	projection	NOUN
easat-2814	21	17	reaching	reach	VERB
easat-2814	21	18	643	643	NUM
easat-2814	21	19	million	million	NUM
easat-2814	21	20	by	by	ADP
easat-2814	21	21	2030	2030	NUM
easat-2814	21	22	and	and	CCONJ
easat-2814	21	23	783	783	NUM
easat-2814	21	24	million	million	NUM
easat-2814	21	25	by	by	ADP
easat-2814	21	26	2045	2045	NUM
easat-2814	21	27	.	.	PUNCT
easat-2814	22	1	[	[	X
easat-2814	22	2	1	1	NUM
easat-2814	22	3	]	]	PUNCT
easat-2814	22	4	.	.	PUNCT
easat-2814	23	1	diabetic	diabetic	ADJ
easat-2814	23	2	retinopathy	retinopathy	ADJ
easat-2814	23	3	(	(	PUNCT
easat-2814	23	4	dr	dr	PROPN
easat-2814	23	5	)	)	PUNCT
easat-2814	23	6	is	be	AUX
easat-2814	23	7	the	the	DET
easat-2814	23	8	leading	lead	VERB
easat-2814	23	9	cause	cause	NOUN
easat-2814	23	10	of	of	ADP
easat-2814	23	11	vision	vision	NOUN
easat-2814	23	12	loss	loss	NOUN
easat-2814	23	13	in	in	ADP
easat-2814	23	14	adults	adult	NOUN
easat-2814	23	15	aged	age	VERB
easat-2814	23	16	20	20	NUM
easat-2814	23	17	to	to	PART
easat-2814	23	18	74	74	NUM
easat-2814	23	19	years	year	NOUN
easat-2814	23	20	.	.	PUNCT
easat-2814	24	1	from	from	ADP
easat-2814	24	2	1990	1990	NUM
easat-2814	24	3	to	to	ADP
easat-2814	24	4	2010	2010	NUM
easat-2814	24	5	,	,	PUNCT
easat-2814	24	6	dr	dr	PROPN
easat-2814	24	7	ranked	rank	VERB
easat-2814	24	8	as	as	ADP
easat-2814	24	9	the	the	DET
easat-2814	24	10	fifth	fifth	ADJ
easat-2814	24	11	most	most	ADV
easat-2814	24	12	common	common	ADJ
easat-2814	24	13	cause	cause	NOUN
easat-2814	24	14	of	of	ADP
easat-2814	24	15	preventable	preventable	ADJ
easat-2814	24	16	blindness	blindness	NOUN
easat-2814	24	17	and	and	CCONJ
easat-2814	24	18	the	the	DET
easat-2814	24	19	fifth	fifth	ADJ
easat-2814	24	20	most	most	ADV
easat-2814	24	21	common	common	ADJ
easat-2814	24	22	cause	cause	NOUN
easat-2814	24	23	of	of	ADP
easat-2814	24	24	moderate	moderate	ADJ
easat-2814	24	25	to	to	ADP
easat-2814	24	26	severe	severe	ADJ
easat-2814	24	27	visual	visual	ADJ
easat-2814	24	28	impairment	impairment	NOUN
easat-2814	24	29	.	.	PUNCT
easat-2814	25	1	in	in	ADP
easat-2814	25	2	2010	2010	NUM
easat-2814	25	3	,	,	PUNCT
easat-2814	25	4	among	among	ADP
easat-2814	25	5	an	an	DET
easat-2814	25	6	estimated	estimate	VERB
easat-2814	25	7	285	285	NUM
easat-2814	25	8	million	million	NUM
easat-2814	25	9	people	people	NOUN
easat-2814	25	10	with	with	ADP
easat-2814	25	11	diabetes	diabetes	NOUN
easat-2814	25	12	worldwide	worldwide	ADV
easat-2814	25	13	,	,	PUNCT
easat-2814	25	14	over	over	ADP
easat-2814	25	15	one	one	NUM
easat-2814	25	16	-	-	PUNCT
easat-2814	25	17	third	third	ADJ
easat-2814	25	18	displayed	display	VERB
easat-2814	25	19	signs	sign	NOUN
easat-2814	25	20	of	of	ADP
easat-2814	25	21	dr	dr	PROPN
easat-2814	25	22	,	,	PUNCT
easat-2814	25	23	and	and	CCONJ
easat-2814	25	24	one	one	NUM
easat-2814	25	25	-	-	PUNCT
easat-2814	25	26	third	third	NOUN
easat-2814	25	27	of	of	ADP
easat-2814	25	28	these	these	DET
easat-2814	25	29	cases	case	NOUN
easat-2814	25	30	were	be	AUX
easat-2814	25	31	vision	vision	NOUN
easat-2814	25	32	-	-	PUNCT
easat-2814	25	33	threatening	threaten	VERB
easat-2814	25	34	diabetic	diabetic	ADJ
easat-2814	25	35	retinopathy	retinopathy	ADJ
easat-2814	25	36	(	(	PUNCT
easat-2814	25	37	vtdr	vtdr	NOUN
easat-2814	25	38	)	)	PUNCT
easat-2814	25	39	,	,	PUNCT
easat-2814	25	40	which	which	PRON
easat-2814	25	41	includes	include	VERB
easat-2814	25	42	severe	severe	ADJ
easat-2814	25	43	non	non	ADJ
easat-2814	25	44	-	-	ADJ
easat-2814	25	45	proliferative	proliferative	ADJ
easat-2814	25	46	dr	dr	PROPN
easat-2814	25	47	,	,	PUNCT
easat-2814	25	48	proliferative	proliferative	PROPN
easat-2814	25	49	dr	dr	PROPN
easat-2814	25	50	(	(	PUNCT
easat-2814	25	51	pdr	pdr	PROPN
easat-2814	25	52	)	)	PUNCT
easat-2814	25	53	,	,	PUNCT
easat-2814	25	54	or	or	CCONJ
easat-2814	25	55	diabetic	diabetic	ADJ
easat-2814	25	56	macular	macular	ADJ
easat-2814	25	57	edema	edema	NOUN
easat-2814	25	58	(	(	PUNCT
easat-2814	25	59	dme	dme	PROPN
easat-2814	25	60	)	)	PUNCT
easat-2814	25	61	.	.	PUNCT
easat-2814	26	1	the	the	DET
easat-2814	26	2	prevalence	prevalence	NOUN
easat-2814	26	3	of	of	ADP
easat-2814	26	4	dr	dr	PROPN
easat-2814	26	5	varies	vary	VERB
easat-2814	26	6	across	across	ADP
easat-2814	26	7	regions	region	NOUN
easat-2814	26	8	,	,	PUNCT
easat-2814	26	9	with	with	SCONJ
easat-2814	26	10	rates	rate	NOUN
easat-2814	26	11	in	in	ADP
easat-2814	26	12	most	most	ADJ
easat-2814	26	13	asian	asian	ADJ
easat-2814	26	14	countries	country	NOUN
easat-2814	26	15	reported	report	VERB
easat-2814	26	16	between	between	ADP
easat-2814	26	17	12.1	12.1	NUM
easat-2814	26	18	%	%	NOUN
easat-2814	26	19	and	and	CCONJ
easat-2814	26	20	23.0	23.0	NUM
easat-2814	26	21	%	%	NOUN
easat-2814	26	22	,	,	PUNCT
easat-2814	26	23	and	and	CCONJ
easat-2814	26	24	vtdr	vtdr	NOUN
easat-2814	26	25	prevalence	prevalence	NOUN
easat-2814	26	26	between	between	ADP
easat-2814	26	27	4.3	4.3	NUM
easat-2814	26	28	%	%	NOUN
easat-2814	26	29	and	and	CCONJ
easat-2814	26	30	4.6	4.6	NUM
easat-2814	26	31	%	%	NOUN
easat-2814	26	32	.	.	PUNCT
easat-2814	27	1	in	in	ADP
easat-2814	27	2	indonesia	indonesia	PROPN
easat-2814	27	3	,	,	PUNCT
easat-2814	27	4	the	the	DET
easat-2814	27	5	prevalence	prevalence	NOUN
easat-2814	27	6	of	of	ADP
easat-2814	27	7	diabetes	diabetes	NOUN
easat-2814	27	8	mellitus	mellitus	NOUN
easat-2814	27	9	is	be	AUX
easat-2814	27	10	approximately	approximately	ADV
easat-2814	27	11	6.9	6.9	NUM
easat-2814	27	12	%	%	NOUN
easat-2814	27	13	.	.	PUNCT
easat-2814	28	1	research	research	NOUN
easat-2814	28	2	3723	3723	NUM
easat-2814	28	3	edelweiss	edelweiss	PROPN
easat-2814	28	4	applied	apply	VERB
easat-2814	28	5	science	science	NOUN
easat-2814	28	6	and	and	CCONJ
easat-2814	28	7	technology	technology	NOUN
easat-2814	28	8	issn	issn	PROPN
easat-2814	28	9	:	:	PUNCT
easat-2814	28	10	2576	2576	NUM
easat-2814	28	11	-	-	SYM
easat-2814	28	12	8484	8484	NUM
easat-2814	28	13	vol	vol	NOUN
easat-2814	28	14	.	.	PROPN
easat-2814	29	1	8	8	NUM
easat-2814	29	2	,	,	PUNCT
easat-2814	29	3	no	no	INTJ
easat-2814	29	4	.	.	NOUN
easat-2814	30	1	6	6	NUM
easat-2814	30	2	:	:	SYM
easat-2814	30	3	3722	3722	NUM
easat-2814	30	4	-	-	SYM
easat-2814	30	5	3733	3733	NUM
easat-2814	30	6	,	,	PUNCT
easat-2814	30	7	2024	2024	NUM
easat-2814	30	8	doi	doi	NOUN
easat-2814	30	9	:	:	PUNCT
easat-2814	30	10	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	30	11	©	©	ADP
easat-2814	30	12	2024	2024	NUM
easat-2814	30	13	by	by	ADP
easat-2814	30	14	the	the	DET
easat-2814	30	15	authors	author	NOUN
easat-2814	30	16	;	;	PUNCT
easat-2814	30	17	licensee	licensee	PROPN
easat-2814	30	18	learning	learning	NOUN
easat-2814	30	19	gate	gate	NOUN
easat-2814	30	20	conducted	conduct	VERB
easat-2814	30	21	in	in	ADP
easat-2814	30	22	bali	bali	PROPN
easat-2814	30	23	from	from	ADP
easat-2814	30	24	2005	2005	NUM
easat-2814	30	25	to	to	ADP
easat-2814	30	26	2010	2010	NUM
easat-2814	30	27	reported	report	VERB
easat-2814	30	28	a	a	DET
easat-2814	30	29	dm	dm	NOUN
easat-2814	30	30	prevalence	prevalence	NOUN
easat-2814	30	31	of	of	ADP
easat-2814	30	32	5.9	5.9	NUM
easat-2814	30	33	%	%	NOUN
easat-2814	30	34	,	,	PUNCT
easat-2814	30	35	with	with	SCONJ
easat-2814	30	36	43	43	NUM
easat-2814	30	37	%	%	NOUN
easat-2814	30	38	of	of	ADP
easat-2814	30	39	these	these	DET
easat-2814	30	40	patients	patient	NOUN
easat-2814	30	41	experiencing	experience	VERB
easat-2814	30	42	dr	dr	PROPN
easat-2814	30	43	complications	complication	NOUN
easat-2814	30	44	and	and	CCONJ
easat-2814	30	45	26.3	26.3	NUM
easat-2814	30	46	%	%	NOUN
easat-2814	30	47	developing	develop	VERB
easat-2814	30	48	pdr.[2,3	pdr.[2,3	PROPN
easat-2814	30	49	]	]	PUNCT
easat-2814	30	50	diabetic	diabetic	ADJ
easat-2814	30	51	retinopathy	retinopathy	NOUN
easat-2814	30	52	arises	arise	VERB
easat-2814	30	53	from	from	ADP
easat-2814	30	54	a	a	DET
easat-2814	30	55	multitude	multitude	NOUN
easat-2814	30	56	of	of	ADP
easat-2814	30	57	contributing	contribute	VERB
easat-2814	30	58	factors	factor	NOUN
easat-2814	30	59	,	,	PUNCT
easat-2814	30	60	with	with	ADP
easat-2814	30	61	chronic	chronic	ADJ
easat-2814	30	62	inflammation	inflammation	NOUN
easat-2814	30	63	being	be	AUX
easat-2814	30	64	a	a	DET
easat-2814	30	65	primary	primary	ADJ
easat-2814	30	66	factor	factor	NOUN
easat-2814	30	67	influencing	influence	VERB
easat-2814	30	68	the	the	DET
easat-2814	30	69	onset	onset	NOUN
easat-2814	30	70	of	of	ADP
easat-2814	30	71	diabetes	diabetes	NOUN
easat-2814	30	72	mellitus	mellitus	NOUN
easat-2814	30	73	and	and	CCONJ
easat-2814	30	74	its	its	PRON
easat-2814	30	75	associated	associated	ADJ
easat-2814	30	76	complications	complication	NOUN
easat-2814	30	77	.	.	PUNCT
easat-2814	31	1	diabetic	diabetic	ADJ
easat-2814	31	2	retinopathy	retinopathy	NOUN
easat-2814	31	3	is	be	AUX
easat-2814	31	4	linked	link	VERB
easat-2814	31	5	to	to	ADP
easat-2814	31	6	increased	increase	VERB
easat-2814	31	7	production	production	NOUN
easat-2814	31	8	of	of	ADP
easat-2814	31	9	reactive	reactive	ADJ
easat-2814	31	10	oxygen	oxygen	NOUN
easat-2814	31	11	species	specie	NOUN
easat-2814	31	12	(	(	PUNCT
easat-2814	31	13	ros	ros	PROPN
easat-2814	31	14	)	)	PUNCT
easat-2814	31	15	.	.	PUNCT
easat-2814	32	1	excessive	excessive	ADJ
easat-2814	32	2	accumulation	accumulation	NOUN
easat-2814	32	3	of	of	ADP
easat-2814	32	4	ros	ros	PROPN
easat-2814	32	5	can	can	AUX
easat-2814	32	6	inflict	inflict	VERB
easat-2814	32	7	tissue	tissue	NOUN
easat-2814	32	8	damage	damage	NOUN
easat-2814	32	9	within	within	ADP
easat-2814	32	10	and	and	CCONJ
easat-2814	32	11	around	around	ADP
easat-2814	32	12	retinal	retinal	ADJ
easat-2814	32	13	blood	blood	NOUN
easat-2814	32	14	vessels	vessel	NOUN
easat-2814	32	15	,	,	PUNCT
easat-2814	32	16	as	as	SCONJ
easat-2814	32	17	oxidative	oxidative	ADJ
easat-2814	32	18	stress	stress	NOUN
easat-2814	32	19	disrupts	disrupt	VERB
easat-2814	32	20	the	the	DET
easat-2814	32	21	integrity	integrity	NOUN
easat-2814	32	22	of	of	ADP
easat-2814	32	23	the	the	DET
easat-2814	32	24	blood	blood	NOUN
easat-2814	32	25	-	-	PUNCT
easat-2814	32	26	retina	retina	NOUN
easat-2814	32	27	barrier	barrier	NOUN
easat-2814	32	28	(	(	PUNCT
easat-2814	32	29	brb	brb	PROPN
easat-2814	32	30	)	)	PUNCT
easat-2814	32	31	.	.	PUNCT
easat-2814	33	1	in	in	ADP
easat-2814	33	2	diabetes	diabetes	NOUN
easat-2814	33	3	mellitus	mellitus	NOUN
easat-2814	33	4	(	(	PUNCT
easat-2814	33	5	dm	dm	PROPN
easat-2814	33	6	)	)	PUNCT
easat-2814	33	7	,	,	PUNCT
easat-2814	33	8	oxidative	oxidative	ADJ
easat-2814	33	9	stress	stress	NOUN
easat-2814	33	10	is	be	AUX
easat-2814	33	11	heightened	heighten	VERB
easat-2814	33	12	by	by	ADP
easat-2814	33	13	elevated	elevated	ADJ
easat-2814	33	14	levels	level	NOUN
easat-2814	33	15	of	of	ADP
easat-2814	33	16	free	free	ADJ
easat-2814	33	17	radicals	radical	NOUN
easat-2814	33	18	.	.	PUNCT
easat-2814	34	1	within	within	ADP
easat-2814	34	2	the	the	DET
easat-2814	34	3	vitreoretinal	vitreoretinal	ADJ
easat-2814	34	4	tissue	tissue	NOUN
easat-2814	34	5	,	,	PUNCT
easat-2814	34	6	superoxide	superoxide	NOUN
easat-2814	34	7	dismutase	dismutase	NOUN
easat-2814	34	8	(	(	PUNCT
easat-2814	34	9	sod	sod	NOUN
easat-2814	34	10	)	)	PUNCT
easat-2814	34	11	serves	serve	VERB
easat-2814	34	12	as	as	ADP
easat-2814	34	13	a	a	DET
easat-2814	34	14	crucial	crucial	ADJ
easat-2814	34	15	antioxidant	antioxidant	NOUN
easat-2814	34	16	,	,	PUNCT
easat-2814	34	17	providing	provide	VERB
easat-2814	34	18	essential	essential	ADJ
easat-2814	34	19	protection	protection	NOUN
easat-2814	34	20	against	against	ADP
easat-2814	34	21	the	the	DET
easat-2814	34	22	damaging	damaging	ADJ
easat-2814	34	23	effects	effect	NOUN
easat-2814	34	24	of	of	ADP
easat-2814	34	25	superoxide	superoxide	NOUN
easat-2814	34	26	radicals	radical	NOUN
easat-2814	34	27	.	.	PUNCT
easat-2814	35	1	sod	sod	NOUN
easat-2814	35	2	effectively	effectively	ADV
easat-2814	35	3	shields	shield	VERB
easat-2814	35	4	retinal	retinal	ADJ
easat-2814	35	5	tissues	tissue	NOUN
easat-2814	35	6	from	from	ADP
easat-2814	35	7	oxidative	oxidative	ADJ
easat-2814	35	8	damage	damage	NOUN
easat-2814	35	9	to	to	ADP
easat-2814	35	10	membrane	membrane	NOUN
easat-2814	35	11	phospholipids	phospholipid	NOUN
easat-2814	35	12	caused	cause	VERB
easat-2814	35	13	by	by	ADP
easat-2814	35	14	free	free	ADJ
easat-2814	35	15	radicals	radical	NOUN
easat-2814	35	16	.	.	PUNCT
easat-2814	36	1	[	[	X
easat-2814	36	2	4	4	X
easat-2814	36	3	]	]	PUNCT
easat-2814	36	4	a	a	DET
easat-2814	36	5	study	study	NOUN
easat-2814	36	6	by	by	ADP
easat-2814	36	7	saric	saric	PROPN
easat-2814	36	8	et	et	PROPN
easat-2814	36	9	al	al	PROPN
easat-2814	36	10	.	.	PROPN
easat-2814	36	11	examined	examine	VERB
easat-2814	36	12	oxidative	oxidative	ADJ
easat-2814	36	13	stress	stress	NOUN
easat-2814	36	14	markers	marker	NOUN
easat-2814	36	15	in	in	ADP
easat-2814	36	16	the	the	DET
easat-2814	36	17	vitreous	vitreous	ADJ
easat-2814	36	18	and	and	CCONJ
easat-2814	36	19	blood	blood	NOUN
easat-2814	36	20	serum	serum	NOUN
easat-2814	36	21	of	of	ADP
easat-2814	36	22	patients	patient	NOUN
easat-2814	36	23	with	with	ADP
easat-2814	36	24	diabetic	diabetic	ADJ
easat-2814	36	25	retinopathy	retinopathy	NOUN
easat-2814	36	26	,	,	PUNCT
easat-2814	36	27	revealing	reveal	VERB
easat-2814	36	28	significant	significant	ADJ
easat-2814	36	29	findings	finding	NOUN
easat-2814	36	30	.	.	PUNCT
easat-2814	37	1	in	in	ADP
easat-2814	37	2	the	the	DET
easat-2814	37	3	vitreous	vitreous	NOUN
easat-2814	37	4	of	of	ADP
easat-2814	37	5	patients	patient	NOUN
easat-2814	37	6	with	with	ADP
easat-2814	37	7	proliferative	proliferative	ADJ
easat-2814	37	8	diabetic	diabetic	ADJ
easat-2814	37	9	retinopathy	retinopathy	ADJ
easat-2814	37	10	(	(	PUNCT
easat-2814	37	11	pdr	pdr	NOUN
easat-2814	37	12	)	)	PUNCT
easat-2814	37	13	,	,	PUNCT
easat-2814	37	14	levels	level	NOUN
easat-2814	37	15	of	of	ADP
easat-2814	37	16	vascular	vascular	ADJ
easat-2814	37	17	endothelial	endothelial	ADJ
easat-2814	37	18	growth	growth	NOUN
easat-2814	37	19	factor	factor	NOUN
easat-2814	37	20	(	(	PUNCT
easat-2814	37	21	vegf	vegf	PROPN
easat-2814	37	22	)	)	PUNCT
easat-2814	37	23	,	,	PUNCT
easat-2814	37	24	lipid	lipid	NOUN
easat-2814	37	25	hydroperoxidation	hydroperoxidation	NOUN
easat-2814	37	26	(	(	PUNCT
easat-2814	37	27	lpo	lpo	PROPN
easat-2814	37	28	)	)	PUNCT
easat-2814	37	29	,	,	PUNCT
easat-2814	37	30	and	and	CCONJ
easat-2814	37	31	malondialdehyde	malondialdehyde	NOUN
easat-2814	37	32	(	(	PUNCT
easat-2814	37	33	mda	mda	PROPN
easat-2814	37	34	)	)	PUNCT
easat-2814	37	35	were	be	AUX
easat-2814	37	36	significantly	significantly	ADV
easat-2814	37	37	elevated	elevate	VERB
easat-2814	37	38	(	(	PUNCT
easat-2814	37	39	p<0.05	p<0.05	NOUN
easat-2814	37	40	)	)	PUNCT
easat-2814	37	41	compared	compare	VERB
easat-2814	37	42	to	to	ADP
easat-2814	37	43	non	non	ADJ
easat-2814	37	44	-	-	ADJ
easat-2814	37	45	diabetic	diabetic	ADJ
easat-2814	37	46	individuals	individual	NOUN
easat-2814	37	47	,	,	PUNCT
easat-2814	37	48	while	while	SCONJ
easat-2814	37	49	total	total	ADJ
easat-2814	37	50	sod	sod	NOUN
easat-2814	37	51	levels	level	NOUN
easat-2814	37	52	were	be	AUX
easat-2814	37	53	slightly	slightly	ADV
easat-2814	37	54	reduced	reduce	VERB
easat-2814	37	55	(	(	PUNCT
easat-2814	37	56	p<0.05	p<0.05	NOUN
easat-2814	37	57	)	)	PUNCT
easat-2814	37	58	.	.	PUNCT
easat-2814	38	1	in	in	ADP
easat-2814	38	2	the	the	DET
easat-2814	38	3	blood	blood	NOUN
easat-2814	38	4	serum	serum	NOUN
easat-2814	38	5	of	of	ADP
easat-2814	38	6	pdr	pdr	PROPN
easat-2814	38	7	patients	patient	NOUN
easat-2814	38	8	,	,	PUNCT
easat-2814	38	9	markers	marker	NOUN
easat-2814	38	10	of	of	ADP
easat-2814	38	11	advanced	advanced	ADJ
easat-2814	38	12	oxidation	oxidation	NOUN
easat-2814	38	13	protein	protein	NOUN
easat-2814	38	14	products	product	NOUN
easat-2814	38	15	(	(	PUNCT
easat-2814	38	16	aopp	aopp	PROPN
easat-2814	38	17	)	)	PUNCT
easat-2814	38	18	,	,	PUNCT
easat-2814	38	19	mda	mda	PROPN
easat-2814	38	20	,	,	PUNCT
easat-2814	38	21	and	and	CCONJ
easat-2814	38	22	sod	sod	NOUN
easat-2814	38	23	were	be	AUX
easat-2814	38	24	significantly	significantly	ADV
easat-2814	38	25	elevated	elevate	VERB
easat-2814	38	26	(	(	PUNCT
easat-2814	38	27	p<0.05	p<0.05	NOUN
easat-2814	38	28	)	)	PUNCT
easat-2814	38	29	,	,	PUNCT
easat-2814	38	30	with	with	ADP
easat-2814	38	31	a	a	DET
easat-2814	38	32	modest	modest	ADJ
easat-2814	38	33	increase	increase	NOUN
easat-2814	38	34	in	in	ADP
easat-2814	38	35	vegf	vegf	PROPN
easat-2814	38	36	(	(	PUNCT
easat-2814	38	37	p<0.05	p<0.05	PROPN
easat-2814	38	38	)	)	PUNCT
easat-2814	38	39	when	when	SCONJ
easat-2814	38	40	compared	compare	VERB
easat-2814	38	41	to	to	ADP
easat-2814	38	42	non	non	ADJ
easat-2814	38	43	-	-	ADJ
easat-2814	38	44	diabetic	diabetic	ADJ
easat-2814	38	45	individuals	individual	NOUN
easat-2814	38	46	.	.	PUNCT
easat-2814	39	1	[	[	X
easat-2814	39	2	5	5	NUM
easat-2814	39	3	]	]	SYM
easat-2814	39	4	sod	sod	NOUN
easat-2814	39	5	melon	melon	NOUN
easat-2814	39	6	gliadin	gliadin	NOUN
easat-2814	39	7	(	(	PUNCT
easat-2814	39	8	glisodin	glisodin	NOUN
easat-2814	39	9	®	®	NOUN
easat-2814	39	10	)	)	PUNCT
easat-2814	39	11	is	be	AUX
easat-2814	39	12	a	a	DET
easat-2814	39	13	form	form	NOUN
easat-2814	39	14	of	of	ADP
easat-2814	39	15	exogenous	exogenous	ADJ
easat-2814	39	16	superoxide	superoxide	NOUN
easat-2814	39	17	dismutase	dismutase	NOUN
easat-2814	39	18	(	(	PUNCT
easat-2814	39	19	sod	sod	NOUN
easat-2814	39	20	)	)	PUNCT
easat-2814	39	21	derived	derive	VERB
easat-2814	39	22	from	from	ADP
easat-2814	39	23	melon	melon	NOUN
easat-2814	39	24	(	(	PUNCT
easat-2814	39	25	cucumis	cucumis	PROPN
easat-2814	39	26	melo	melo	PROPN
easat-2814	39	27	sp	sp	PROPN
easat-2814	39	28	.	.	PROPN
easat-2814	39	29	)	)	PUNCT
easat-2814	39	30	.	.	PUNCT
easat-2814	40	1	administering	administer	VERB
easat-2814	40	2	sod	sod	NOUN
easat-2814	40	3	from	from	ADP
easat-2814	40	4	plant	plant	NOUN
easat-2814	40	5	extracts	extract	NOUN
easat-2814	40	6	containing	contain	VERB
easat-2814	40	7	antioxidants	antioxidant	NOUN
easat-2814	40	8	can	can	AUX
easat-2814	40	9	be	be	AUX
easat-2814	40	10	challenging	challenge	VERB
easat-2814	40	11	due	due	ADJ
easat-2814	40	12	to	to	ADP
easat-2814	40	13	the	the	DET
easat-2814	40	14	denaturation	denaturation	NOUN
easat-2814	40	15	of	of	ADP
easat-2814	40	16	antioxidants	antioxidant	NOUN
easat-2814	40	17	,	,	PUNCT
easat-2814	40	18	especially	especially	ADV
easat-2814	40	19	when	when	SCONJ
easat-2814	40	20	taken	take	VERB
easat-2814	40	21	orally	orally	ADV
easat-2814	40	22	.	.	PUNCT
easat-2814	41	1	this	this	DET
easat-2814	41	2	limitation	limitation	NOUN
easat-2814	41	3	can	can	AUX
easat-2814	41	4	be	be	AUX
easat-2814	41	5	overcome	overcome	VERB
easat-2814	41	6	by	by	ADP
easat-2814	41	7	coating	coat	VERB
easat-2814	41	8	sod	sod	NOUN
easat-2814	41	9	with	with	ADP
easat-2814	41	10	lipid	lipid	NOUN
easat-2814	41	11	and	and	CCONJ
easat-2814	41	12	protein	protein	NOUN
easat-2814	41	13	layers	layer	NOUN
easat-2814	41	14	.	.	PUNCT
easat-2814	42	1	the	the	DET
easat-2814	42	2	wheat	wheat	NOUN
easat-2814	42	3	gliadin	gliadin	VERB
easat-2814	42	4	in	in	ADP
easat-2814	42	5	glisodin	glisodin	NOUN
easat-2814	42	6	®	®	NOUN
easat-2814	42	7	is	be	AUX
easat-2814	42	8	particularly	particularly	ADV
easat-2814	42	9	effective	effective	ADJ
easat-2814	42	10	for	for	ADP
easat-2814	42	11	preserving	preserve	VERB
easat-2814	42	12	the	the	DET
easat-2814	42	13	oral	oral	ADJ
easat-2814	42	14	bioavailability	bioavailability	NOUN
easat-2814	42	15	of	of	ADP
easat-2814	42	16	sod	sod	NOUN
easat-2814	42	17	.	.	PUNCT
easat-2814	43	1	this	this	DET
easat-2814	43	2	approach	approach	NOUN
easat-2814	43	3	—	—	PUNCT
easat-2814	43	4	often	often	ADV
easat-2814	43	5	referred	refer	VERB
easat-2814	43	6	to	to	ADP
easat-2814	43	7	as	as	ADP
easat-2814	43	8	protected	protect	VERB
easat-2814	43	9	sod	sod	NOUN
easat-2814	43	10	,	,	PUNCT
easat-2814	43	11	encapsulated	encapsulate	VERB
easat-2814	43	12	sod	sod	NOUN
easat-2814	43	13	,	,	PUNCT
easat-2814	43	14	coated	coated	ADJ
easat-2814	43	15	sod	sod	NOUN
easat-2814	43	16	,	,	PUNCT
easat-2814	43	17	or	or	CCONJ
easat-2814	43	18	bioactive	bioactive	VERB
easat-2814	43	19	sod	sod	NOUN
easat-2814	43	20	—	—	PUNCT
easat-2814	43	21	describes	describe	VERB
easat-2814	43	22	formulations	formulation	NOUN
easat-2814	43	23	of	of	ADP
easat-2814	43	24	sod	sod	NOUN
easat-2814	43	25	-	-	PUNCT
easat-2814	43	26	gliadin	gliadin	NOUN
easat-2814	43	27	designed	design	VERB
easat-2814	43	28	to	to	PART
easat-2814	43	29	resist	resist	VERB
easat-2814	43	30	gastrointestinal	gastrointestinal	ADJ
easat-2814	43	31	degradation.[6,7	degradation.[6,7	NOUN
easat-2814	43	32	]	]	X
easat-2814	43	33	sod	sod	NOUN
easat-2814	43	34	melon	melon	NOUN
easat-2814	43	35	gliadin	gliadin	NOUN
easat-2814	43	36	(	(	PUNCT
easat-2814	43	37	glisodin	glisodin	NOUN
easat-2814	43	38	®	®	NOUN
easat-2814	43	39	)	)	PUNCT
easat-2814	43	40	has	have	AUX
easat-2814	43	41	shown	show	VERB
easat-2814	43	42	potential	potential	NOUN
easat-2814	43	43	as	as	ADP
easat-2814	43	44	an	an	DET
easat-2814	43	45	antioxidant	antioxidant	NOUN
easat-2814	43	46	that	that	PRON
easat-2814	43	47	reduces	reduce	VERB
easat-2814	43	48	ros	ros	PROPN
easat-2814	43	49	levels	level	NOUN
easat-2814	43	50	inhibits	inhibit	VERB
easat-2814	43	51	cell	cell	NOUN
easat-2814	43	52	death	death	NOUN
easat-2814	43	53	,	,	PUNCT
easat-2814	43	54	and	and	CCONJ
easat-2814	43	55	mitigates	mitigate	VERB
easat-2814	43	56	angiogenesis	angiogenesis	NOUN
easat-2814	43	57	,	,	PUNCT
easat-2814	43	58	lipid	lipid	NOUN
easat-2814	43	59	peroxidation	peroxidation	NOUN
easat-2814	43	60	,	,	PUNCT
easat-2814	43	61	and	and	CCONJ
easat-2814	43	62	inflammation	inflammation	NOUN
easat-2814	43	63	.	.	PUNCT
easat-2814	44	1	while	while	SCONJ
easat-2814	44	2	research	research	NOUN
easat-2814	44	3	on	on	ADP
easat-2814	44	4	the	the	DET
easat-2814	44	5	effects	effect	NOUN
easat-2814	44	6	of	of	ADP
easat-2814	44	7	glisodin	glisodin	NOUN
easat-2814	44	8	®	®	NOUN
easat-2814	44	9	on	on	ADP
easat-2814	44	10	diabetic	diabetic	ADJ
easat-2814	44	11	retinopathy	retinopathy	ADJ
easat-2814	44	12	complications	complication	NOUN
easat-2814	44	13	remains	remain	VERB
easat-2814	44	14	limited	limited	ADJ
easat-2814	44	15	in	in	ADP
easat-2814	44	16	ophthalmology	ophthalmology	NOUN
easat-2814	44	17	,	,	PUNCT
easat-2814	44	18	studies	study	NOUN
easat-2814	44	19	involving	involve	VERB
easat-2814	44	20	other	other	ADJ
easat-2814	44	21	sources	source	NOUN
easat-2814	44	22	of	of	ADP
easat-2814	44	23	exogenous	exogenous	ADJ
easat-2814	44	24	sod	sod	NOUN
easat-2814	44	25	have	have	AUX
easat-2814	44	26	been	be	AUX
easat-2814	44	27	conducted	conduct	VERB
easat-2814	44	28	.	.	PUNCT
easat-2814	45	1	administration	administration	NOUN
easat-2814	45	2	of	of	ADP
easat-2814	45	3	sod	sod	NOUN
easat-2814	45	4	melon	melon	NOUN
easat-2814	45	5	gliadin	gliadin	NOUN
easat-2814	45	6	supplements	supplement	NOUN
easat-2814	45	7	in	in	ADP
easat-2814	45	8	hyperglycemic	hyperglycemic	ADJ
easat-2814	45	9	rat	rat	NOUN
easat-2814	45	10	models	model	NOUN
easat-2814	45	11	has	have	AUX
easat-2814	45	12	shown	show	VERB
easat-2814	45	13	promising	promise	VERB
easat-2814	45	14	antioxidant	antioxidant	ADJ
easat-2814	45	15	effects	effect	NOUN
easat-2814	45	16	,	,	PUNCT
easat-2814	45	17	suggesting	suggest	VERB
easat-2814	45	18	it	it	PRON
easat-2814	45	19	may	may	AUX
easat-2814	45	20	protect	protect	VERB
easat-2814	45	21	against	against	ADP
easat-2814	45	22	hyperglycemia	hyperglycemia	NOUN
easat-2814	45	23	-	-	PUNCT
easat-2814	45	24	induced	induce	VERB
easat-2814	45	25	retinal	retinal	ADJ
easat-2814	45	26	complications	complication	NOUN
easat-2814	45	27	,	,	PUNCT
easat-2814	45	28	including	include	VERB
easat-2814	45	29	diabetic	diabetic	ADJ
easat-2814	45	30	retinopathy	retinopathy	NOUN
easat-2814	45	31	,	,	PUNCT
easat-2814	45	32	by	by	ADP
easat-2814	45	33	modulating	modulate	VERB
easat-2814	45	34	vegf	vegf	PROPN
easat-2814	45	35	and	and	CCONJ
easat-2814	45	36	tgf	tgf	PROPN
easat-2814	45	37	-	-	PUNCT
easat-2814	45	38	β	β	PROPN
easat-2814	45	39	levels	level	NOUN
easat-2814	45	40	in	in	ADP
easat-2814	45	41	blood	blood	NOUN
easat-2814	45	42	serum	serum	NOUN
easat-2814	45	43	and	and	CCONJ
easat-2814	45	44	vitreous	vitreous	ADJ
easat-2814	45	45	retina	retina	NOUN
easat-2814	45	46	.	.	PUNCT
easat-2814	46	1	this	this	DET
easat-2814	46	2	research	research	NOUN
easat-2814	46	3	points	point	VERB
easat-2814	46	4	to	to	ADP
easat-2814	46	5	the	the	DET
easat-2814	46	6	potential	potential	ADJ
easat-2814	46	7	future	future	ADJ
easat-2814	46	8	application	application	NOUN
easat-2814	46	9	of	of	ADP
easat-2814	46	10	glisodin	glisodin	NOUN
easat-2814	46	11	®	®	NOUN
easat-2814	46	12	as	as	ADP
easat-2814	46	13	a	a	DET
easat-2814	46	14	therapeutic	therapeutic	ADJ
easat-2814	46	15	antioxidant	antioxidant	NOUN
easat-2814	46	16	for	for	ADP
easat-2814	46	17	ocular	ocular	ADJ
easat-2814	46	18	protection	protection	NOUN
easat-2814	46	19	in	in	ADP
easat-2814	46	20	diabetic	diabetic	ADJ
easat-2814	46	21	patients	patient	NOUN
easat-2814	46	22	.	.	PUNCT
easat-2814	47	1	1.1	1.1	NUM
easat-2814	47	2	.	.	PUNCT
easat-2814	48	1	the	the	DET
easat-2814	48	2	impact	impact	NOUN
easat-2814	48	3	of	of	ADP
easat-2814	48	4	diabetes	diabetes	NOUN
easat-2814	48	5	mellitus	mellitus	NOUN
easat-2814	48	6	on	on	ADP
easat-2814	48	7	the	the	DET
easat-2814	48	8	progression	progression	NOUN
easat-2814	48	9	of	of	ADP
easat-2814	48	10	diabetic	diabetic	ADJ
easat-2814	48	11	retinopathy	retinopathy	ADJ
easat-2814	48	12	diabetic	diabetic	ADJ
easat-2814	48	13	retinopathy	retinopathy	ADJ
easat-2814	48	14	(	(	PUNCT
easat-2814	48	15	dr	dr	PROPN
easat-2814	48	16	)	)	PUNCT
easat-2814	48	17	is	be	AUX
easat-2814	48	18	a	a	DET
easat-2814	48	19	common	common	ADJ
easat-2814	48	20	complication	complication	NOUN
easat-2814	48	21	of	of	ADP
easat-2814	48	22	diabetes	diabetes	NOUN
easat-2814	48	23	mellitus	mellitus	NOUN
easat-2814	48	24	and	and	CCONJ
easat-2814	48	25	a	a	DET
easat-2814	48	26	leading	lead	VERB
easat-2814	48	27	cause	cause	NOUN
easat-2814	48	28	of	of	ADP
easat-2814	48	29	vision	vision	NOUN
easat-2814	48	30	loss	loss	NOUN
easat-2814	48	31	in	in	ADP
easat-2814	48	32	middle	middle	NOUN
easat-2814	48	33	-	-	PUNCT
easat-2814	48	34	aged	aged	ADJ
easat-2814	48	35	and	and	CCONJ
easat-2814	48	36	elderly	elderly	ADJ
easat-2814	48	37	individuals	individual	NOUN
easat-2814	48	38	.	.	PUNCT
easat-2814	49	1	approximately	approximately	ADV
easat-2814	49	2	one	one	NUM
easat-2814	49	3	-	-	PUNCT
easat-2814	49	4	third	third	NOUN
easat-2814	49	5	of	of	ADP
easat-2814	49	6	people	people	NOUN
easat-2814	49	7	with	with	ADP
easat-2814	49	8	diabetes	diabetes	NOUN
easat-2814	49	9	are	be	AUX
easat-2814	49	10	affected	affect	VERB
easat-2814	49	11	by	by	ADP
easat-2814	49	12	dr	dr	PROPN
easat-2814	49	13	.	.	PROPN
easat-2814	50	1	the	the	DET
easat-2814	50	2	severe	severe	ADJ
easat-2814	50	3	stages	stage	NOUN
easat-2814	50	4	of	of	ADP
easat-2814	50	5	dr	dr	PROPN
easat-2814	50	6	include	include	VERB
easat-2814	50	7	proliferative	proliferative	ADJ
easat-2814	50	8	diabetic	diabetic	ADJ
easat-2814	50	9	retinopathy	retinopathy	ADJ
easat-2814	50	10	(	(	PUNCT
easat-2814	50	11	pdr	pdr	PROPN
easat-2814	50	12	)	)	PUNCT
easat-2814	50	13	,	,	PUNCT
easat-2814	50	14	characterized	characterize	VERB
easat-2814	50	15	by	by	ADP
easat-2814	50	16	the	the	DET
easat-2814	50	17	abnormal	abnormal	ADJ
easat-2814	50	18	proliferation	proliferation	NOUN
easat-2814	50	19	of	of	ADP
easat-2814	50	20	new	new	ADJ
easat-2814	50	21	retinal	retinal	ADJ
easat-2814	50	22	blood	blood	NOUN
easat-2814	50	23	vessels	vessel	NOUN
easat-2814	50	24	,	,	PUNCT
easat-2814	50	25	and	and	CCONJ
easat-2814	50	26	diabetic	diabetic	ADJ
easat-2814	50	27	macular	macular	ADJ
easat-2814	50	28	edema	edema	NOUN
easat-2814	50	29	(	(	PUNCT
easat-2814	50	30	dme	dme	PROPN
easat-2814	50	31	)	)	PUNCT
easat-2814	50	32	,	,	PUNCT
easat-2814	50	33	where	where	SCONJ
easat-2814	50	34	fluid	fluid	ADJ
easat-2814	50	35	accumulation	accumulation	NOUN
easat-2814	50	36	and	and	CCONJ
easat-2814	50	37	swelling	swelling	NOUN
easat-2814	50	38	occur	occur	VERB
easat-2814	50	39	in	in	ADP
easat-2814	50	40	the	the	DET
easat-2814	50	41	central	central	ADJ
easat-2814	50	42	retina	retina	NOUN
easat-2814	50	43	.	.	PUNCT
easat-2814	51	1	dr	dr	PROPN
easat-2814	51	2	is	be	AUX
easat-2814	51	3	strongly	strongly	ADV
easat-2814	51	4	associated	associate	VERB
easat-2814	51	5	with	with	ADP
easat-2814	51	6	prolonged	prolonged	ADJ
easat-2814	51	7	diabetes	diabetes	NOUN
easat-2814	51	8	duration	duration	NOUN
easat-2814	51	9	,	,	PUNCT
easat-2814	51	10	hyperglycemia	hyperglycemia	NOUN
easat-2814	51	11	,	,	PUNCT
easat-2814	51	12	and	and	CCONJ
easat-2814	51	13	hypertension	hypertension	NOUN
easat-2814	51	14	.	.	PUNCT
easat-2814	52	1	complex	complex	ADJ
easat-2814	52	2	interrelated	interrelated	ADJ
easat-2814	52	3	pathophysiological	pathophysiological	ADJ
easat-2814	52	4	mechanisms	mechanism	NOUN
easat-2814	52	5	triggered	trigger	VERB
easat-2814	52	6	by	by	ADP
easat-2814	52	7	hyperglycemia	hyperglycemia	NOUN
easat-2814	52	8	underline	underline	NOUN
easat-2814	52	9	the	the	DET
easat-2814	52	10	development	development	NOUN
easat-2814	52	11	of	of	ADP
easat-2814	52	12	dr	dr	PROPN
easat-2814	52	13	.	.	PROPN
easat-2814	53	1	these	these	DET
easat-2814	53	2	mechanisms	mechanism	NOUN
easat-2814	53	3	include	include	VERB
easat-2814	53	4	genetic	genetic	ADJ
easat-2814	53	5	and	and	CCONJ
easat-2814	53	6	epigenetic	epigenetic	ADJ
easat-2814	53	7	factors	factor	NOUN
easat-2814	53	8	,	,	PUNCT
easat-2814	53	9	increased	increase	VERB
easat-2814	53	10	production	production	NOUN
easat-2814	53	11	of	of	ADP
easat-2814	53	12	free	free	ADJ
easat-2814	53	13	radicals	radical	NOUN
easat-2814	53	14	,	,	PUNCT
easat-2814	53	15	advanced	advanced	ADJ
easat-2814	53	16	glycosylation	glycosylation	NOUN
easat-2814	53	17	end	end	NOUN
easat-2814	53	18	products	product	NOUN
easat-2814	53	19	,	,	PUNCT
easat-2814	53	20	inflammatory	inflammatory	ADJ
easat-2814	53	21	factors	factor	NOUN
easat-2814	53	22	,	,	PUNCT
easat-2814	53	23	and	and	CCONJ
easat-2814	53	24	vascular	vascular	VERB
easat-2814	53	25	endothelial	endothelial	ADJ
easat-2814	53	26	growth	growth	NOUN
easat-2814	53	27	factor	factor	NOUN
easat-2814	53	28	(	(	PUNCT
easat-2814	53	29	vegf	vegf	PROPN
easat-2814	53	30	)	)	PUNCT
easat-2814	53	31	.	.	PUNCT
easat-2814	54	1	[	[	X
easat-2814	54	2	8	8	X
easat-2814	54	3	]	]	X
easat-2814	54	4	the	the	DET
easat-2814	54	5	pathogenesis	pathogenesis	NOUN
easat-2814	54	6	of	of	ADP
easat-2814	54	7	dr	dr	PROPN
easat-2814	54	8	involves	involve	VERB
easat-2814	54	9	complex	complex	ADJ
easat-2814	54	10	,	,	PUNCT
easat-2814	54	11	interrelated	interrelated	ADJ
easat-2814	54	12	mechanisms	mechanism	NOUN
easat-2814	54	13	triggered	trigger	VERB
easat-2814	54	14	by	by	ADP
easat-2814	54	15	hyperglycemia	hyperglycemia	NOUN
easat-2814	54	16	,	,	PUNCT
easat-2814	54	17	including	include	VERB
easat-2814	54	18	genetic	genetic	ADJ
easat-2814	54	19	and	and	CCONJ
easat-2814	54	20	epigenetic	epigenetic	ADJ
easat-2814	54	21	factors	factor	NOUN
easat-2814	54	22	,	,	PUNCT
easat-2814	54	23	increased	increase	VERB
easat-2814	54	24	free	free	ADJ
easat-2814	54	25	radical	radical	ADJ
easat-2814	54	26	production	production	NOUN
easat-2814	54	27	,	,	PUNCT
easat-2814	54	28	advanced	advanced	ADJ
easat-2814	54	29	glycation	glycation	NOUN
easat-2814	54	30	end	end	NOUN
easat-2814	54	31	-	-	PUNCT
easat-2814	54	32	products	product	NOUN
easat-2814	54	33	(	(	PUNCT
easat-2814	54	34	ages	age	NOUN
easat-2814	54	35	)	)	PUNCT
easat-2814	54	36	,	,	PUNCT
easat-2814	54	37	inflammatory	inflammatory	ADJ
easat-2814	54	38	mediators	mediator	NOUN
easat-2814	54	39	,	,	PUNCT
easat-2814	54	40	and	and	CCONJ
easat-2814	54	41	elevated	elevated	ADJ
easat-2814	54	42	vascular	vascular	ADJ
easat-2814	54	43	endothelial	endothelial	NOUN
easat-2814	54	44	growth	growth	NOUN
easat-2814	54	45	factor	factor	NOUN
easat-2814	54	46	(	(	PUNCT
easat-2814	54	47	vegf	vegf	NOUN
easat-2814	54	48	)	)	PUNCT
easat-2814	54	49	levels	level	NOUN
easat-2814	54	50	.	.	PUNCT
easat-2814	55	1	hyperglycemia	hyperglycemia	NOUN
easat-2814	55	2	is	be	AUX
easat-2814	55	3	regarded	regard	VERB
easat-2814	55	4	as	as	ADP
easat-2814	55	5	the	the	DET
easat-2814	55	6	primary	primary	ADJ
easat-2814	55	7	precipitating	precipitating	NOUN
easat-2814	55	8	factor	factor	NOUN
easat-2814	55	9	in	in	ADP
easat-2814	55	10	diabetic	diabetic	ADJ
easat-2814	55	11	complications	complication	NOUN
easat-2814	55	12	,	,	PUNCT
easat-2814	55	13	with	with	ADP
easat-2814	55	14	chronic	chronic	ADJ
easat-2814	55	15	hyperglycemia	hyperglycemia	NOUN
easat-2814	55	16	inducing	induce	VERB
easat-2814	55	17	microvascular	microvascular	ADJ
easat-2814	55	18	damage	damage	NOUN
easat-2814	55	19	through	through	ADP
easat-2814	55	20	four	four	NUM
easat-2814	55	21	biochemical	biochemical	ADJ
easat-2814	55	22	pathways	pathway	NOUN
easat-2814	55	23	:	:	PUNCT
easat-2814	55	24	activation	activation	NOUN
easat-2814	55	25	of	of	ADP
easat-2814	55	26	protein	protein	NOUN
easat-2814	55	27	kinase	kinase	PROPN
easat-2814	55	28	c	c	PROPN
easat-2814	55	29	(	(	PUNCT
easat-2814	55	30	pkc	pkc	PROPN
easat-2814	55	31	)	)	PUNCT
easat-2814	55	32	,	,	PUNCT
easat-2814	55	33	the	the	DET
easat-2814	55	34	hexosamine	hexosamine	ADJ
easat-2814	55	35	pathway	pathway	NOUN
easat-2814	55	36	,	,	PUNCT
easat-2814	55	37	the	the	DET
easat-2814	55	38	polyol	polyol	NOUN
easat-2814	55	39	pathway	pathway	NOUN
easat-2814	55	40	,	,	PUNCT
easat-2814	55	41	and	and	CCONJ
easat-2814	55	42	the	the	DET
easat-2814	55	43	accumulation	accumulation	NOUN
easat-2814	55	44	of	of	ADP
easat-2814	55	45	ages	age	NOUN
easat-2814	55	46	.	.	PUNCT
easat-2814	56	1	extensive	extensive	ADJ
easat-2814	56	2	research	research	NOUN
easat-2814	56	3	has	have	AUX
easat-2814	56	4	shed	shed	VERB
easat-2814	56	5	light	light	NOUN
easat-2814	56	6	on	on	ADP
easat-2814	56	7	the	the	DET
easat-2814	56	8	molecular	molecular	ADJ
easat-2814	56	9	pathways	pathway	NOUN
easat-2814	56	10	involved	involve	VERB
easat-2814	56	11	in	in	ADP
easat-2814	56	12	dr	dr	PROPN
easat-2814	56	13	.	.	PROPN
easat-2814	56	14	metabolic	metabolic	PROPN
easat-2814	56	15	alterations	alteration	NOUN
easat-2814	56	16	triggered	trigger	VERB
easat-2814	56	17	by	by	ADP
easat-2814	56	18	hyperglycemia	hyperglycemia	NOUN
easat-2814	56	19	,	,	PUNCT
easat-2814	56	20	such	such	ADJ
easat-2814	56	21	as	as	ADP
easat-2814	56	22	activation	activation	NOUN
easat-2814	56	23	of	of	ADP
easat-2814	56	24	the	the	DET
easat-2814	56	25	polyol	polyol	NOUN
easat-2814	56	26	and	and	CCONJ
easat-2814	56	27	hexosamine	hexosamine	NOUN
easat-2814	56	28	pathways	pathway	NOUN
easat-2814	56	29	,	,	PUNCT
easat-2814	56	30	de	de	X
easat-2814	56	31	novo	novo	NOUN
easat-2814	56	32	synthesis	synthesis	NOUN
easat-2814	56	33	of	of	ADP
easat-2814	56	34	3724	3724	NUM
easat-2814	56	35	edelweiss	edelweiss	PROPN
easat-2814	56	36	applied	apply	VERB
easat-2814	56	37	science	science	NOUN
easat-2814	56	38	and	and	CCONJ
easat-2814	56	39	technology	technology	NOUN
easat-2814	56	40	issn	issn	PROPN
easat-2814	56	41	:	:	PUNCT
easat-2814	56	42	2576	2576	NUM
easat-2814	56	43	-	-	SYM
easat-2814	56	44	8484	8484	NUM
easat-2814	56	45	vol	vol	NOUN
easat-2814	56	46	.	.	PROPN
easat-2814	57	1	8	8	NUM
easat-2814	57	2	,	,	PUNCT
easat-2814	57	3	no	no	INTJ
easat-2814	57	4	.	.	NOUN
easat-2814	58	1	6	6	NUM
easat-2814	58	2	:	:	SYM
easat-2814	58	3	3722	3722	NUM
easat-2814	58	4	-	-	SYM
easat-2814	58	5	3733	3733	NUM
easat-2814	58	6	,	,	PUNCT
easat-2814	58	7	2024	2024	NUM
easat-2814	58	8	doi	doi	NOUN
easat-2814	58	9	:	:	PUNCT
easat-2814	58	10	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	58	11	©	©	ADP
easat-2814	58	12	2024	2024	NUM
easat-2814	58	13	by	by	ADP
easat-2814	58	14	the	the	DET
easat-2814	58	15	authors	author	NOUN
easat-2814	58	16	;	;	PUNCT
easat-2814	58	17	licensee	licensee	PROPN
easat-2814	58	18	learning	learn	VERB
easat-2814	58	19	gate	gate	NOUN
easat-2814	58	20	diacylglycerol	diacylglycerol	NOUN
easat-2814	58	21	via	via	ADP
easat-2814	58	22	pkc	pkc	PROPN
easat-2814	58	23	,	,	PUNCT
easat-2814	58	24	and	and	CCONJ
easat-2814	58	25	the	the	DET
easat-2814	58	26	production	production	NOUN
easat-2814	58	27	of	of	ADP
easat-2814	58	28	free	free	ADJ
easat-2814	58	29	radicals	radical	NOUN
easat-2814	58	30	and	and	CCONJ
easat-2814	58	31	ages	age	NOUN
easat-2814	58	32	,	,	PUNCT
easat-2814	58	33	are	be	AUX
easat-2814	58	34	central	central	ADJ
easat-2814	58	35	to	to	ADP
easat-2814	58	36	dr	dr	PROPN
easat-2814	58	37	progression	progression	NOUN
easat-2814	58	38	.	.	PUNCT
easat-2814	59	1	emerging	emerge	VERB
easat-2814	59	2	evidence	evidence	NOUN
easat-2814	59	3	further	far	ADV
easat-2814	59	4	indicates	indicate	VERB
easat-2814	59	5	that	that	SCONJ
easat-2814	59	6	neurodegeneration	neurodegeneration	NOUN
easat-2814	59	7	,	,	PUNCT
easat-2814	59	8	neuroinflammation	neuroinflammation	NOUN
easat-2814	59	9	,	,	PUNCT
easat-2814	59	10	and	and	CCONJ
easat-2814	59	11	renin	renin	ADJ
easat-2814	59	12	-	-	PUNCT
easat-2814	59	13	angiotensin	angiotensin	NOUN
easat-2814	59	14	system	system	NOUN
easat-2814	59	15	(	(	PUNCT
easat-2814	59	16	ras	ras	NOUN
easat-2814	59	17	)	)	PUNCT
easat-2814	59	18	activation	activation	NOUN
easat-2814	59	19	also	also	ADV
easat-2814	59	20	play	play	VERB
easat-2814	59	21	significant	significant	ADJ
easat-2814	59	22	roles	role	NOUN
easat-2814	59	23	in	in	ADP
easat-2814	59	24	dr	dr	PROPN
easat-2814	59	25	pathogenesis	pathogenesis	PROPN
easat-2814	59	26	.	.	PUNCT
easat-2814	60	1	additionally	additionally	ADV
easat-2814	60	2	,	,	PUNCT
easat-2814	60	3	mitochondrial	mitochondrial	ADJ
easat-2814	60	4	dysfunction	dysfunction	NOUN
easat-2814	60	5	,	,	PUNCT
easat-2814	60	6	oxidative	oxidative	ADJ
easat-2814	60	7	stress	stress	NOUN
easat-2814	60	8	,	,	PUNCT
easat-2814	60	9	and	and	CCONJ
easat-2814	60	10	endoplasmic	endoplasmic	ADJ
easat-2814	60	11	reticulum	reticulum	NOUN
easat-2814	60	12	(	(	PUNCT
easat-2814	60	13	er	er	INTJ
easat-2814	60	14	)	)	PUNCT
easat-2814	60	15	stress	stress	NOUN
easat-2814	60	16	contribute	contribute	VERB
easat-2814	60	17	to	to	ADP
easat-2814	60	18	dr	dr	PROPN
easat-2814	60	19	development	development	PROPN
easat-2814	60	20	,	,	PUNCT
easat-2814	60	21	with	with	ADP
easat-2814	60	22	mitochondrial	mitochondrial	ADJ
easat-2814	60	23	impairment	impairment	NOUN
easat-2814	60	24	and	and	CCONJ
easat-2814	60	25	oxidative	oxidative	ADJ
easat-2814	60	26	stress	stress	NOUN
easat-2814	60	27	being	be	AUX
easat-2814	60	28	key	key	ADJ
easat-2814	60	29	areas	area	NOUN
easat-2814	60	30	of	of	ADP
easat-2814	60	31	focus	focus	NOUN
easat-2814	60	32	in	in	ADP
easat-2814	60	33	recent	recent	ADJ
easat-2814	60	34	reviews	review	NOUN
easat-2814	60	35	on	on	ADP
easat-2814	60	36	dr	dr	PROPN
easat-2814	60	37	pathology	pathology	PROPN
easat-2814	60	38	.	.	PUNCT
easat-2814	61	1	{	{	PUNCT
easat-2814	61	2	9,10	9,10	NUM
easat-2814	61	3	]	]	X
easat-2814	61	4	the	the	DET
easat-2814	61	5	initial	initial	ADJ
easat-2814	61	6	vascular	vascular	ADJ
easat-2814	61	7	changes	change	NOUN
easat-2814	61	8	in	in	ADP
easat-2814	61	9	the	the	DET
easat-2814	61	10	retina	retina	NOUN
easat-2814	61	11	observed	observe	VERB
easat-2814	61	12	in	in	ADP
easat-2814	61	13	histopathology	histopathology	NOUN
easat-2814	61	14	include	include	VERB
easat-2814	61	15	basement	basement	NOUN
easat-2814	61	16	membrane	membrane	NOUN
easat-2814	61	17	thickening	thickening	NOUN
easat-2814	61	18	,	,	PUNCT
easat-2814	61	19	endothelial	endothelial	ADJ
easat-2814	61	20	injury	injury	NOUN
easat-2814	61	21	,	,	PUNCT
easat-2814	61	22	subsequent	subsequent	ADJ
easat-2814	61	23	disruption	disruption	NOUN
easat-2814	61	24	of	of	ADP
easat-2814	61	25	tight	tight	ADJ
easat-2814	61	26	junctions	junction	NOUN
easat-2814	61	27	,	,	PUNCT
easat-2814	61	28	and	and	CCONJ
easat-2814	61	29	pericyte	pericyte	NOUN
easat-2814	61	30	loss	loss	NOUN
easat-2814	61	31	.	.	PUNCT
easat-2814	62	1	the	the	DET
easat-2814	62	2	loss	loss	NOUN
easat-2814	62	3	of	of	ADP
easat-2814	62	4	pericytes	pericyte	NOUN
easat-2814	62	5	leads	lead	VERB
easat-2814	62	6	to	to	ADP
easat-2814	62	7	vascular	vascular	ADJ
easat-2814	62	8	dysregulation	dysregulation	NOUN
easat-2814	62	9	and	and	CCONJ
easat-2814	62	10	unchecked	unchecked	ADJ
easat-2814	62	11	endothelial	endothelial	ADJ
easat-2814	62	12	cell	cell	NOUN
easat-2814	62	13	growth	growth	NOUN
easat-2814	62	14	due	due	ADP
easat-2814	62	15	to	to	ADP
easat-2814	62	16	the	the	DET
easat-2814	62	17	absence	absence	NOUN
easat-2814	62	18	of	of	ADP
easat-2814	62	19	transforming	transform	VERB
easat-2814	62	20	growth	growth	NOUN
easat-2814	62	21	factor	factor	NOUN
easat-2814	62	22	-	-	PUNCT
easat-2814	62	23	β	β	X
easat-2814	62	24	(	(	PUNCT
easat-2814	62	25	tgf	tgf	PROPN
easat-2814	62	26	-	-	PUNCT
easat-2814	62	27	β	β	NOUN
easat-2814	62	28	)	)	PUNCT
easat-2814	62	29	normally	normally	ADV
easat-2814	62	30	produced	produce	VERB
easat-2814	62	31	by	by	ADP
easat-2814	62	32	pericytes	pericyte	NOUN
easat-2814	62	33	.	.	PUNCT
easat-2814	63	1	these	these	DET
easat-2814	63	2	changes	change	NOUN
easat-2814	63	3	contribute	contribute	VERB
easat-2814	63	4	to	to	ADP
easat-2814	63	5	the	the	DET
easat-2814	63	6	development	development	NOUN
easat-2814	63	7	of	of	ADP
easat-2814	63	8	microaneurysms	microaneurysm	NOUN
easat-2814	63	9	and	and	CCONJ
easat-2814	63	10	intraretinal	intraretinal	ADJ
easat-2814	63	11	dot	dot	NOUN
easat-2814	63	12	hemorrhages	hemorrhage	NOUN
easat-2814	63	13	,	,	PUNCT
easat-2814	63	14	two	two	NUM
easat-2814	63	15	of	of	ADP
easat-2814	63	16	the	the	DET
easat-2814	63	17	earliest	early	ADJ
easat-2814	63	18	detectable	detectable	ADJ
easat-2814	63	19	clinical	clinical	ADJ
easat-2814	63	20	abnormalities	abnormality	NOUN
easat-2814	63	21	in	in	ADP
easat-2814	63	22	early	early	ADJ
easat-2814	63	23	non	non	ADJ
easat-2814	63	24	-	-	ADJ
easat-2814	63	25	proliferative	proliferative	ADJ
easat-2814	63	26	diabetic	diabetic	ADJ
easat-2814	63	27	retinopathy	retinopathy	ADJ
easat-2814	63	28	(	(	PUNCT
easat-2814	63	29	npdr	npdr	NOUN
easat-2814	63	30	)	)	PUNCT
easat-2814	63	31	.	.	PUNCT
easat-2814	64	1	basement	basement	NOUN
easat-2814	64	2	membrane	membrane	NOUN
easat-2814	64	3	thickening	thickening	NOUN
easat-2814	64	4	and	and	CCONJ
easat-2814	64	5	tight	tight	ADJ
easat-2814	64	6	junction	junction	NOUN
easat-2814	64	7	disruption	disruption	NOUN
easat-2814	64	8	are	be	AUX
easat-2814	64	9	significant	significant	ADJ
easat-2814	64	10	contributors	contributor	NOUN
easat-2814	64	11	to	to	ADP
easat-2814	64	12	retinal	retinal	ADJ
easat-2814	64	13	capillary	capillary	ADJ
easat-2814	64	14	leakage	leakage	NOUN
easat-2814	64	15	.	.	PUNCT
easat-2814	65	1	although	although	SCONJ
easat-2814	65	2	thickened	thicken	VERB
easat-2814	65	3	,	,	PUNCT
easat-2814	65	4	the	the	DET
easat-2814	65	5	basement	basement	NOUN
easat-2814	65	6	membrane	membrane	NOUN
easat-2814	65	7	becomes	become	VERB
easat-2814	65	8	dysfunctional	dysfunctional	ADJ
easat-2814	65	9	,	,	PUNCT
easat-2814	65	10	allowing	allow	VERB
easat-2814	65	11	the	the	DET
easat-2814	65	12	passage	passage	NOUN
easat-2814	65	13	of	of	ADP
easat-2814	65	14	intravascular	intravascular	ADJ
easat-2814	65	15	contents	content	NOUN
easat-2814	65	16	—	—	PUNCT
easat-2814	65	17	such	such	ADJ
easat-2814	65	18	as	as	ADP
easat-2814	65	19	proteins	protein	NOUN
easat-2814	65	20	,	,	PUNCT
easat-2814	65	21	lipids	lipid	NOUN
easat-2814	65	22	,	,	PUNCT
easat-2814	65	23	inflammatory	inflammatory	ADJ
easat-2814	65	24	mediators	mediator	NOUN
easat-2814	65	25	,	,	PUNCT
easat-2814	65	26	and	and	CCONJ
easat-2814	65	27	other	other	ADJ
easat-2814	65	28	plasma	plasma	NOUN
easat-2814	65	29	components	component	NOUN
easat-2814	65	30	—	—	PUNCT
easat-2814	65	31	into	into	ADP
easat-2814	65	32	the	the	DET
easat-2814	65	33	interstitial	interstitial	ADJ
easat-2814	65	34	space	space	NOUN
easat-2814	65	35	.	.	PUNCT
easat-2814	66	1	vascular	vascular	ADJ
easat-2814	66	2	endothelial	endothelial	ADJ
easat-2814	66	3	growth	growth	NOUN
easat-2814	66	4	factor	factor	NOUN
easat-2814	66	5	(	(	PUNCT
easat-2814	66	6	vegf	vegf	PROPN
easat-2814	66	7	)	)	PUNCT
easat-2814	66	8	and	and	CCONJ
easat-2814	66	9	proinflammatory	proinflammatory	ADJ
easat-2814	66	10	cytokines	cytokine	NOUN
easat-2814	66	11	,	,	PUNCT
easat-2814	66	12	including	include	VERB
easat-2814	66	13	il-1β	il-1β	PROPN
easat-2814	66	14	,	,	PUNCT
easat-2814	66	15	tumor	tumor	NOUN
easat-2814	66	16	necrosis	necrosis	NOUN
easat-2814	66	17	factor	factor	NOUN
easat-2814	66	18	(	(	PUNCT
easat-2814	66	19	tnf	tnf	PROPN
easat-2814	66	20	)	)	PUNCT
easat-2814	66	21	,	,	PUNCT
easat-2814	66	22	il-6	il-6	NOUN
easat-2814	66	23	,	,	PUNCT
easat-2814	66	24	il-8	il-8	NOUN
easat-2814	66	25	,	,	PUNCT
easat-2814	66	26	and	and	CCONJ
easat-2814	66	27	monocyte	monocyte	PROPN
easat-2814	66	28	chemoattractant	chemoattractant	PROPN
easat-2814	66	29	protein-1	protein-1	PROPN
easat-2814	66	30	(	(	PUNCT
easat-2814	66	31	mcp-1	mcp-1	NOUN
easat-2814	66	32	)	)	PUNCT
easat-2814	66	33	,	,	PUNCT
easat-2814	66	34	are	be	AUX
easat-2814	66	35	produced	produce	VERB
easat-2814	66	36	by	by	ADP
easat-2814	66	37	retinal	retinal	ADJ
easat-2814	66	38	glial	glial	ADJ
easat-2814	66	39	cells	cell	NOUN
easat-2814	66	40	(	(	PUNCT
easat-2814	66	41	müller	müller	NOUN
easat-2814	66	42	cells	cell	NOUN
easat-2814	66	43	and	and	CCONJ
easat-2814	66	44	microglia	microglia	NOUN
easat-2814	66	45	)	)	PUNCT
easat-2814	66	46	,	,	PUNCT
easat-2814	66	47	the	the	DET
easat-2814	66	48	retinal	retinal	ADJ
easat-2814	66	49	pigment	pigment	NOUN
easat-2814	66	50	epithelium	epithelium	NOUN
easat-2814	66	51	(	(	PUNCT
easat-2814	66	52	rpe	rpe	PROPN
easat-2814	66	53	)	)	PUNCT
easat-2814	66	54	,	,	PUNCT
easat-2814	66	55	and	and	CCONJ
easat-2814	66	56	macrophages	macrophage	NOUN
easat-2814	66	57	.	.	PUNCT
easat-2814	67	1	these	these	DET
easat-2814	67	2	factors	factor	NOUN
easat-2814	67	3	play	play	VERB
easat-2814	67	4	essential	essential	ADJ
easat-2814	67	5	roles	role	NOUN
easat-2814	67	6	in	in	ADP
easat-2814	67	7	early	early	ADJ
easat-2814	67	8	microvascular	microvascular	ADJ
easat-2814	67	9	impairment	impairment	NOUN
easat-2814	67	10	and	and	CCONJ
easat-2814	67	11	contribute	contribute	VERB
easat-2814	67	12	to	to	ADP
easat-2814	67	13	the	the	DET
easat-2814	67	14	breakdown	breakdown	NOUN
easat-2814	67	15	of	of	ADP
easat-2814	67	16	the	the	DET
easat-2814	67	17	blood	blood	NOUN
easat-2814	67	18	-	-	PUNCT
easat-2814	67	19	retinal	retinal	ADJ
easat-2814	67	20	barrier	barrier	NOUN
easat-2814	67	21	(	(	PUNCT
easat-2814	67	22	brb	brb	PROPN
easat-2814	67	23	)	)	PUNCT
easat-2814	67	24	.	.	PUNCT
easat-2814	68	1	elevated	elevate	VERB
easat-2814	68	2	inflammatory	inflammatory	ADJ
easat-2814	68	3	mediator	mediator	NOUN
easat-2814	68	4	levels	level	NOUN
easat-2814	68	5	induce	induce	VERB
easat-2814	68	6	a	a	DET
easat-2814	68	7	chronic	chronic	ADJ
easat-2814	68	8	inflammatory	inflammatory	ADJ
easat-2814	68	9	state	state	NOUN
easat-2814	68	10	in	in	ADP
easat-2814	68	11	the	the	DET
easat-2814	68	12	diabetic	diabetic	ADJ
easat-2814	68	13	retina	retina	NOUN
easat-2814	68	14	,	,	PUNCT
easat-2814	68	15	leading	lead	VERB
easat-2814	68	16	to	to	ADP
easat-2814	68	17	leukocyte	leukocyte	ADJ
easat-2814	68	18	activation	activation	NOUN
easat-2814	68	19	,	,	PUNCT
easat-2814	68	20	adhesion	adhesion	NOUN
easat-2814	68	21	to	to	PART
easat-2814	68	22	vascular	vascular	VERB
easat-2814	68	23	endothelium	endothelium	NOUN
easat-2814	68	24	(	(	PUNCT
easat-2814	68	25	leukostasis	leukostasis	NOUN
easat-2814	68	26	)	)	PUNCT
easat-2814	68	27	,	,	PUNCT
easat-2814	68	28	and	and	CCONJ
easat-2814	68	29	further	far	ADV
easat-2814	68	30	brb	brb	PROPN
easat-2814	68	31	disruption	disruption	NOUN
easat-2814	68	32	,	,	PUNCT
easat-2814	68	33	resulting	result	VERB
easat-2814	68	34	in	in	ADP
easat-2814	68	35	increased	increase	VERB
easat-2814	68	36	vascular	vascular	ADJ
easat-2814	68	37	permeability	permeability	NOUN
easat-2814	68	38	.	.	PUNCT
easat-2814	69	1	diabetic	diabetic	ADJ
easat-2814	69	2	macular	macular	ADJ
easat-2814	69	3	edema	edema	PROPN
easat-2814	69	4	(	(	PUNCT
easat-2814	69	5	dme	dme	PROPN
easat-2814	69	6	)	)	PUNCT
easat-2814	69	7	,	,	PUNCT
easat-2814	69	8	a	a	DET
easat-2814	69	9	primary	primary	ADJ
easat-2814	69	10	complication	complication	NOUN
easat-2814	69	11	of	of	ADP
easat-2814	69	12	dr	dr	PROPN
easat-2814	69	13	,	,	PUNCT
easat-2814	69	14	is	be	AUX
easat-2814	69	15	driven	drive	VERB
easat-2814	69	16	largely	largely	ADV
easat-2814	69	17	by	by	ADP
easat-2814	69	18	vegf	vegf	NOUN
easat-2814	69	19	and	and	CCONJ
easat-2814	69	20	pro	pro	ADJ
easat-2814	69	21	-	-	ADJ
easat-2814	69	22	inflammatory	inflammatory	ADJ
easat-2814	69	23	cytokines	cytokine	NOUN
easat-2814	69	24	.	.	PUNCT
easat-2814	70	1	local	local	ADJ
easat-2814	70	2	synthesis	synthesis	NOUN
easat-2814	70	3	within	within	ADP
easat-2814	70	4	the	the	DET
easat-2814	70	5	retina	retina	NOUN
easat-2814	70	6	serves	serve	VERB
easat-2814	70	7	as	as	ADP
easat-2814	70	8	the	the	DET
easat-2814	70	9	primary	primary	ADJ
easat-2814	70	10	source	source	NOUN
easat-2814	70	11	of	of	ADP
easat-2814	70	12	these	these	DET
easat-2814	70	13	inflammatory	inflammatory	ADJ
easat-2814	70	14	mediators	mediator	NOUN
easat-2814	70	15	.	.	PUNCT
easat-2814	71	1	the	the	DET
easat-2814	71	2	brb	brb	PROPN
easat-2814	71	3	breakdown	breakdown	NOUN
easat-2814	71	4	and	and	CCONJ
easat-2814	71	5	subsequent	subsequent	ADJ
easat-2814	71	6	vascular	vascular	ADJ
easat-2814	71	7	leakage	leakage	NOUN
easat-2814	71	8	in	in	ADP
easat-2814	71	9	the	the	DET
easat-2814	71	10	macular	macular	ADJ
easat-2814	71	11	area	area	NOUN
easat-2814	71	12	lead	lead	VERB
easat-2814	71	13	to	to	ADP
easat-2814	71	14	dme	dme	PROPN
easat-2814	71	15	,	,	PUNCT
easat-2814	71	16	which	which	PRON
easat-2814	71	17	can	can	AUX
easat-2814	71	18	progress	progress	VERB
easat-2814	71	19	from	from	ADP
easat-2814	71	20	mild	mild	ADJ
easat-2814	71	21	to	to	ADP
easat-2814	71	22	severe	severe	ADJ
easat-2814	71	23	forms	form	NOUN
easat-2814	71	24	.	.	PUNCT
easat-2814	72	1	in	in	ADP
easat-2814	72	2	npdr	npdr	NOUN
easat-2814	72	3	,	,	PUNCT
easat-2814	72	4	vascular	vascular	ADJ
easat-2814	72	5	changes	change	NOUN
easat-2814	72	6	such	such	ADJ
easat-2814	72	7	as	as	ADP
easat-2814	72	8	basement	basement	NOUN
easat-2814	72	9	membrane	membrane	NOUN
easat-2814	72	10	thickening	thickening	NOUN
easat-2814	72	11	,	,	PUNCT
easat-2814	72	12	endothelial	endothelial	ADJ
easat-2814	72	13	injury	injury	NOUN
easat-2814	72	14	with	with	ADP
easat-2814	72	15	tight	tight	ADJ
easat-2814	72	16	junction	junction	NOUN
easat-2814	72	17	disruption	disruption	NOUN
easat-2814	72	18	,	,	PUNCT
easat-2814	72	19	and	and	CCONJ
easat-2814	72	20	pericyte	pericyte	NOUN
easat-2814	72	21	loss	loss	NOUN
easat-2814	72	22	contribute	contribute	VERB
easat-2814	72	23	to	to	ADP
easat-2814	72	24	clinical	clinical	ADJ
easat-2814	72	25	features	feature	NOUN
easat-2814	72	26	,	,	PUNCT
easat-2814	72	27	including	include	VERB
easat-2814	72	28	dot	dot	NOUN
easat-2814	72	29	hemorrhages	hemorrhage	NOUN
easat-2814	72	30	,	,	PUNCT
easat-2814	72	31	microaneurysms	microaneurysm	NOUN
easat-2814	72	32	,	,	PUNCT
easat-2814	72	33	and	and	CCONJ
easat-2814	72	34	hard	hard	ADJ
easat-2814	72	35	exudates	exudate	NOUN
easat-2814	72	36	.	.	PUNCT
easat-2814	73	1	as	as	SCONJ
easat-2814	73	2	dr	dr	PROPN
easat-2814	73	3	progresses	progress	VERB
easat-2814	73	4	to	to	ADP
easat-2814	73	5	the	the	DET
easat-2814	73	6	pre	pre	ADJ
easat-2814	73	7	-	-	ADJ
easat-2814	73	8	proliferative	proliferative	ADJ
easat-2814	73	9	stage	stage	NOUN
easat-2814	73	10	,	,	PUNCT
easat-2814	73	11	endothelial	endothelial	ADJ
easat-2814	73	12	damage	damage	NOUN
easat-2814	73	13	triggers	trigger	NOUN
easat-2814	73	14	vasoconstriction	vasoconstriction	NOUN
easat-2814	73	15	due	due	ADP
easat-2814	73	16	to	to	ADP
easat-2814	73	17	the	the	DET
easat-2814	73	18	release	release	NOUN
easat-2814	73	19	of	of	ADP
easat-2814	73	20	vasoconstrictors	vasoconstrictor	NOUN
easat-2814	73	21	(	(	PUNCT
easat-2814	73	22	e.g.	e.g.	ADV
easat-2814	73	23	,	,	PUNCT
easat-2814	73	24	endothelin-1	endothelin-1	NOUN
easat-2814	73	25	and	and	CCONJ
easat-2814	73	26	thromboxane	thromboxane	NOUN
easat-2814	73	27	a2	a2	PROPN
easat-2814	73	28	)	)	PUNCT
easat-2814	73	29	,	,	PUNCT
easat-2814	73	30	exacerbating	exacerbate	VERB
easat-2814	73	31	hypoxia	hypoxia	NOUN
easat-2814	73	32	due	due	ADP
easat-2814	73	33	to	to	ADP
easat-2814	73	34	capillary	capillary	ADJ
easat-2814	73	35	occlusion	occlusion	NOUN
easat-2814	73	36	.	.	PUNCT
easat-2814	74	1	in	in	ADP
easat-2814	74	2	advanced	advanced	ADJ
easat-2814	74	3	stages	stage	NOUN
easat-2814	74	4	of	of	ADP
easat-2814	74	5	dr	dr	PROPN
easat-2814	74	6	,	,	PUNCT
easat-2814	74	7	severe	severe	ADJ
easat-2814	74	8	hypoxia	hypoxia	NOUN
easat-2814	74	9	promotes	promote	VERB
easat-2814	74	10	neovascularization	neovascularization	NOUN
easat-2814	74	11	.	.	PUNCT
easat-2814	75	1	these	these	DET
easat-2814	75	2	newly	newly	ADV
easat-2814	75	3	formed	form	VERB
easat-2814	75	4	blood	blood	NOUN
easat-2814	75	5	vessels	vessel	NOUN
easat-2814	75	6	often	often	ADV
easat-2814	75	7	extend	extend	VERB
easat-2814	75	8	into	into	ADP
easat-2814	75	9	the	the	DET
easat-2814	75	10	vitreous	vitreous	ADJ
easat-2814	75	11	,	,	PUNCT
easat-2814	75	12	where	where	SCONJ
easat-2814	75	13	they	they	PRON
easat-2814	75	14	are	be	AUX
easat-2814	75	15	prone	prone	ADJ
easat-2814	75	16	to	to	AUX
easat-2814	75	17	rupture	rupture	VERB
easat-2814	75	18	,	,	PUNCT
easat-2814	75	19	increasing	increase	VERB
easat-2814	75	20	the	the	DET
easat-2814	75	21	risk	risk	NOUN
easat-2814	75	22	of	of	ADP
easat-2814	75	23	severe	severe	ADJ
easat-2814	75	24	visual	visual	ADJ
easat-2814	75	25	impairment.[8	impairment.[8	NOUN
easat-2814	75	26	]	]	X
easat-2814	75	27	.	.	PUNCT
easat-2814	76	1	3725	3725	NUM
easat-2814	76	2	edelweiss	edelweiss	PROPN
easat-2814	76	3	applied	apply	VERB
easat-2814	76	4	science	science	NOUN
easat-2814	76	5	and	and	CCONJ
easat-2814	76	6	technology	technology	NOUN
easat-2814	76	7	issn	issn	PROPN
easat-2814	76	8	:	:	PUNCT
easat-2814	76	9	2576	2576	NUM
easat-2814	76	10	-	-	SYM
easat-2814	76	11	8484	8484	NUM
easat-2814	76	12	vol	vol	NOUN
easat-2814	76	13	.	.	PROPN
easat-2814	76	14	8	8	NUM
easat-2814	76	15	,	,	PUNCT
easat-2814	76	16	no	no	INTJ
easat-2814	76	17	.	.	NOUN
easat-2814	77	1	6	6	NUM
easat-2814	77	2	:	:	SYM
easat-2814	77	3	3722	3722	NUM
easat-2814	77	4	-	-	SYM
easat-2814	77	5	3733	3733	NUM
easat-2814	77	6	,	,	PUNCT
easat-2814	77	7	2024	2024	NUM
easat-2814	77	8	doi	doi	NOUN
easat-2814	77	9	:	:	PUNCT
easat-2814	77	10	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	77	11	©	©	ADP
easat-2814	77	12	2024	2024	NUM
easat-2814	77	13	by	by	ADP
easat-2814	77	14	the	the	DET
easat-2814	77	15	authors	author	NOUN
easat-2814	77	16	;	;	PUNCT
easat-2814	77	17	licensee	licensee	PROPN
easat-2814	77	18	learning	learn	VERB
easat-2814	77	19	gate	gate	NOUN
easat-2814	77	20	figure	figure	NOUN
easat-2814	77	21	1	1	NUM
easat-2814	77	22	.	.	PUNCT
easat-2814	77	23	main	main	ADJ
easat-2814	77	24	pathogenic	pathogenic	ADJ
easat-2814	77	25	mechanisms	mechanism	NOUN
easat-2814	77	26	in	in	ADP
easat-2814	77	27	the	the	DET
easat-2814	77	28	development	development	NOUN
easat-2814	77	29	of	of	ADP
easat-2814	77	30	diabetic	diabetic	ADJ
easat-2814	77	31	retinopathy	retinopathy	NOUN
easat-2814	78	1	[	[	X
easat-2814	78	2	8	8	NUM
easat-2814	78	3	]	]	X
easat-2814	78	4	.	.	PUNCT
easat-2814	79	1	3726	3726	NUM
easat-2814	79	2	edelweiss	edelweiss	PROPN
easat-2814	79	3	applied	apply	VERB
easat-2814	79	4	science	science	NOUN
easat-2814	79	5	and	and	CCONJ
easat-2814	79	6	technology	technology	NOUN
easat-2814	79	7	issn	issn	PROPN
easat-2814	79	8	:	:	PUNCT
easat-2814	79	9	2576	2576	NUM
easat-2814	79	10	-	-	SYM
easat-2814	79	11	8484	8484	NUM
easat-2814	79	12	vol	vol	NOUN
easat-2814	79	13	.	.	PROPN
easat-2814	79	14	8	8	NUM
easat-2814	79	15	,	,	PUNCT
easat-2814	79	16	no	no	INTJ
easat-2814	79	17	.	.	NOUN
easat-2814	80	1	6	6	NUM
easat-2814	80	2	:	:	SYM
easat-2814	80	3	3722	3722	NUM
easat-2814	80	4	-	-	SYM
easat-2814	80	5	3733	3733	NUM
easat-2814	80	6	,	,	PUNCT
easat-2814	80	7	2024	2024	NUM
easat-2814	80	8	doi	doi	NOUN
easat-2814	80	9	:	:	PUNCT
easat-2814	80	10	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	80	11	©	©	ADP
easat-2814	80	12	2024	2024	NUM
easat-2814	80	13	by	by	ADP
easat-2814	80	14	the	the	DET
easat-2814	80	15	authors	author	NOUN
easat-2814	80	16	;	;	PUNCT
easat-2814	80	17	licensee	licensee	PROPN
easat-2814	80	18	learning	learn	VERB
easat-2814	80	19	gate	gate	NOUN
easat-2814	80	20	figure	figure	NOUN
easat-2814	80	21	2	2	NUM
easat-2814	80	22	.	.	PUNCT
easat-2814	80	23	potential	potential	ADJ
easat-2814	80	24	mechanisms	mechanism	NOUN
easat-2814	80	25	linking	link	VERB
easat-2814	80	26	neurodegeneration	neurodegeneration	NOUN
easat-2814	80	27	and	and	CCONJ
easat-2814	80	28	microangiopathy	microangiopathy	ADJ
easat-2814	80	29	in	in	ADP
easat-2814	80	30	diabetic	diabetic	ADJ
easat-2814	80	31	retinopathy	retinopathy	NOUN
easat-2814	81	1	[	[	X
easat-2814	81	2	8	8	NUM
easat-2814	81	3	]	]	PUNCT
easat-2814	81	4	.	.	PUNCT
easat-2814	82	1	the	the	DET
easat-2814	82	2	accumulation	accumulation	NOUN
easat-2814	82	3	of	of	ADP
easat-2814	82	4	glutamate	glutamate	NOUN
easat-2814	82	5	in	in	ADP
easat-2814	82	6	the	the	DET
easat-2814	82	7	extracellular	extracellular	ADJ
easat-2814	82	8	space	space	NOUN
easat-2814	82	9	,	,	PUNCT
easat-2814	82	10	specifically	specifically	ADV
easat-2814	82	11	within	within	ADP
easat-2814	82	12	the	the	DET
easat-2814	82	13	inter	inter	ADJ
easat-2814	82	14	-	-	ADJ
easat-2814	82	15	synaptic	synaptic	ADJ
easat-2814	82	16	cleft	cleft	NOUN
easat-2814	82	17	of	of	ADP
easat-2814	82	18	retinal	retinal	ADJ
easat-2814	82	19	neurons	neuron	NOUN
easat-2814	82	20	—	—	PUNCT
easat-2814	82	21	along	along	ADP
easat-2814	82	22	with	with	ADP
easat-2814	82	23	a	a	DET
easat-2814	82	24	reduction	reduction	NOUN
easat-2814	82	25	in	in	ADP
easat-2814	82	26	the	the	DET
easat-2814	82	27	production	production	NOUN
easat-2814	82	28	of	of	ADP
easat-2814	82	29	neuroprotective	neuroprotective	ADJ
easat-2814	82	30	factors	factor	NOUN
easat-2814	82	31	,	,	PUNCT
easat-2814	82	32	are	be	AUX
easat-2814	82	33	critical	critical	ADJ
easat-2814	82	34	events	event	NOUN
easat-2814	82	35	leading	lead	VERB
easat-2814	82	36	to	to	ADP
easat-2814	82	37	neuronal	neuronal	ADJ
easat-2814	82	38	apoptosis	apoptosis	NOUN
easat-2814	82	39	and	and	CCONJ
easat-2814	82	40	glial	glial	ADJ
easat-2814	82	41	dysfunction	dysfunction	NOUN
easat-2814	82	42	.	.	PUNCT
easat-2814	83	1	this	this	DET
easat-2814	83	2	process	process	NOUN
easat-2814	83	3	also	also	ADV
easat-2814	83	4	triggers	trigger	VERB
easat-2814	83	5	the	the	DET
easat-2814	83	6	overexpression	overexpression	NOUN
easat-2814	83	7	of	of	ADP
easat-2814	83	8	vascular	vascular	ADJ
easat-2814	83	9	endothelial	endothelial	ADJ
easat-2814	83	10	growth	growth	NOUN
easat-2814	83	11	factor	factor	NOUN
easat-2814	83	12	(	(	PUNCT
easat-2814	83	13	vegf	vegf	PROPN
easat-2814	83	14	)	)	PUNCT
easat-2814	83	15	,	,	PUNCT
easat-2814	83	16	which	which	PRON
easat-2814	83	17	plays	play	VERB
easat-2814	83	18	role	role	NOUN
easat-2814	83	19	in	in	ADP
easat-2814	83	20	the	the	DET
easat-2814	83	21	disruption	disruption	NOUN
easat-2814	83	22	of	of	ADP
easat-2814	83	23	the	the	DET
easat-2814	83	24	blood	blood	NOUN
easat-2814	83	25	-	-	PUNCT
easat-2814	83	26	retinal	retinal	ADJ
easat-2814	83	27	barrier	barrier	NOUN
easat-2814	83	28	(	(	PUNCT
easat-2814	83	29	brb).in	brb).in	VERB
easat-2814	83	30	addition	addition	NOUN
easat-2814	83	31	to	to	ADP
easat-2814	83	32	vegf	vegf	PROPN
easat-2814	83	33	and	and	CCONJ
easat-2814	83	34	other	other	ADJ
easat-2814	83	35	vasoactive	vasoactive	ADJ
easat-2814	83	36	agents	agent	NOUN
easat-2814	83	37	,	,	PUNCT
easat-2814	83	38	several	several	ADJ
easat-2814	83	39	factors	factor	NOUN
easat-2814	83	40	link	link	VERB
easat-2814	83	41	neurodegeneration	neurodegeneration	NOUN
easat-2814	83	42	with	with	ADP
easat-2814	83	43	early	early	ADJ
easat-2814	83	44	microvascular	microvascular	ADJ
easat-2814	83	45	impairment	impairment	NOUN
easat-2814	83	46	.	.	PUNCT
easat-2814	84	1	these	these	PRON
easat-2814	84	2	include	include	VERB
easat-2814	84	3	the	the	DET
easat-2814	84	4	upregulation	upregulation	NOUN
easat-2814	84	5	of	of	ADP
easat-2814	84	6	inflammatory	inflammatory	ADJ
easat-2814	84	7	mediators	mediator	NOUN
easat-2814	84	8	,	,	PUNCT
easat-2814	84	9	increased	increase	VERB
easat-2814	84	10	expression	expression	NOUN
easat-2814	84	11	of	of	ADP
easat-2814	84	12	receptors	receptor	NOUN
easat-2814	84	13	for	for	ADP
easat-2814	84	14	advanced	advanced	ADJ
easat-2814	84	15	glycation	glycation	NOUN
easat-2814	84	16	end	end	NOUN
easat-2814	84	17	products	product	NOUN
easat-2814	84	18	(	(	PUNCT
easat-2814	84	19	rage	rage	NOUN
easat-2814	84	20	)	)	PUNCT
easat-2814	84	21	,	,	PUNCT
easat-2814	84	22	and	and	CCONJ
easat-2814	84	23	activation	activation	NOUN
easat-2814	84	24	of	of	ADP
easat-2814	84	25	the	the	DET
easat-2814	84	26	renin	renin	ADJ
easat-2814	84	27	-	-	PUNCT
easat-2814	84	28	angiotensin	angiotensin	NOUN
easat-2814	84	29	system	system	NOUN
easat-2814	84	30	(	(	PUNCT
easat-2814	84	31	ras	ras	NOUN
easat-2814	84	32	)	)	PUNCT
easat-2814	84	33	.	.	PUNCT
easat-2814	85	1	furthermore	furthermore	ADV
easat-2814	85	2	,	,	PUNCT
easat-2814	85	3	heightened	heighten	VERB
easat-2814	85	4	intraretinal	intraretinal	ADJ
easat-2814	85	5	production	production	NOUN
easat-2814	85	6	of	of	ADP
easat-2814	85	7	endothelin-1	endothelin-1	PROPN
easat-2814	85	8	(	(	PUNCT
easat-2814	85	9	et-1	et-1	X
easat-2814	85	10	)	)	PUNCT
easat-2814	85	11	has	have	AUX
easat-2814	85	12	been	be	AUX
easat-2814	85	13	shown	show	VERB
easat-2814	85	14	to	to	PART
easat-2814	85	15	induce	induce	VERB
easat-2814	85	16	retinal	retinal	ADJ
easat-2814	85	17	neurodegeneration	neurodegeneration	NOUN
easat-2814	85	18	,	,	PUNCT
easat-2814	85	19	thereby	thereby	ADV
easat-2814	85	20	facilitating	facilitate	VERB
easat-2814	85	21	crosstalk	crosstalk	NOUN
easat-2814	85	22	between	between	ADP
easat-2814	85	23	endothelial	endothelial	ADJ
easat-2814	85	24	cells	cell	NOUN
easat-2814	85	25	and	and	CCONJ
easat-2814	85	26	the	the	DET
easat-2814	85	27	neuroretina	neuroretina	NOUN
easat-2814	85	28	.	.	PUNCT
easat-2814	86	1	[	[	X
easat-2814	86	2	8	8	NUM
easat-2814	86	3	]	]	SYM
easat-2814	86	4	1.2	1.2	NUM
easat-2814	86	5	.	.	PUNCT
easat-2814	87	1	the	the	DET
easat-2814	87	2	role	role	NOUN
easat-2814	87	3	of	of	ADP
easat-2814	87	4	diabetes	diabetes	NOUN
easat-2814	87	5	mellitus	mellitus	NOUN
easat-2814	87	6	in	in	ADP
easat-2814	87	7	inducing	induce	VERB
easat-2814	87	8	reactive	reactive	ADJ
easat-2814	87	9	oxygen	oxygen	NOUN
easat-2814	87	10	species	specie	NOUN
easat-2814	87	11	(	(	PUNCT
easat-2814	87	12	ros	ros	PROPN
easat-2814	87	13	)	)	PUNCT
easat-2814	87	14	and	and	CCONJ
easat-2814	87	15	their	their	PRON
easat-2814	87	16	impact	impact	NOUN
easat-2814	87	17	on	on	ADP
easat-2814	87	18	vascular	vascular	ADJ
easat-2814	87	19	endothelial	endothelial	ADJ
easat-2814	87	20	growth	growth	NOUN
easat-2814	87	21	factor	factor	NOUN
easat-2814	87	22	(	(	PUNCT
easat-2814	87	23	vegf	vegf	PROPN
easat-2814	87	24	)	)	PUNCT
easat-2814	87	25	and	and	CCONJ
easat-2814	87	26	transforming	transform	VERB
easat-2814	87	27	growth	growth	NOUN
easat-2814	87	28	factor	factor	NOUN
easat-2814	87	29	beta	beta	NOUN
easat-2814	87	30	(	(	PUNCT
easat-2814	87	31	tgf	tgf	PROPN
easat-2814	87	32	-	-	PUNCT
easat-2814	87	33	β	β	NOUN
easat-2814	87	34	)	)	PUNCT
easat-2814	87	35	chronic	chronic	ADJ
easat-2814	87	36	hyperglycemia	hyperglycemia	NOUN
easat-2814	87	37	leads	lead	VERB
easat-2814	87	38	to	to	ADP
easat-2814	87	39	microvascular	microvascular	ADJ
easat-2814	87	40	damage	damage	NOUN
easat-2814	87	41	through	through	ADP
easat-2814	87	42	four	four	NUM
easat-2814	87	43	primary	primary	ADJ
easat-2814	87	44	biochemical	biochemical	ADJ
easat-2814	87	45	mechanisms	mechanism	NOUN
easat-2814	87	46	:	:	PUNCT
easat-2814	87	47	the	the	DET
easat-2814	87	48	polyol	polyol	NOUN
easat-2814	87	49	pathway	pathway	NOUN
easat-2814	87	50	,	,	PUNCT
easat-2814	87	51	the	the	DET
easat-2814	87	52	protein	protein	NOUN
easat-2814	87	53	kinase	kinase	NOUN
easat-2814	87	54	c	c	PROPN
easat-2814	87	55	(	(	PUNCT
easat-2814	87	56	pkc	pkc	NOUN
easat-2814	87	57	)	)	PUNCT
easat-2814	87	58	pathway	pathway	NOUN
easat-2814	87	59	,	,	PUNCT
easat-2814	87	60	the	the	DET
easat-2814	87	61	accumulation	accumulation	NOUN
easat-2814	87	62	of	of	ADP
easat-2814	87	63	advanced	advanced	ADJ
easat-2814	87	64	glycation	glycation	NOUN
easat-2814	87	65	end	end	NOUN
easat-2814	87	66	-	-	PUNCT
easat-2814	87	67	products	product	NOUN
easat-2814	87	68	(	(	PUNCT
easat-2814	87	69	ages	age	NOUN
easat-2814	87	70	)	)	PUNCT
easat-2814	87	71	,	,	PUNCT
easat-2814	87	72	and	and	CCONJ
easat-2814	87	73	the	the	DET
easat-2814	87	74	activation	activation	NOUN
easat-2814	87	75	of	of	ADP
easat-2814	87	76	the	the	DET
easat-2814	87	77	hexosamine	hexosamine	ADJ
easat-2814	87	78	pathway	pathway	NOUN
easat-2814	87	79	.	.	PUNCT
easat-2814	88	1	hyperglycemia	hyperglycemia	NOUN
easat-2814	88	2	induced	induce	VERB
easat-2814	88	3	by	by	ADP
easat-2814	88	4	these	these	DET
easat-2814	88	5	mechanisms	mechanism	NOUN
easat-2814	88	6	can	can	AUX
easat-2814	88	7	stimulate	stimulate	VERB
easat-2814	88	8	the	the	DET
easat-2814	88	9	production	production	NOUN
easat-2814	88	10	of	of	ADP
easat-2814	88	11	reactive	reactive	ADJ
easat-2814	88	12	oxygen	oxygen	NOUN
easat-2814	88	13	species	specie	NOUN
easat-2814	88	14	(	(	PUNCT
easat-2814	88	15	ros	ros	PROPN
easat-2814	88	16	)	)	PUNCT
easat-2814	88	17	,	,	PUNCT
easat-2814	88	18	and	and	CCONJ
easat-2814	88	19	excessive	excessive	ADJ
easat-2814	88	20	accumulation	accumulation	NOUN
easat-2814	88	21	of	of	ADP
easat-2814	88	22	ros	ros	PROPN
easat-2814	88	23	can	can	AUX
easat-2814	88	24	cause	cause	VERB
easat-2814	88	25	significant	significant	ADJ
easat-2814	88	26	damage	damage	NOUN
easat-2814	88	27	to	to	ADP
easat-2814	88	28	tissues	tissue	NOUN
easat-2814	88	29	surrounding	surround	VERB
easat-2814	88	30	retinal	retinal	ADJ
easat-2814	88	31	vessels	vessel	NOUN
easat-2814	88	32	.	.	PUNCT
easat-2814	89	1	this	this	DET
easat-2814	89	2	oxidative	oxidative	ADJ
easat-2814	89	3	stress	stress	NOUN
easat-2814	89	4	negatively	negatively	ADV
easat-2814	89	5	impacts	impact	VERB
easat-2814	89	6	the	the	DET
easat-2814	89	7	blood	blood	NOUN
easat-2814	89	8	-	-	PUNCT
easat-2814	89	9	retinal	retinal	ADJ
easat-2814	89	10	barrier	barrier	NOUN
easat-2814	89	11	(	(	PUNCT
easat-2814	89	12	brb	brb	PROPN
easat-2814	89	13	)	)	PUNCT
easat-2814	89	14	.	.	PUNCT
easat-2814	90	1	vascular	vascular	ADJ
easat-2814	90	2	endothelial	endothelial	ADJ
easat-2814	90	3	growth	growth	NOUN
easat-2814	90	4	factor	factor	NOUN
easat-2814	90	5	(	(	PUNCT
easat-2814	90	6	vegf	vegf	PROPN
easat-2814	90	7	)	)	PUNCT
easat-2814	90	8	and	and	CCONJ
easat-2814	90	9	transforming	transform	VERB
easat-2814	90	10	growth	growth	NOUN
easat-2814	90	11	factor	factor	NOUN
easat-2814	90	12	beta	beta	NOUN
easat-2814	90	13	(	(	PUNCT
easat-2814	90	14	tgf	tgf	PROPN
easat-2814	90	15	-	-	PUNCT
easat-2814	90	16	β	β	NOUN
easat-2814	90	17	)	)	PUNCT
easat-2814	90	18	serve	serve	VERB
easat-2814	90	19	as	as	ADP
easat-2814	90	20	important	important	ADJ
easat-2814	90	21	biomarkers	biomarker	NOUN
easat-2814	90	22	for	for	ADP
easat-2814	90	23	retinal	retinal	ADJ
easat-2814	90	24	disorders	disorder	NOUN
easat-2814	90	25	.	.	PUNCT
easat-2814	91	1	the	the	DET
easat-2814	91	2	accumulation	accumulation	NOUN
easat-2814	91	3	of	of	ADP
easat-2814	91	4	ros	ros	PROPN
easat-2814	91	5	and	and	CCONJ
easat-2814	91	6	elevated	elevated	ADJ
easat-2814	91	7	vegf	vegf	PROPN
easat-2814	91	8	levels	level	NOUN
easat-2814	91	9	within	within	ADP
easat-2814	91	10	the	the	DET
easat-2814	91	11	eye	eye	NOUN
easat-2814	91	12	play	play	VERB
easat-2814	91	13	critical	critical	ADJ
easat-2814	91	14	roles	role	NOUN
easat-2814	91	15	in	in	ADP
easat-2814	91	16	the	the	DET
easat-2814	91	17	disruption	disruption	NOUN
easat-2814	91	18	of	of	ADP
easat-2814	91	19	the	the	DET
easat-2814	91	20	brb	brb	PROPN
easat-2814	91	21	,	,	PUNCT
easat-2814	91	22	while	while	SCONJ
easat-2814	91	23	tgf	tgf	PROPN
easat-2814	91	24	-	-	PUNCT
easat-2814	91	25	β	β	PROPN
easat-2814	91	26	is	be	AUX
easat-2814	91	27	essential	essential	ADJ
easat-2814	91	28	for	for	ADP
easat-2814	91	29	maintaining	maintain	VERB
easat-2814	91	30	ocular	ocular	ADJ
easat-2814	91	31	homeostasis	homeostasis	NOUN
easat-2814	91	32	.	.	PUNCT
easat-2814	92	1	research	research	NOUN
easat-2814	92	2	by	by	ADP
easat-2814	92	3	panahi	panahi	PROPN
easat-2814	92	4	et	et	PROPN
easat-2814	92	5	al	al	PROPN
easat-2814	92	6	.	.	PROPN
easat-2814	92	7	demonstrated	demonstrate	VERB
easat-2814	92	8	a	a	DET
easat-2814	92	9	correlation	correlation	NOUN
easat-2814	92	10	between	between	ADP
easat-2814	92	11	vitreous	vitreous	ADJ
easat-2814	92	12	and	and	CCONJ
easat-2814	92	13	serum	serum	PROPN
easat-2814	92	14	vegf	vegf	PROPN
easat-2814	92	15	levels	level	NOUN
easat-2814	92	16	in	in	ADP
easat-2814	92	17	patients	patient	NOUN
easat-2814	92	18	with	with	ADP
easat-2814	92	19	proliferative	proliferative	ADJ
easat-2814	92	20	diabetic	diabetic	ADJ
easat-2814	92	21	retinopathy	retinopathy	ADJ
easat-2814	92	22	(	(	PUNCT
easat-2814	92	23	pdr	pdr	NOUN
easat-2814	92	24	)	)	PUNCT
easat-2814	92	25	.	.	PUNCT
easat-2814	93	1	they	they	PRON
easat-2814	93	2	found	find	VERB
easat-2814	93	3	that	that	SCONJ
easat-2814	93	4	serum	serum	NOUN
easat-2814	93	5	and	and	CCONJ
easat-2814	93	6	vitreous	vitreous	ADJ
easat-2814	93	7	vegf	vegf	NOUN
easat-2814	93	8	levels	level	NOUN
easat-2814	93	9	were	be	AUX
easat-2814	93	10	significantly	significantly	ADV
easat-2814	93	11	lower	low	ADJ
easat-2814	93	12	in	in	ADP
easat-2814	93	13	patients	patient	NOUN
easat-2814	93	14	receiving	receive	VERB
easat-2814	93	15	oral	oral	ADJ
easat-2814	93	16	diabetes	diabetes	NOUN
easat-2814	93	17	therapy	therapy	NOUN
easat-2814	93	18	,	,	PUNCT
easat-2814	93	19	those	those	PRON
easat-2814	93	20	with	with	ADP
easat-2814	93	21	well	well	ADV
easat-2814	93	22	-	-	PUNCT
easat-2814	93	23	controlled	control	VERB
easat-2814	93	24	glycemia	glycemia	NOUN
easat-2814	93	25	,	,	PUNCT
easat-2814	93	26	and	and	CCONJ
easat-2814	93	27	early	early	ADJ
easat-2814	93	28	-	-	PUNCT
easat-2814	93	29	stage	stage	NOUN
easat-2814	93	30	retinopathy	retinopathy	ADJ
easat-2814	93	31	patients	patient	NOUN
easat-2814	93	32	.	.	PUNCT
easat-2814	94	1	additionally	additionally	ADV
easat-2814	94	2	,	,	PUNCT
easat-2814	94	3	bonfiglio	bonfiglio	PROPN
easat-2814	94	4	et	et	PROPN
easat-2814	94	5	al	al	PROPN
easat-2814	94	6	.	.	PROPN
easat-2814	94	7	investigated	investigate	VERB
easat-2814	94	8	serum	serum	PROPN
easat-2814	94	9	tgf	tgf	PROPN
easat-2814	94	10	-	-	PUNCT
easat-2814	94	11	β	β	PROPN
easat-2814	94	12	levels	level	NOUN
easat-2814	94	13	in	in	ADP
easat-2814	94	14	individuals	individual	NOUN
easat-2814	94	15	with	with	ADP
easat-2814	94	16	3727	3727	NUM
easat-2814	94	17	edelweiss	edelweiss	PROPN
easat-2814	94	18	applied	apply	VERB
easat-2814	94	19	science	science	NOUN
easat-2814	94	20	and	and	CCONJ
easat-2814	94	21	technology	technology	NOUN
easat-2814	94	22	issn	issn	PROPN
easat-2814	94	23	:	:	PUNCT
easat-2814	94	24	2576	2576	NUM
easat-2814	94	25	-	-	SYM
easat-2814	94	26	8484	8484	NUM
easat-2814	94	27	vol	vol	NOUN
easat-2814	94	28	.	.	PROPN
easat-2814	94	29	8	8	NUM
easat-2814	94	30	,	,	PUNCT
easat-2814	94	31	no	no	INTJ
easat-2814	94	32	.	.	NOUN
easat-2814	94	33	6	6	NUM
easat-2814	94	34	:	:	SYM
easat-2814	94	35	3722	3722	NUM
easat-2814	94	36	-	-	SYM
easat-2814	94	37	3733	3733	NUM
easat-2814	94	38	,	,	PUNCT
easat-2814	94	39	2024	2024	NUM
easat-2814	94	40	doi	doi	NOUN
easat-2814	94	41	:	:	PUNCT
easat-2814	94	42	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	94	43	©	©	ADP
easat-2814	94	44	2024	2024	NUM
easat-2814	94	45	by	by	ADP
easat-2814	94	46	the	the	DET
easat-2814	94	47	authors	author	NOUN
easat-2814	94	48	;	;	PUNCT
easat-2814	94	49	licensee	licensee	PROPN
easat-2814	94	50	learning	learn	VERB
easat-2814	94	51	gate	gate	PROPN
easat-2814	94	52	pdr	pdr	PROPN
easat-2814	94	53	,	,	PUNCT
easat-2814	94	54	identifying	identify	VERB
easat-2814	94	55	serum	serum	PROPN
easat-2814	94	56	tgf	tgf	PROPN
easat-2814	94	57	-	-	PUNCT
easat-2814	94	58	β1	β1	PROPN
easat-2814	94	59	levels	level	NOUN
easat-2814	94	60	as	as	ADP
easat-2814	94	61	predictive	predictive	ADJ
easat-2814	94	62	markers	marker	NOUN
easat-2814	94	63	for	for	ADP
easat-2814	94	64	disease	disease	NOUN
easat-2814	94	65	progression	progression	NOUN
easat-2814	94	66	from	from	ADP
easat-2814	94	67	nonproliferative	nonproliferative	ADJ
easat-2814	94	68	diabetic	diabetic	ADJ
easat-2814	94	69	retinopathy	retinopathy	ADJ
easat-2814	94	70	(	(	PUNCT
easat-2814	94	71	npdr	npdr	NOUN
easat-2814	94	72	)	)	PUNCT
easat-2814	94	73	to	to	ADP
easat-2814	94	74	pdr	pdr	PROPN
easat-2814	94	75	.	.	PUNCT
easat-2814	95	1	cells	cell	NOUN
easat-2814	95	2	possess	possess	VERB
easat-2814	95	3	a	a	DET
easat-2814	95	4	defense	defense	NOUN
easat-2814	95	5	system	system	NOUN
easat-2814	95	6	against	against	ADP
easat-2814	95	7	ros	ros	PROPN
easat-2814	95	8	,	,	PUNCT
easat-2814	95	9	which	which	PRON
easat-2814	95	10	includes	include	VERB
easat-2814	95	11	antioxidants	antioxidant	NOUN
easat-2814	95	12	such	such	ADJ
easat-2814	95	13	as	as	ADP
easat-2814	95	14	superoxide	superoxide	NOUN
easat-2814	95	15	dismutase	dismutase	NOUN
easat-2814	95	16	(	(	PUNCT
easat-2814	95	17	sod	sod	NOUN
easat-2814	95	18	)	)	PUNCT
easat-2814	95	19	,	,	PUNCT
easat-2814	95	20	glutathione	glutathione	NOUN
easat-2814	95	21	reductase	reductase	NOUN
easat-2814	95	22	,	,	PUNCT
easat-2814	95	23	glutathione	glutathione	NOUN
easat-2814	95	24	peroxidase	peroxidase	NOUN
easat-2814	95	25	,	,	PUNCT
easat-2814	95	26	and	and	CCONJ
easat-2814	95	27	catalase	catalase	NOUN
easat-2814	95	28	.	.	PUNCT
easat-2814	96	1	the	the	DET
easat-2814	96	2	sod	sod	NOUN
easat-2814	96	3	enzyme	enzyme	NOUN
easat-2814	96	4	catalyzes	catalyze	VERB
easat-2814	96	5	the	the	DET
easat-2814	96	6	conversion	conversion	NOUN
easat-2814	96	7	of	of	ADP
easat-2814	96	8	superoxide	superoxide	NOUN
easat-2814	96	9	(	(	PUNCT
easat-2814	96	10	o2−	o2−	NOUN
easat-2814	96	11	)	)	PUNCT
easat-2814	96	12	to	to	ADP
easat-2814	96	13	hydrogen	hydrogen	NOUN
easat-2814	96	14	peroxide	peroxide	NOUN
easat-2814	96	15	(	(	PUNCT
easat-2814	96	16	h2o2	h2o2	NOUN
easat-2814	96	17	)	)	PUNCT
easat-2814	96	18	and	and	CCONJ
easat-2814	96	19	molecular	molecular	ADJ
easat-2814	96	20	oxygen	oxygen	NOUN
easat-2814	96	21	(	(	PUNCT
easat-2814	96	22	o2	o2	PROPN
easat-2814	96	23	)	)	PUNCT
easat-2814	96	24	and	and	CCONJ
easat-2814	96	25	is	be	AUX
easat-2814	96	26	present	present	ADJ
easat-2814	96	27	in	in	ADP
easat-2814	96	28	all	all	DET
easat-2814	96	29	aerobic	aerobic	ADJ
easat-2814	96	30	organisms	organism	NOUN
easat-2814	96	31	,	,	PUNCT
easat-2814	96	32	from	from	ADP
easat-2814	96	33	bacteria	bacteria	NOUN
easat-2814	96	34	to	to	ADP
easat-2814	96	35	humans	human	NOUN
easat-2814	96	36	.	.	PUNCT
easat-2814	97	1	the	the	DET
easat-2814	97	2	enzymatic	enzymatic	ADJ
easat-2814	97	3	activity	activity	NOUN
easat-2814	97	4	of	of	ADP
easat-2814	97	5	sod	sod	NOUN
easat-2814	97	6	was	be	AUX
easat-2814	97	7	first	first	ADV
easat-2814	97	8	discovered	discover	VERB
easat-2814	97	9	by	by	ADP
easat-2814	97	10	biochemists	biochemist	NOUN
easat-2814	97	11	joe	joe	PROPN
easat-2814	97	12	mccord	mccord	PROPN
easat-2814	97	13	and	and	CCONJ
easat-2814	97	14	irwin	irwin	PROPN
easat-2814	97	15	fridovich	fridovich	PROPN
easat-2814	97	16	,	,	PUNCT
easat-2814	97	17	and	and	CCONJ
easat-2814	97	18	its	its	PRON
easat-2814	97	19	role	role	NOUN
easat-2814	97	20	as	as	ADP
easat-2814	97	21	a	a	DET
easat-2814	97	22	major	major	ADJ
easat-2814	97	23	antioxidant	antioxidant	ADJ
easat-2814	97	24	defense	defense	NOUN
easat-2814	97	25	mechanism	mechanism	NOUN
easat-2814	97	26	is	be	AUX
easat-2814	97	27	well	well	ADV
easat-2814	97	28	established	establish	VERB
easat-2814	97	29	.	.	PUNCT
easat-2814	98	1	sod	sod	NOUN
easat-2814	98	2	is	be	AUX
easat-2814	98	3	crucial	crucial	ADJ
easat-2814	98	4	for	for	ADP
easat-2814	98	5	delineating	delineate	VERB
easat-2814	98	6	the	the	DET
easat-2814	98	7	balance	balance	NOUN
easat-2814	98	8	between	between	ADP
easat-2814	98	9	oxidant	oxidant	NOUN
easat-2814	98	10	and	and	CCONJ
easat-2814	98	11	antioxidant	antioxidant	ADJ
easat-2814	98	12	processes	process	NOUN
easat-2814	98	13	in	in	ADP
easat-2814	98	14	ischemia	ischemia	NOUN
easat-2814	98	15	/	/	SYM
easat-2814	98	16	reperfusion	reperfusion	NOUN
easat-2814	98	17	-	-	PUNCT
easat-2814	98	18	related	relate	VERB
easat-2814	98	19	pathologies	pathology	NOUN
easat-2814	98	20	in	in	ADP
easat-2814	98	21	both	both	DET
easat-2814	98	22	humans	human	NOUN
easat-2814	98	23	and	and	CCONJ
easat-2814	98	24	animal	animal	NOUN
easat-2814	98	25	models.[13	models.[13	PROPN
easat-2814	98	26	-	-	PUNCT
easat-2814	98	27	16	16	NUM
easat-2814	98	28	]	]	PUNCT
easat-2814	98	29	research	research	NOUN
easat-2814	98	30	conducted	conduct	VERB
easat-2814	98	31	by	by	ADP
easat-2814	98	32	zhang	zhang	PROPN
easat-2814	98	33	et	et	PROPN
easat-2814	98	34	al	al	PROPN
easat-2814	98	35	.	.	PROPN
easat-2814	98	36	investigated	investigate	VERB
easat-2814	98	37	the	the	DET
easat-2814	98	38	levels	level	NOUN
easat-2814	98	39	of	of	ADP
easat-2814	98	40	vascular	vascular	ADJ
easat-2814	98	41	endothelial	endothelial	ADJ
easat-2814	98	42	growth	growth	NOUN
easat-2814	98	43	factor	factor	NOUN
easat-2814	98	44	(	(	PUNCT
easat-2814	98	45	vegf	vegf	PROPN
easat-2814	98	46	)	)	PUNCT
easat-2814	98	47	and	and	CCONJ
easat-2814	98	48	the	the	DET
easat-2814	98	49	kinase	kinase	PROPN
easat-2814	98	50	insert	insert	PROPN
easat-2814	98	51	domain	domain	NOUN
easat-2814	98	52	-	-	PUNCT
easat-2814	98	53	containing	contain	VERB
easat-2814	98	54	receptor	receptor	NOUN
easat-2814	98	55	(	(	PUNCT
easat-2814	98	56	kdr	kdr	PROPN
easat-2814	98	57	)	)	PUNCT
easat-2814	98	58	in	in	ADP
easat-2814	98	59	the	the	DET
easat-2814	98	60	vitreous	vitreous	ADJ
easat-2814	98	61	humor	humor	NOUN
easat-2814	98	62	of	of	ADP
easat-2814	98	63	diabetic	diabetic	ADJ
easat-2814	98	64	rats	rat	NOUN
easat-2814	98	65	.	.	PUNCT
easat-2814	99	1	their	their	PRON
easat-2814	99	2	findings	finding	NOUN
easat-2814	99	3	revealed	reveal	VERB
easat-2814	99	4	elevated	elevated	ADJ
easat-2814	99	5	levels	level	NOUN
easat-2814	99	6	of	of	ADP
easat-2814	99	7	both	both	CCONJ
easat-2814	99	8	vegf	vegf	PROPN
easat-2814	99	9	and	and	CCONJ
easat-2814	99	10	kdr	kdr	PROPN
easat-2814	99	11	in	in	ADP
easat-2814	99	12	the	the	DET
easat-2814	99	13	vitreous	vitreous	NOUN
easat-2814	99	14	of	of	ADP
easat-2814	99	15	these	these	DET
easat-2814	99	16	diabetic	diabetic	ADJ
easat-2814	99	17	rats	rat	NOUN
easat-2814	99	18	.	.	PUNCT
easat-2814	100	1	these	these	DET
easat-2814	100	2	alterations	alteration	NOUN
easat-2814	100	3	in	in	ADP
easat-2814	100	4	vegf	vegf	PROPN
easat-2814	100	5	and	and	CCONJ
easat-2814	100	6	kdr	kdr	PROPN
easat-2814	100	7	levels	level	NOUN
easat-2814	100	8	are	be	AUX
easat-2814	100	9	associated	associate	VERB
easat-2814	100	10	with	with	ADP
easat-2814	100	11	the	the	DET
easat-2814	100	12	early	early	ADJ
easat-2814	100	13	onset	onset	NOUN
easat-2814	100	14	of	of	ADP
easat-2814	100	15	diabetes	diabetes	NOUN
easat-2814	100	16	-	-	PUNCT
easat-2814	100	17	induced	induce	VERB
easat-2814	100	18	retinopathy	retinopathy	NOUN
easat-2814	100	19	.	.	PUNCT
easat-2814	101	1	additionally	additionally	ADV
easat-2814	101	2	,	,	PUNCT
easat-2814	101	3	a	a	DET
easat-2814	101	4	study	study	NOUN
easat-2814	101	5	by	by	ADP
easat-2814	101	6	lee	lee	PROPN
easat-2814	101	7	et	et	PROPN
easat-2814	101	8	al	al	PROPN
easat-2814	101	9	.	.	PROPN
easat-2814	101	10	demonstrated	demonstrate	VERB
easat-2814	101	11	that	that	PRON
easat-2814	101	12	intravitreal	intravitreal	ADJ
easat-2814	101	13	administration	administration	NOUN
easat-2814	101	14	of	of	ADP
easat-2814	101	15	superoxide	superoxide	NOUN
easat-2814	101	16	dismutase	dismutase	NOUN
easat-2814	101	17	3	3	NUM
easat-2814	101	18	(	(	PUNCT
easat-2814	101	19	sod3	sod3	PROPN
easat-2814	101	20	)	)	PUNCT
easat-2814	101	21	therapy	therapy	NOUN
easat-2814	101	22	improved	improve	VERB
easat-2814	101	23	müller	müller	NOUN
easat-2814	101	24	cell	cell	NOUN
easat-2814	101	25	activation	activation	NOUN
easat-2814	101	26	and	and	CCONJ
easat-2814	101	27	mitigated	mitigate	VERB
easat-2814	101	28	pericyte	pericyte	NOUN
easat-2814	101	29	dysfunction	dysfunction	NOUN
easat-2814	101	30	in	in	ADP
easat-2814	101	31	diabetic	diabetic	ADJ
easat-2814	101	32	mice	mouse	NOUN
easat-2814	101	33	.	.	PUNCT
easat-2814	102	1	[	[	X
easat-2814	102	2	17	17	NUM
easat-2814	102	3	-	-	SYM
easat-2814	102	4	18	18	NUM
easat-2814	102	5	]	]	PUNCT
easat-2814	102	6	figure	figure	NOUN
easat-2814	102	7	3	3	NUM
easat-2814	102	8	.	.	PUNCT
easat-2814	102	9	mechanisms	mechanism	NOUN
easat-2814	102	10	of	of	ADP
easat-2814	102	11	hyperglycemia	hyperglycemia	NOUN
easat-2814	102	12	and	and	CCONJ
easat-2814	102	13	their	their	PRON
easat-2814	102	14	correlation	correlation	NOUN
easat-2814	102	15	with	with	ADP
easat-2814	102	16	increased	increase	VERB
easat-2814	102	17	vegf	vegf	NOUN
easat-2814	102	18	and	and	CCONJ
easat-2814	102	19	tgf	tgf	PROPN
easat-2814	102	20	β	β	X
easat-2814	103	1	[	[	X
easat-2814	103	2	10	10	NUM
easat-2814	103	3	]	]	PUNCT
easat-2814	103	4	.	.	PUNCT
easat-2814	103	5	3728	3728	NUM
easat-2814	103	6	edelweiss	edelweiss	PROPN
easat-2814	103	7	applied	apply	VERB
easat-2814	103	8	science	science	NOUN
easat-2814	103	9	and	and	CCONJ
easat-2814	103	10	technology	technology	NOUN
easat-2814	103	11	issn	issn	PROPN
easat-2814	103	12	:	:	PUNCT
easat-2814	103	13	2576	2576	NUM
easat-2814	103	14	-	-	SYM
easat-2814	103	15	8484	8484	NUM
easat-2814	103	16	vol	vol	NOUN
easat-2814	103	17	.	.	PROPN
easat-2814	103	18	8	8	NUM
easat-2814	103	19	,	,	PUNCT
easat-2814	103	20	no	no	INTJ
easat-2814	103	21	.	.	NOUN
easat-2814	104	1	6	6	NUM
easat-2814	104	2	:	:	SYM
easat-2814	104	3	3722	3722	NUM
easat-2814	104	4	-	-	SYM
easat-2814	104	5	3733	3733	NUM
easat-2814	104	6	,	,	PUNCT
easat-2814	104	7	2024	2024	NUM
easat-2814	104	8	doi	doi	NOUN
easat-2814	104	9	:	:	PUNCT
easat-2814	104	10	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	104	11	©	©	ADP
easat-2814	104	12	2024	2024	NUM
easat-2814	104	13	by	by	ADP
easat-2814	104	14	the	the	DET
easat-2814	104	15	authors	author	NOUN
easat-2814	104	16	;	;	PUNCT
easat-2814	104	17	licensee	licensee	PROPN
easat-2814	104	18	learning	learn	VERB
easat-2814	104	19	gate	gate	NOUN
easat-2814	104	20	figure	figure	NOUN
easat-2814	104	21	4	4	NUM
easat-2814	104	22	.	.	PUNCT
easat-2814	104	23	correlation	correlation	NOUN
easat-2814	104	24	vegf	vegf	PROPN
easat-2814	104	25	,	,	PUNCT
easat-2814	104	26	tgf	tgf	PROPN
easat-2814	104	27	β	β	PROPN
easat-2814	104	28	,	,	PUNCT
easat-2814	104	29	sod	sod	NOUN
easat-2814	104	30	,	,	PUNCT
easat-2814	104	31	ros	ros	PROPN
easat-2814	104	32	,	,	PUNCT
easat-2814	104	33	and	and	CCONJ
easat-2814	104	34	diabetic	diabetic	ADJ
easat-2814	104	35	retinopathy	retinopathy	NOUN
easat-2814	105	1	[	[	X
easat-2814	105	2	11	11	NUM
easat-2814	105	3	]	]	PUNCT
easat-2814	105	4	.	.	PUNCT
easat-2814	106	1	figure	figure	NOUN
easat-2814	106	2	5	5	NUM
easat-2814	106	3	.	.	PUNCT
easat-2814	106	4	mechanism	mechanism	NOUN
easat-2814	106	5	diabetes	diabetes	NOUN
easat-2814	106	6	,	,	PUNCT
easat-2814	106	7	ros	ros	PROPN
easat-2814	106	8	,	,	PUNCT
easat-2814	106	9	and	and	CCONJ
easat-2814	106	10	blood	blood	NOUN
easat-2814	106	11	-	-	PUNCT
easat-2814	106	12	retinal	retinal	ADJ
easat-2814	106	13	barrier	barrier	NOUN
easat-2814	107	1	[	[	X
easat-2814	107	2	12	12	NUM
easat-2814	107	3	]	]	PUNCT
easat-2814	107	4	.	.	PUNCT
easat-2814	108	1	transforming	transform	VERB
easat-2814	108	2	growth	growth	NOUN
easat-2814	108	3	factor	factor	NOUN
easat-2814	108	4	beta	beta	NOUN
easat-2814	108	5	(	(	PUNCT
easat-2814	108	6	tgf	tgf	PROPN
easat-2814	108	7	-	-	PUNCT
easat-2814	108	8	β	β	NOUN
easat-2814	108	9	)	)	PUNCT
easat-2814	108	10	is	be	AUX
easat-2814	108	11	a	a	DET
easat-2814	108	12	proliferative	proliferative	ADJ
easat-2814	108	13	growth	growth	NOUN
easat-2814	108	14	factor	factor	NOUN
easat-2814	108	15	that	that	PRON
easat-2814	108	16	exerts	exert	VERB
easat-2814	108	17	its	its	PRON
easat-2814	108	18	effects	effect	NOUN
easat-2814	108	19	through	through	ADP
easat-2814	108	20	multiple	multiple	ADJ
easat-2814	108	21	pathways	pathway	NOUN
easat-2814	108	22	,	,	PUNCT
easat-2814	108	23	including	include	VERB
easat-2814	108	24	the	the	DET
easat-2814	108	25	proliferation	proliferation	NOUN
easat-2814	108	26	and	and	CCONJ
easat-2814	108	27	migration	migration	NOUN
easat-2814	108	28	of	of	ADP
easat-2814	108	29	pro	pro	ADJ
easat-2814	108	30	-	-	ADJ
easat-2814	108	31	fibrotic	fibrotic	ADJ
easat-2814	108	32	cells	cell	NOUN
easat-2814	108	33	,	,	PUNCT
easat-2814	108	34	both	both	PRON
easat-2814	108	35	independently	independently	ADV
easat-2814	108	36	and	and	CCONJ
easat-2814	108	37	via	via	ADP
easat-2814	108	38	connective	connective	ADJ
easat-2814	108	39	tissue	tissue	NOUN
easat-2814	108	40	growth	growth	NOUN
easat-2814	108	41	factor	factor	NOUN
easat-2814	108	42	(	(	PUNCT
easat-2814	108	43	ctgf	ctgf	NOUN
easat-2814	108	44	)	)	PUNCT
easat-2814	108	45	in	in	ADP
easat-2814	108	46	the	the	DET
easat-2814	108	47	eye	eye	NOUN
easat-2814	108	48	.	.	PUNCT
easat-2814	109	1	the	the	DET
easat-2814	109	2	tgf	tgf	PROPN
easat-2814	109	3	-	-	PUNCT
easat-2814	109	4	β	β	PROPN
easat-2814	109	5	cytokine	cytokine	NOUN
easat-2814	109	6	was	be	AUX
easat-2814	109	7	first	first	ADV
easat-2814	109	8	identified	identify	VERB
easat-2814	109	9	in	in	ADP
easat-2814	109	10	the	the	DET
easat-2814	109	11	early	early	ADJ
easat-2814	109	12	1980s	1980s	NUM
easat-2814	109	13	,	,	PUNCT
easat-2814	109	14	and	and	CCONJ
easat-2814	109	15	three	three	NUM
easat-2814	109	16	isoforms	isoform	NOUN
easat-2814	109	17	have	have	AUX
easat-2814	109	18	been	be	AUX
easat-2814	109	19	characterized	characterize	VERB
easat-2814	109	20	in	in	ADP
easat-2814	109	21	mammals	mammal	NOUN
easat-2814	109	22	:	:	PUNCT
easat-2814	109	23	tgf	tgf	PROPN
easat-2814	109	24	-	-	PUNCT
easat-2814	109	25	β1	β1	PROPN
easat-2814	109	26	,	,	PUNCT
easat-2814	109	27	3729	3729	NUM
easat-2814	109	28	edelweiss	edelweiss	PROPN
easat-2814	109	29	applied	apply	VERB
easat-2814	109	30	science	science	NOUN
easat-2814	109	31	and	and	CCONJ
easat-2814	109	32	technology	technology	NOUN
easat-2814	109	33	issn	issn	PROPN
easat-2814	109	34	:	:	PUNCT
easat-2814	109	35	2576	2576	NUM
easat-2814	109	36	-	-	SYM
easat-2814	109	37	8484	8484	NUM
easat-2814	109	38	vol	vol	NOUN
easat-2814	109	39	.	.	PROPN
easat-2814	110	1	8	8	NUM
easat-2814	110	2	,	,	PUNCT
easat-2814	110	3	no	no	INTJ
easat-2814	110	4	.	.	NOUN
easat-2814	111	1	6	6	NUM
easat-2814	111	2	:	:	SYM
easat-2814	111	3	3722	3722	NUM
easat-2814	111	4	-	-	SYM
easat-2814	111	5	3733	3733	NUM
easat-2814	111	6	,	,	PUNCT
easat-2814	111	7	2024	2024	NUM
easat-2814	111	8	doi	doi	NOUN
easat-2814	111	9	:	:	PUNCT
easat-2814	111	10	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	111	11	©	©	ADP
easat-2814	111	12	2024	2024	NUM
easat-2814	111	13	by	by	ADP
easat-2814	111	14	the	the	DET
easat-2814	111	15	authors	author	NOUN
easat-2814	111	16	;	;	PUNCT
easat-2814	111	17	licensee	licensee	PROPN
easat-2814	111	18	learning	learning	PROPN
easat-2814	111	19	gate	gate	PROPN
easat-2814	111	20	tgf	tgf	PROPN
easat-2814	111	21	-	-	PUNCT
easat-2814	111	22	β2	β2	PROPN
easat-2814	111	23	,	,	PUNCT
easat-2814	111	24	and	and	CCONJ
easat-2814	111	25	tgf	tgf	NOUN
easat-2814	111	26	-	-	PUNCT
easat-2814	111	27	β3	β3	ADJ
easat-2814	111	28	.	.	PUNCT
easat-2814	112	1	all	all	DET
easat-2814	112	2	three	three	NUM
easat-2814	112	3	isoforms	isoform	NOUN
easat-2814	112	4	have	have	AUX
easat-2814	112	5	been	be	AUX
easat-2814	112	6	detected	detect	VERB
easat-2814	112	7	in	in	ADP
easat-2814	112	8	the	the	DET
easat-2814	112	9	aqueous	aqueous	ADJ
easat-2814	112	10	and	and	CCONJ
easat-2814	112	11	vitreous	vitreous	ADJ
easat-2814	112	12	humor	humor	NOUN
easat-2814	112	13	of	of	ADP
easat-2814	112	14	the	the	DET
easat-2814	112	15	human	human	PROPN
easat-2814	112	16	eye.additionally	eye.additionally	ADV
easat-2814	112	17	,	,	PUNCT
easat-2814	112	18	tgf	tgf	PROPN
easat-2814	112	19	-	-	PUNCT
easat-2814	112	20	β	β	PROPN
easat-2814	112	21	is	be	AUX
easat-2814	112	22	expressed	express	VERB
easat-2814	112	23	in	in	ADP
easat-2814	112	24	various	various	ADJ
easat-2814	112	25	ocular	ocular	ADJ
easat-2814	112	26	tissues	tissue	NOUN
easat-2814	112	27	,	,	PUNCT
easat-2814	112	28	including	include	VERB
easat-2814	112	29	the	the	DET
easat-2814	112	30	cornea	cornea	NOUN
easat-2814	112	31	,	,	PUNCT
easat-2814	112	32	ciliary	ciliary	ADJ
easat-2814	112	33	epithelium	epithelium	NOUN
easat-2814	112	34	,	,	PUNCT
easat-2814	112	35	crystalline	crystalline	ADJ
easat-2814	112	36	lens	len	NOUN
easat-2814	112	37	,	,	PUNCT
easat-2814	112	38	retina	retina	NOUN
easat-2814	112	39	,	,	PUNCT
easat-2814	112	40	and	and	CCONJ
easat-2814	112	41	blood	blood	NOUN
easat-2814	112	42	vessels	vessel	NOUN
easat-2814	112	43	.	.	PUNCT
easat-2814	113	1	tgf	tgf	PROPN
easat-2814	113	2	-	-	PUNCT
easat-2814	113	3	β1	β1	PROPN
easat-2814	113	4	and	and	CCONJ
easat-2814	113	5	tgf	tgf	PROPN
easat-2814	113	6	-	-	PUNCT
easat-2814	113	7	β2	β2	NOUN
easat-2814	113	8	demonstrate	demonstrate	VERB
easat-2814	113	9	a	a	DET
easat-2814	113	10	distinct	distinct	ADJ
easat-2814	113	11	and	and	CCONJ
easat-2814	113	12	specific	specific	ADJ
easat-2814	113	13	distribution	distribution	NOUN
easat-2814	113	14	in	in	ADP
easat-2814	113	15	the	the	DET
easat-2814	113	16	anterior	anterior	ADJ
easat-2814	113	17	segment	segment	NOUN
easat-2814	113	18	of	of	ADP
easat-2814	113	19	the	the	DET
easat-2814	113	20	human	human	ADJ
easat-2814	113	21	eye	eye	NOUN
easat-2814	113	22	,	,	PUNCT
easat-2814	113	23	whereas	whereas	SCONJ
easat-2814	113	24	tgf	tgf	PROPN
easat-2814	113	25	-	-	PUNCT
easat-2814	113	26	β3	β3	PROPN
easat-2814	113	27	has	have	AUX
easat-2814	113	28	not	not	PART
easat-2814	113	29	been	be	AUX
easat-2814	113	30	detected	detect	VERB
easat-2814	113	31	in	in	ADP
easat-2814	113	32	any	any	DET
easat-2814	113	33	structures	structure	NOUN
easat-2814	113	34	of	of	ADP
easat-2814	113	35	the	the	DET
easat-2814	113	36	anterior	anterior	ADJ
easat-2814	113	37	eye[19	eye[19	NOUN
easat-2814	113	38	]	]	PUNCT
easat-2814	113	39	hyperglycemia	hyperglycemia	NOUN
easat-2814	113	40	and	and	CCONJ
easat-2814	113	41	diabetes	diabetes	NOUN
easat-2814	113	42	mellitus	mellitus	NOUN
easat-2814	113	43	can	can	AUX
easat-2814	113	44	activate	activate	VERB
easat-2814	113	45	the	the	DET
easat-2814	113	46	protein	protein	NOUN
easat-2814	113	47	kinase	kinase	NOUN
easat-2814	113	48	c	c	PROPN
easat-2814	113	49	(	(	PUNCT
easat-2814	113	50	pkc	pkc	NOUN
easat-2814	113	51	)	)	PUNCT
easat-2814	113	52	pathway	pathway	NOUN
easat-2814	113	53	,	,	PUNCT
easat-2814	113	54	leading	lead	VERB
easat-2814	113	55	to	to	ADP
easat-2814	113	56	increased	increase	VERB
easat-2814	113	57	levels	level	NOUN
easat-2814	113	58	of	of	ADP
easat-2814	113	59	vascular	vascular	ADJ
easat-2814	113	60	endothelial	endothelial	ADJ
easat-2814	113	61	growth	growth	NOUN
easat-2814	113	62	factor	factor	NOUN
easat-2814	113	63	(	(	PUNCT
easat-2814	113	64	vegf	vegf	PROPN
easat-2814	113	65	)	)	PUNCT
easat-2814	113	66	and	and	CCONJ
easat-2814	113	67	transforming	transform	VERB
easat-2814	113	68	growth	growth	NOUN
easat-2814	113	69	factor	factor	NOUN
easat-2814	113	70	beta	beta	NOUN
easat-2814	113	71	(	(	PUNCT
easat-2814	113	72	tgf	tgf	PROPN
easat-2814	113	73	-	-	PUNCT
easat-2814	113	74	β	β	NOUN
easat-2814	113	75	)	)	PUNCT
easat-2814	113	76	.	.	PUNCT
easat-2814	114	1	these	these	DET
easat-2814	114	2	conditions	condition	NOUN
easat-2814	114	3	also	also	ADV
easat-2814	114	4	contribute	contribute	VERB
easat-2814	114	5	to	to	ADP
easat-2814	114	6	the	the	DET
easat-2814	114	7	induction	induction	NOUN
easat-2814	114	8	of	of	ADP
easat-2814	114	9	reactive	reactive	ADJ
easat-2814	114	10	oxygen	oxygen	NOUN
easat-2814	114	11	species	specie	NOUN
easat-2814	114	12	(	(	PUNCT
easat-2814	114	13	ros	ros	PROPN
easat-2814	114	14	)	)	PUNCT
easat-2814	114	15	,	,	PUNCT
easat-2814	114	16	promote	promote	VERB
easat-2814	114	17	angiogenesis	angiogenesis	NOUN
easat-2814	114	18	,	,	PUNCT
easat-2814	114	19	and	and	CCONJ
easat-2814	114	20	facilitate	facilitate	VERB
easat-2814	114	21	cellular	cellular	ADJ
easat-2814	114	22	apoptosis	apoptosis	NOUN
easat-2814	114	23	,	,	PUNCT
easat-2814	114	24	ultimately	ultimately	ADV
easat-2814	114	25	compromising	compromise	VERB
easat-2814	114	26	the	the	DET
easat-2814	114	27	integrity	integrity	NOUN
easat-2814	114	28	of	of	ADP
easat-2814	114	29	the	the	DET
easat-2814	114	30	blood	blood	NOUN
easat-2814	114	31	-	-	PUNCT
easat-2814	114	32	retinal	retinal	ADJ
easat-2814	114	33	barrier	barrier	NOUN
easat-2814	114	34	(	(	PUNCT
easat-2814	114	35	brb	brb	PROPN
easat-2814	114	36	)	)	PUNCT
easat-2814	114	37	.	.	PUNCT
easat-2814	115	1	the	the	DET
easat-2814	115	2	disruption	disruption	NOUN
easat-2814	115	3	of	of	ADP
easat-2814	115	4	these	these	DET
easat-2814	115	5	processes	process	NOUN
easat-2814	115	6	significantly	significantly	ADV
easat-2814	115	7	contributes	contribute	VERB
easat-2814	115	8	to	to	ADP
easat-2814	115	9	the	the	DET
easat-2814	115	10	development	development	NOUN
easat-2814	115	11	of	of	ADP
easat-2814	115	12	diabetic	diabetic	ADJ
easat-2814	115	13	retinopathy	retinopathy	NOUN
easat-2814	115	14	.	.	PUNCT
easat-2814	116	1	table	table	NOUN
easat-2814	116	2	1	1	NUM
easat-2814	116	3	.	.	PUNCT
easat-2814	116	4	expression	expression	NOUN
easat-2814	116	5	and	and	CCONJ
easat-2814	116	6	role	role	NOUN
easat-2814	116	7	of	of	ADP
easat-2814	116	8	tgf	tgf	PROPN
easat-2814	116	9	β	β	PROPN
easat-2814	116	10	in	in	ADP
easat-2814	116	11	ocular	ocular	ADJ
easat-2814	116	12	pathology	pathology	NOUN
easat-2814	117	1	[	[	X
easat-2814	117	2	19	19	NUM
easat-2814	117	3	]	]	PUNCT
easat-2814	117	4	.	.	PUNCT
easat-2814	118	1	1.3	1.3	NUM
easat-2814	118	2	.	.	PUNCT
easat-2814	118	3	sod	sod	NOUN
easat-2814	118	4	melon	melon	NOUN
easat-2814	118	5	gliadin	gliadin	NOUN
easat-2814	118	6	(	(	PUNCT
easat-2814	118	7	glisodin	glisodin	NOUN
easat-2814	118	8	®	®	NOUN
easat-2814	118	9	)	)	PUNCT
easat-2814	118	10	as	as	ADP
easat-2814	118	11	an	an	DET
easat-2814	118	12	antioxidant	antioxidant	NOUN
easat-2814	118	13	in	in	ADP
easat-2814	118	14	opthalmology	opthalmology	NOUN
easat-2814	118	15	the	the	DET
easat-2814	118	16	enzyme	enzyme	NOUN
easat-2814	118	17	superoxide	superoxide	NOUN
easat-2814	118	18	dismutase	dismutase	NOUN
easat-2814	118	19	(	(	PUNCT
easat-2814	118	20	sod	sod	NOUN
easat-2814	118	21	)	)	PUNCT
easat-2814	118	22	facilitates	facilitate	VERB
easat-2814	118	23	the	the	DET
easat-2814	118	24	conversion	conversion	NOUN
easat-2814	118	25	of	of	ADP
easat-2814	118	26	superoxide	superoxide	NOUN
easat-2814	118	27	anions(o2-	anions(o2-	NOUN
easat-2814	118	28	)	)	PUNCT
easat-2814	118	29	into	into	ADP
easat-2814	118	30	hydrogen	hydrogen	NOUN
easat-2814	118	31	peroxide	peroxide	NOUN
easat-2814	118	32	(	(	PUNCT
easat-2814	118	33	h2o2	h2o2	NOUN
easat-2814	118	34	)	)	PUNCT
easat-2814	118	35	and	and	CCONJ
easat-2814	118	36	molecular	molecular	ADJ
easat-2814	118	37	oxygen	oxygen	NOUN
easat-2814	118	38	(	(	PUNCT
easat-2814	118	39	o2	o2	PROPN
easat-2814	118	40	)	)	PUNCT
easat-2814	118	41	.	.	PUNCT
easat-2814	119	1	sod	sod	NOUN
easat-2814	119	2	is	be	AUX
easat-2814	119	3	present	present	ADJ
easat-2814	119	4	in	in	ADP
easat-2814	119	5	all	all	DET
easat-2814	119	6	aerobic	aerobic	ADJ
easat-2814	119	7	organisms	organism	NOUN
easat-2814	119	8	,	,	PUNCT
easat-2814	119	9	from	from	ADP
easat-2814	119	10	bacteria	bacteria	NOUN
easat-2814	119	11	to	to	ADP
easat-2814	119	12	humans	human	NOUN
easat-2814	119	13	.	.	PUNCT
easat-2814	120	1	its	its	PRON
easat-2814	120	2	enzymatic	enzymatic	ADJ
easat-2814	120	3	activity	activity	NOUN
easat-2814	120	4	was	be	AUX
easat-2814	120	5	first	first	ADV
easat-2814	120	6	identified	identify	VERB
easat-2814	120	7	by	by	ADP
easat-2814	120	8	joe	joe	PROPN
easat-2814	120	9	mccord	mccord	PROPN
easat-2814	120	10	and	and	CCONJ
easat-2814	120	11	irwin	irwin	PROPN
easat-2814	120	12	fridovich	fridovich	PROPN
easat-2814	120	13	,	,	PUNCT
easat-2814	120	14	who	who	PRON
easat-2814	120	15	underscored	underscore	VERB
easat-2814	120	16	its	its	PRON
easat-2814	120	17	critical	critical	ADJ
easat-2814	120	18	role	role	NOUN
easat-2814	120	19	in	in	ADP
easat-2814	120	20	protecting	protect	VERB
easat-2814	120	21	organisms	organism	NOUN
easat-2814	120	22	from	from	ADP
easat-2814	120	23	the	the	DET
easat-2814	120	24	detrimental	detrimental	ADJ
easat-2814	120	25	effects	effect	NOUN
easat-2814	120	26	of	of	ADP
easat-2814	120	27	reactive	reactive	ADJ
easat-2814	120	28	oxygen	oxygen	NOUN
easat-2814	120	29	species	specie	NOUN
easat-2814	120	30	(	(	PUNCT
easat-2814	120	31	ros	ros	PROPN
easat-2814	120	32	)	)	PUNCT
easat-2814	120	33	.	.	PUNCT
easat-2814	121	1	sod	sod	NOUN
easat-2814	121	2	functions	function	NOUN
easat-2814	121	3	as	as	ADP
easat-2814	121	4	a	a	DET
easat-2814	121	5	metalloenzyme	metalloenzyme	NOUN
easat-2814	121	6	,	,	PUNCT
easat-2814	121	7	requiring	require	VERB
easat-2814	121	8	a	a	DET
easat-2814	121	9	specific	specific	ADJ
easat-2814	121	10	conformation	conformation	NOUN
easat-2814	121	11	and	and	CCONJ
easat-2814	121	12	the	the	DET
easat-2814	121	13	presence	presence	NOUN
easat-2814	121	14	of	of	ADP
easat-2814	121	15	copper	copper	NOUN
easat-2814	121	16	and	and	CCONJ
easat-2814	121	17	zinc	zinc	NOUN
easat-2814	121	18	,	,	PUNCT
easat-2814	121	19	as	as	ADV
easat-2814	121	20	well	well	ADV
easat-2814	121	21	as	as	ADP
easat-2814	121	22	one	one	NUM
easat-2814	121	23	of	of	ADP
easat-2814	121	24	the	the	DET
easat-2814	121	25	following	follow	VERB
easat-2814	121	26	cofactors	cofactor	NOUN
easat-2814	121	27	:	:	PUNCT
easat-2814	121	28	nickel	nickel	NOUN
easat-2814	121	29	,	,	PUNCT
easat-2814	121	30	iron	iron	NOUN
easat-2814	121	31	,	,	PUNCT
easat-2814	121	32	or	or	CCONJ
easat-2814	121	33	manganese	manganese	NOUN
easat-2814	121	34	.	.	PUNCT
easat-2814	122	1	in	in	ADP
easat-2814	122	2	humans	human	NOUN
easat-2814	122	3	,	,	PUNCT
easat-2814	122	4	three	three	NUM
easat-2814	122	5	isoforms	isoform	NOUN
easat-2814	122	6	of	of	ADP
easat-2814	122	7	sod	sod	NOUN
easat-2814	122	8	are	be	AUX
easat-2814	122	9	identified	identify	VERB
easat-2814	122	10	:	:	PUNCT
easat-2814	122	11	extracellular	extracellular	ADJ
easat-2814	122	12	copper	copper	NOUN
easat-2814	122	13	-	-	PUNCT
easat-2814	122	14	zinc	zinc	NOUN
easat-2814	122	15	sod	sod	NOUN
easat-2814	122	16	(	(	PUNCT
easat-2814	122	17	sod3	sod3	PROPN
easat-2814	122	18	)	)	PUNCT
easat-2814	122	19	,	,	PUNCT
easat-2814	122	20	mitochondrial	mitochondrial	ADJ
easat-2814	122	21	manganese	manganese	NOUN
easat-2814	122	22	sod	sod	NOUN
easat-2814	122	23	(	(	PUNCT
easat-2814	122	24	sod2	sod2	NOUN
easat-2814	122	25	)	)	PUNCT
easat-2814	122	26	,	,	PUNCT
easat-2814	122	27	and	and	CCONJ
easat-2814	122	28	cytosolic	cytosolic	ADJ
easat-2814	122	29	copper	copper	NOUN
easat-2814	122	30	-	-	PUNCT
easat-2814	122	31	zinc	zinc	NOUN
easat-2814	122	32	sod	sod	NOUN
easat-2814	122	33	(	(	PUNCT
easat-2814	122	34	sod1	sod1	NOUN
easat-2814	122	35	)	)	PUNCT
easat-2814	122	36	.	.	PUNCT
easat-2814	123	1	it	it	PRON
easat-2814	123	2	is	be	AUX
easat-2814	123	3	important	important	ADJ
easat-2814	123	4	to	to	PART
easat-2814	123	5	note	note	VERB
easat-2814	123	6	that	that	SCONJ
easat-2814	123	7	sod	sod	NOUN
easat-2814	123	8	's	's	PART
easat-2814	123	9	catalytic	catalytic	ADJ
easat-2814	123	10	action	action	NOUN
easat-2814	123	11	produces	produce	VERB
easat-2814	123	12	h2o2	h2o2	NOUN
easat-2814	123	13	,	,	PUNCT
easat-2814	123	14	which	which	PRON
easat-2814	123	15	is	be	AUX
easat-2814	123	16	classified	classify	VERB
easat-2814	123	17	as	as	ADP
easat-2814	123	18	a	a	DET
easat-2814	123	19	reactive	reactive	ADJ
easat-2814	123	20	oxygen	oxygen	NOUN
easat-2814	123	21	species	specie	NOUN
easat-2814	123	22	and	and	CCONJ
easat-2814	123	23	can	can	AUX
easat-2814	123	24	be	be	AUX
easat-2814	123	25	more	more	ADV
easat-2814	123	26	accurately	accurately	ADV
easat-2814	123	27	described	describe	VERB
easat-2814	123	28	as	as	ADP
easat-2814	123	29	a	a	DET
easat-2814	123	30	pro	pro	ADJ
easat-2814	123	31	-	-	ADJ
easat-2814	123	32	oxidant	oxidant	ADJ
easat-2814	123	33	rather	rather	ADV
easat-2814	123	34	than	than	ADP
easat-2814	123	35	solely	solely	ADV
easat-2814	123	36	as	as	ADP
easat-2814	123	37	an	an	DET
easat-2814	123	38	antioxidant	antioxidant	NOUN
easat-2814	123	39	.	.	PUNCT
easat-2814	124	1	glisodin	glisodin	NOUN
easat-2814	124	2	®	®	NOUN
easat-2814	124	3	is	be	AUX
easat-2814	124	4	a	a	DET
easat-2814	124	5	rich	rich	ADJ
easat-2814	124	6	source	source	NOUN
easat-2814	124	7	of	of	ADP
easat-2814	124	8	sod	sod	NOUN
easat-2814	124	9	derived	derive	VERB
easat-2814	124	10	from	from	ADP
easat-2814	124	11	melon	melon	NOUN
easat-2814	124	12	(	(	PUNCT
easat-2814	124	13	cucumis	cucumis	PROPN
easat-2814	124	14	melo	melo	PROPN
easat-2814	124	15	)	)	PUNCT
easat-2814	124	16	combined	combine	VERB
easat-2814	124	17	with	with	ADP
easat-2814	124	18	wheat	wheat	NOUN
easat-2814	124	19	gliadin	gliadin	NOUN
easat-2814	124	20	.	.	PUNCT
easat-2814	125	1	notably	notably	ADV
easat-2814	125	2	,	,	PUNCT
easat-2814	125	3	sod	sod	NOUN
easat-2814	125	4	extracted	extract	VERB
easat-2814	125	5	from	from	ADP
easat-2814	125	6	melon	melon	NOUN
easat-2814	125	7	exhibits	exhibit	VERB
easat-2814	125	8	five	five	NUM
easat-2814	125	9	to	to	PART
easat-2814	125	10	seven	seven	NUM
easat-2814	125	11	times	time	NOUN
easat-2814	125	12	greater	great	ADJ
easat-2814	125	13	activity	activity	NOUN
easat-2814	125	14	than	than	ADP
easat-2814	125	15	that	that	PRON
easat-2814	125	16	from	from	ADP
easat-2814	125	17	the	the	DET
easat-2814	125	18	classic	classic	ADJ
easat-2814	125	19	“	"	PUNCT
easat-2814	125	20	charentais	charentais	NOUN
easat-2814	125	21	”	"	PUNCT
easat-2814	125	22	melon	melon	NOUN
easat-2814	125	23	.	.	PUNCT
easat-2814	126	1	gliadin	gliadin	NOUN
easat-2814	126	2	,	,	PUNCT
easat-2814	126	3	a	a	DET
easat-2814	126	4	biopolymer	biopolymer	NOUN
easat-2814	126	5	,	,	PUNCT
easat-2814	126	6	serves	serve	VERB
easat-2814	126	7	to	to	PART
easat-2814	126	8	protect	protect	VERB
easat-2814	126	9	active	active	ADJ
easat-2814	126	10	molecules	molecule	NOUN
easat-2814	126	11	from	from	ADP
easat-2814	126	12	enzymatic	enzymatic	ADJ
easat-2814	126	13	digestion	digestion	NOUN
easat-2814	126	14	.	.	PUNCT
easat-2814	127	1	research	research	NOUN
easat-2814	127	2	has	have	AUX
easat-2814	127	3	demonstrated	demonstrate	VERB
easat-2814	127	4	that	that	SCONJ
easat-2814	127	5	the	the	DET
easat-2814	127	6	sod	sod	NOUN
easat-2814	127	7	activity	activity	NOUN
easat-2814	127	8	of	of	ADP
easat-2814	127	9	glisodin	glisodin	NOUN
easat-2814	127	10	®	®	NOUN
easat-2814	127	11	increases	increase	NOUN
easat-2814	127	12	significantly	significantly	ADV
easat-2814	127	13	and	and	CCONJ
easat-2814	127	14	progressively	progressively	ADV
easat-2814	127	15	in	in	ADP
easat-2814	127	16	a	a	DET
easat-2814	127	17	medium	medium	NOUN
easat-2814	127	18	that	that	PRON
easat-2814	127	19	simulates	simulate	VERB
easat-2814	127	20	the	the	DET
easat-2814	127	21	digestive	digestive	ADJ
easat-2814	127	22	process	process	NOUN
easat-2814	127	23	.	.	PUNCT
easat-2814	128	1	oral	oral	ADJ
easat-2814	128	2	supplementation	supplementation	NOUN
easat-2814	128	3	with	with	ADP
easat-2814	128	4	melon	melon	NOUN
easat-2814	128	5	-	-	PUNCT
easat-2814	128	6	derived	derive	VERB
easat-2814	128	7	sod	sod	NOUN
easat-2814	128	8	combined	combine	VERB
easat-2814	128	9	with	with	ADP
easat-2814	128	10	wheat	wheat	NOUN
easat-2814	128	11	gliadin	gliadin	NOUN
easat-2814	128	12	has	have	AUX
easat-2814	128	13	been	be	AUX
easat-2814	128	14	shown	show	VERB
easat-2814	128	15	to	to	PART
easat-2814	128	16	enhance	enhance	VERB
easat-2814	128	17	endogenous	endogenous	ADJ
easat-2814	128	18	antioxidant	antioxidant	ADJ
easat-2814	128	19	defenses	defense	NOUN
easat-2814	128	20	.	.	PUNCT
easat-2814	129	1	recent	recent	ADJ
easat-2814	129	2	studies	study	NOUN
easat-2814	129	3	indicate	indicate	VERB
easat-2814	129	4	that	that	SCONJ
easat-2814	129	5	gliadin	gliadin	NOUN
easat-2814	129	6	may	may	AUX
easat-2814	129	7	stimulate	stimulate	VERB
easat-2814	129	8	the	the	DET
easat-2814	129	9	release	release	NOUN
easat-2814	129	10	of	of	ADP
easat-2814	129	11	zonulin	zonulin	PROPN
easat-2814	129	12	from	from	ADP
easat-2814	129	13	intestinal	intestinal	ADJ
easat-2814	129	14	epithelial	epithelial	ADJ
easat-2814	129	15	cells	cell	NOUN
easat-2814	129	16	,	,	PUNCT
easat-2814	129	17	which	which	PRON
easat-2814	129	18	is	be	AUX
easat-2814	129	19	involved	involve	VERB
easat-2814	129	20	in	in	ADP
easat-2814	129	21	the	the	DET
easat-2814	129	22	modulation	modulation	NOUN
easat-2814	129	23	of	of	ADP
easat-2814	129	24	intestinal	intestinal	ADJ
easat-2814	129	25	3730	3730	NUM
easat-2814	129	26	edelweiss	edelweiss	PROPN
easat-2814	129	27	applied	apply	VERB
easat-2814	129	28	science	science	NOUN
easat-2814	129	29	and	and	CCONJ
easat-2814	129	30	technology	technology	NOUN
easat-2814	129	31	issn	issn	PROPN
easat-2814	129	32	:	:	PUNCT
easat-2814	129	33	2576	2576	NUM
easat-2814	129	34	-	-	SYM
easat-2814	129	35	8484	8484	NUM
easat-2814	129	36	vol	vol	NOUN
easat-2814	129	37	.	.	PROPN
easat-2814	129	38	8	8	NUM
easat-2814	129	39	,	,	PUNCT
easat-2814	129	40	no	no	INTJ
easat-2814	129	41	.	.	NOUN
easat-2814	129	42	6	6	NUM
easat-2814	129	43	:	:	SYM
easat-2814	129	44	3722	3722	NUM
easat-2814	129	45	-	-	SYM
easat-2814	129	46	3733	3733	NUM
easat-2814	129	47	,	,	PUNCT
easat-2814	129	48	2024	2024	NUM
easat-2814	129	49	doi	doi	NOUN
easat-2814	129	50	:	:	PUNCT
easat-2814	129	51	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	129	52	©	©	ADP
easat-2814	129	53	2024	2024	NUM
easat-2814	129	54	by	by	ADP
easat-2814	129	55	the	the	DET
easat-2814	129	56	authors	author	NOUN
easat-2814	129	57	;	;	PUNCT
easat-2814	129	58	licensee	licensee	PROPN
easat-2814	129	59	learning	learn	VERB
easat-2814	129	60	gate	gate	PROPN
easat-2814	129	61	permeability	permeability	NOUN
easat-2814	129	62	.	.	PUNCT
easat-2814	130	1	this	this	DET
easat-2814	130	2	interaction	interaction	NOUN
easat-2814	130	3	with	with	ADP
easat-2814	130	4	the	the	DET
easat-2814	130	5	intestinal	intestinal	ADJ
easat-2814	130	6	epithelial	epithelial	ADJ
easat-2814	130	7	barrier	barrier	NOUN
easat-2814	130	8	facilitates	facilitate	VERB
easat-2814	130	9	the	the	DET
easat-2814	130	10	release	release	NOUN
easat-2814	130	11	of	of	ADP
easat-2814	130	12	active	active	ADJ
easat-2814	130	13	molecules	molecule	NOUN
easat-2814	130	14	into	into	ADP
easat-2814	130	15	the	the	DET
easat-2814	130	16	mucous	mucous	ADJ
easat-2814	130	17	membrane	membrane	NOUN
easat-2814	130	18	,	,	PUNCT
easat-2814	130	19	enabling	enable	VERB
easat-2814	130	20	sod	sod	NOUN
easat-2814	130	21	to	to	PART
easat-2814	130	22	enter	enter	VERB
easat-2814	130	23	the	the	DET
easat-2814	130	24	bloodstream	bloodstream	NOUN
easat-2814	130	25	.	.	PUNCT
easat-2814	131	1	rosa	rosa	PROPN
easat-2814	131	2	et	et	PROPN
easat-2814	131	3	al	al	PROPN
easat-2814	131	4	.	.	PROPN
easat-2814	131	5	reported	report	VERB
easat-2814	131	6	that	that	SCONJ
easat-2814	131	7	sod3	sod3	NOUN
easat-2814	131	8	-	-	PUNCT
easat-2814	131	9	deficient	deficient	ADJ
easat-2814	131	10	mice	mouse	NOUN
easat-2814	131	11	exhibit	exhibit	VERB
easat-2814	131	12	signs	sign	NOUN
easat-2814	131	13	of	of	ADP
easat-2814	131	14	premature	premature	ADJ
easat-2814	131	15	aging	aging	NOUN
easat-2814	131	16	beginning	beginning	NOUN
easat-2814	131	17	in	in	ADP
easat-2814	131	18	the	the	DET
easat-2814	131	19	second	second	ADJ
easat-2814	131	20	month	month	NOUN
easat-2814	131	21	of	of	ADP
easat-2814	131	22	life	life	NOUN
easat-2814	131	23	,	,	PUNCT
easat-2814	131	24	characterized	characterize	VERB
easat-2814	131	25	by	by	ADP
easat-2814	131	26	a	a	DET
easat-2814	131	27	reduction	reduction	NOUN
easat-2814	131	28	in	in	ADP
easat-2814	131	29	endothelial	endothelial	ADJ
easat-2814	131	30	cell	cell	NOUN
easat-2814	131	31	density	density	NOUN
easat-2814	131	32	in	in	ADP
easat-2814	131	33	the	the	DET
easat-2814	131	34	cornea	cornea	NOUN
easat-2814	131	35	and	and	CCONJ
easat-2814	131	36	increased	increase	VERB
easat-2814	131	37	susceptibility	susceptibility	NOUN
easat-2814	131	38	to	to	PART
easat-2814	131	39	acute	acute	VERB
easat-2814	131	40	inflammatory	inflammatory	ADJ
easat-2814	131	41	endothelial	endothelial	ADJ
easat-2814	131	42	injury	injury	NOUN
easat-2814	131	43	.	.	PUNCT
easat-2814	132	1	in	in	ADP
easat-2814	132	2	a	a	DET
easat-2814	132	3	comparative	comparative	ADJ
easat-2814	132	4	study	study	NOUN
easat-2814	132	5	utilizing	utilize	VERB
easat-2814	132	6	an	an	DET
easat-2814	132	7	experimental	experimental	ADJ
easat-2814	132	8	rat	rat	NOUN
easat-2814	132	9	model	model	NOUN
easat-2814	132	10	,	,	PUNCT
easat-2814	132	11	researchers	researcher	NOUN
easat-2814	132	12	evaluated	evaluate	VERB
easat-2814	132	13	the	the	DET
easat-2814	132	14	pharmacological	pharmacological	ADJ
easat-2814	132	15	properties	property	NOUN
easat-2814	132	16	of	of	ADP
easat-2814	132	17	sod	sod	NOUN
easat-2814	132	18	enzymes	enzyme	NOUN
easat-2814	132	19	derived	derive	VERB
easat-2814	132	20	from	from	ADP
easat-2814	132	21	rats	rat	NOUN
easat-2814	132	22	,	,	PUNCT
easat-2814	132	23	bovines	bovine	NOUN
easat-2814	132	24	,	,	PUNCT
easat-2814	132	25	and	and	CCONJ
easat-2814	132	26	humans	human	NOUN
easat-2814	132	27	.	.	PUNCT
easat-2814	133	1	the	the	DET
easat-2814	133	2	results	result	NOUN
easat-2814	133	3	indicated	indicate	VERB
easat-2814	133	4	that	that	SCONJ
easat-2814	133	5	both	both	DET
easat-2814	133	6	human	human	ADJ
easat-2814	133	7	and	and	CCONJ
easat-2814	133	8	bovine	bovine	ADJ
easat-2814	133	9	sod	sod	NOUN
easat-2814	133	10	enzymes	enzyme	NOUN
easat-2814	133	11	demonstrated	demonstrate	VERB
easat-2814	133	12	significantly	significantly	ADV
easat-2814	133	13	greater	great	ADJ
easat-2814	133	14	pharmacological	pharmacological	ADJ
easat-2814	133	15	activity	activity	NOUN
easat-2814	133	16	compared	compare	VERB
easat-2814	133	17	to	to	ADP
easat-2814	133	18	their	their	PRON
easat-2814	133	19	rat	rat	NOUN
easat-2814	133	20	counterparts	counterpart	NOUN
easat-2814	133	21	,	,	PUNCT
easat-2814	133	22	despite	despite	SCONJ
easat-2814	133	23	exhibiting	exhibit	VERB
easat-2814	133	24	similar	similar	ADJ
easat-2814	133	25	biochemical	biochemical	ADJ
easat-2814	133	26	characteristics	characteristic	NOUN
easat-2814	133	27	.	.	PUNCT
easat-2814	134	1	in	in	ADP
easat-2814	134	2	light	light	NOUN
easat-2814	134	3	of	of	ADP
easat-2814	134	4	concerns	concern	NOUN
easat-2814	134	5	regarding	regard	VERB
easat-2814	134	6	creutzfeldt	creutzfeldt	ADJ
easat-2814	134	7	-	-	PUNCT
easat-2814	134	8	jakob	jakob	ADJ
easat-2814	134	9	disease	disease	NOUN
easat-2814	134	10	,	,	PUNCT
easat-2814	134	11	the	the	DET
easat-2814	134	12	availability	availability	NOUN
easat-2814	134	13	of	of	ADP
easat-2814	134	14	sod	sod	NOUN
easat-2814	134	15	products	product	NOUN
easat-2814	134	16	derived	derive	VERB
easat-2814	134	17	from	from	ADP
easat-2814	134	18	cattle	cattle	NOUN
easat-2814	134	19	for	for	ADP
easat-2814	134	20	human	human	ADJ
easat-2814	134	21	use	use	NOUN
easat-2814	134	22	has	have	AUX
easat-2814	134	23	become	become	VERB
easat-2814	134	24	restricted	restrict	VERB
easat-2814	134	25	.	.	PUNCT
easat-2814	135	1	consequently	consequently	ADV
easat-2814	135	2	,	,	PUNCT
easat-2814	135	3	a	a	DET
easat-2814	135	4	viable	viable	ADJ
easat-2814	135	5	alternative	alternative	NOUN
easat-2814	135	6	has	have	AUX
easat-2814	135	7	been	be	AUX
easat-2814	135	8	developed	develop	VERB
easat-2814	135	9	utilizing	utilize	VERB
easat-2814	135	10	plant	plant	NOUN
easat-2814	135	11	-	-	PUNCT
easat-2814	135	12	derived	derive	VERB
easat-2814	135	13	sod	sod	NOUN
easat-2814	135	14	.	.	PUNCT
easat-2814	136	1	non	non	ADJ
easat-2814	136	2	-	-	ADJ
easat-2814	136	3	genetically	genetically	ADV
easat-2814	136	4	modified	modify	VERB
easat-2814	136	5	melons	melon	NOUN
easat-2814	136	6	from	from	ADP
easat-2814	136	7	the	the	DET
easat-2814	136	8	species	species	NOUN
easat-2814	136	9	cucumis	cucumis	NOUN
easat-2814	136	10	melo	melo	PROPN
easat-2814	136	11	l.c	l.c	PROPN
easat-2814	136	12	.	.	PROPN
easat-2814	136	13	are	be	AUX
easat-2814	136	14	a	a	DET
easat-2814	136	15	particularly	particularly	ADV
easat-2814	136	16	suitable	suitable	ADJ
easat-2814	136	17	source	source	NOUN
easat-2814	136	18	of	of	ADP
easat-2814	136	19	this	this	DET
easat-2814	136	20	enzyme	enzyme	NOUN
easat-2814	136	21	,	,	PUNCT
easat-2814	136	22	exhibiting	exhibit	VERB
easat-2814	136	23	extremely	extremely	ADV
easat-2814	136	24	high	high	ADJ
easat-2814	136	25	levels	level	NOUN
easat-2814	136	26	of	of	ADP
easat-2814	136	27	sod	sod	NOUN
easat-2814	136	28	(	(	PUNCT
easat-2814	136	29	100	100	NUM
easat-2814	136	30	u	u	NOUN
easat-2814	136	31	/	/	SYM
easat-2814	136	32	mg	mg	PROPN
easat-2814	136	33	)	)	PUNCT
easat-2814	136	34	while	while	SCONJ
easat-2814	136	35	containing	contain	VERB
easat-2814	136	36	comparatively	comparatively	ADV
easat-2814	136	37	lower	low	ADJ
easat-2814	136	38	amounts	amount	NOUN
easat-2814	136	39	of	of	ADP
easat-2814	136	40	other	other	ADJ
easat-2814	136	41	antioxidant	antioxidant	ADJ
easat-2814	136	42	components	component	NOUN
easat-2814	136	43	,	,	PUNCT
easat-2814	136	44	such	such	ADJ
easat-2814	136	45	as	as	ADP
easat-2814	136	46	10	10	NUM
easat-2814	136	47	u	u	NOUN
easat-2814	136	48	/	/	SYM
easat-2814	136	49	mg	mg	NOUN
easat-2814	136	50	of	of	ADP
easat-2814	136	51	catalase	catalase	NOUN
easat-2814	136	52	(	(	PUNCT
easat-2814	136	53	cat	cat	NOUN
easat-2814	136	54	)	)	PUNCT
easat-2814	136	55	and	and	CCONJ
easat-2814	136	56	1	1	NUM
easat-2814	136	57	u	u	NOUN
easat-2814	136	58	/	/	SYM
easat-2814	136	59	mg	mg	NOUN
easat-2814	136	60	of	of	ADP
easat-2814	136	61	glutathione	glutathione	NOUN
easat-2814	136	62	peroxidase	peroxidase	NOUN
easat-2814	136	63	(	(	PUNCT
easat-2814	136	64	gpx	gpx	PROPN
easat-2814	136	65	)	)	PUNCT
easat-2814	136	66	.	.	PUNCT
easat-2814	137	1	ongoing	ongoing	ADJ
easat-2814	137	2	research	research	NOUN
easat-2814	137	3	has	have	AUX
easat-2814	137	4	led	lead	VERB
easat-2814	137	5	to	to	ADP
easat-2814	137	6	the	the	DET
easat-2814	137	7	development	development	NOUN
easat-2814	137	8	of	of	ADP
easat-2814	137	9	sod	sod	NOUN
easat-2814	137	10	-	-	PUNCT
easat-2814	137	11	based	base	VERB
easat-2814	137	12	compounds	compound	NOUN
easat-2814	137	13	with	with	ADP
easat-2814	137	14	potential	potential	ADJ
easat-2814	137	15	therapeutic	therapeutic	ADJ
easat-2814	137	16	applications	application	NOUN
easat-2814	137	17	[	[	X
easat-2814	137	18	7,20,21	7,20,21	NUM
easat-2814	137	19	]	]	PUNCT
easat-2814	137	20	research	research	NOUN
easat-2814	137	21	involving	involve	VERB
easat-2814	137	22	sod	sod	NOUN
easat-2814	137	23	melon	melon	NOUN
easat-2814	137	24	gliadin	gliadin	NOUN
easat-2814	137	25	(	(	PUNCT
easat-2814	137	26	glisodin	glisodin	NOUN
easat-2814	137	27	®	®	NOUN
easat-2814	137	28	)	)	PUNCT
easat-2814	137	29	in	in	ADP
easat-2814	137	30	the	the	DET
easat-2814	137	31	field	field	NOUN
easat-2814	137	32	of	of	ADP
easat-2814	137	33	ophthalmology	ophthalmology	NOUN
easat-2814	137	34	was	be	AUX
easat-2814	137	35	conducted	conduct	VERB
easat-2814	137	36	by	by	ADP
easat-2814	137	37	sicard	sicard	PROPN
easat-2814	137	38	et	et	PROPN
easat-2814	137	39	al	al	PROPN
easat-2814	137	40	.	.	PROPN
easat-2814	137	41	,	,	PUNCT
easat-2814	137	42	who	who	PRON
easat-2814	137	43	reported	report	VERB
easat-2814	137	44	a	a	DET
easat-2814	137	45	significant	significant	ADJ
easat-2814	137	46	reduction	reduction	NOUN
easat-2814	137	47	in	in	ADP
easat-2814	137	48	reactive	reactive	ADJ
easat-2814	137	49	oxygen	oxygen	NOUN
easat-2814	137	50	species	specie	NOUN
easat-2814	137	51	(	(	PUNCT
easat-2814	137	52	ros	ros	PROPN
easat-2814	137	53	)	)	PUNCT
easat-2814	137	54	levels	level	NOUN
easat-2814	137	55	in	in	ADP
easat-2814	137	56	the	the	DET
easat-2814	137	57	retinal	retinal	ADJ
easat-2814	137	58	layers	layer	NOUN
easat-2814	137	59	of	of	ADP
easat-2814	137	60	mice	mouse	NOUN
easat-2814	137	61	subjected	subject	VERB
easat-2814	137	62	to	to	PART
easat-2814	137	63	oxidative	oxidative	ADJ
easat-2814	137	64	stress	stress	NOUN
easat-2814	137	65	from	from	ADP
easat-2814	137	66	light	light	ADJ
easat-2814	137	67	exposure	exposure	NOUN
easat-2814	137	68	.	.	PUNCT
easat-2814	138	1	this	this	DET
easat-2814	138	2	reduction	reduction	NOUN
easat-2814	138	3	was	be	AUX
easat-2814	138	4	achieved	achieve	VERB
easat-2814	138	5	through	through	ADP
easat-2814	138	6	the	the	DET
easat-2814	138	7	administration	administration	NOUN
easat-2814	138	8	of	of	ADP
easat-2814	138	9	oral	oral	ADJ
easat-2814	138	10	melon	melon	NOUN
easat-2814	138	11	-	-	PUNCT
easat-2814	138	12	gliadin	gliadin	NOUN
easat-2814	138	13	sod	sod	NOUN
easat-2814	138	14	over	over	ADP
easat-2814	138	15	seven	seven	NUM
easat-2814	138	16	days	day	NOUN
easat-2814	138	17	.	.	PUNCT
easat-2814	139	1	additionally	additionally	ADV
easat-2814	139	2	,	,	PUNCT
easat-2814	139	3	a	a	DET
easat-2814	139	4	study	study	NOUN
easat-2814	139	5	by	by	ADP
easat-2814	139	6	yollamanda	yollamanda	PROPN
easat-2814	139	7	et	et	PROPN
easat-2814	139	8	al	al	PROPN
easat-2814	139	9	.	.	PROPN
easat-2814	139	10	investigated	investigate	VERB
easat-2814	139	11	the	the	DET
easat-2814	139	12	use	use	NOUN
easat-2814	139	13	of	of	ADP
easat-2814	139	14	glisodin	glisodin	NOUN
easat-2814	139	15	®	®	NOUN
easat-2814	139	16	as	as	ADP
easat-2814	139	17	a	a	DET
easat-2814	139	18	therapeutic	therapeutic	ADJ
easat-2814	139	19	option	option	NOUN
easat-2814	139	20	for	for	ADP
easat-2814	139	21	optic	optic	ADJ
easat-2814	139	22	nerve	nerve	NOUN
easat-2814	139	23	trauma	trauma	NOUN
easat-2814	139	24	.	.	PUNCT
easat-2814	140	1	the	the	DET
easat-2814	140	2	findings	finding	NOUN
easat-2814	140	3	indicated	indicate	VERB
easat-2814	140	4	no	no	DET
easat-2814	140	5	significant	significant	ADJ
easat-2814	140	6	difference	difference	NOUN
easat-2814	140	7	in	in	ADP
easat-2814	140	8	the	the	DET
easat-2814	140	9	density	density	NOUN
easat-2814	140	10	of	of	ADP
easat-2814	140	11	retinal	retinal	ADJ
easat-2814	140	12	ganglion	ganglion	NOUN
easat-2814	140	13	cells	cell	NOUN
easat-2814	140	14	between	between	ADP
easat-2814	140	15	rats	rat	NOUN
easat-2814	140	16	with	with	ADP
easat-2814	140	17	optic	optic	ADJ
easat-2814	140	18	nerve	nerve	NOUN
easat-2814	140	19	injury	injury	NOUN
easat-2814	140	20	that	that	PRON
easat-2814	140	21	received	receive	VERB
easat-2814	140	22	a	a	DET
easat-2814	140	23	combination	combination	NOUN
easat-2814	140	24	therapy	therapy	NOUN
easat-2814	140	25	of	of	ADP
easat-2814	140	26	methylprednisolone	methylprednisolone	PROPN
easat-2814	140	27	and	and	CCONJ
easat-2814	140	28	sod	sod	NOUN
easat-2814	140	29	melon	melon	NOUN
easat-2814	140	30	gliadin	gliadin	NOUN
easat-2814	140	31	(	(	PUNCT
easat-2814	140	32	glisodin	glisodin	NOUN
easat-2814	140	33	®	®	NOUN
easat-2814	140	34	)	)	PUNCT
easat-2814	140	35	and	and	CCONJ
easat-2814	140	36	those	those	PRON
easat-2814	140	37	treated	treat	VERB
easat-2814	140	38	with	with	ADP
easat-2814	140	39	methylprednisolone	methylprednisolone	NOUN
easat-2814	140	40	alone	alone	ADV
easat-2814	140	41	.	.	PUNCT
easat-2814	141	1	as	as	ADP
easat-2814	141	2	of	of	ADP
easat-2814	141	3	now	now	ADV
easat-2814	141	4	,	,	PUNCT
easat-2814	141	5	there	there	PRON
easat-2814	141	6	have	have	AUX
easat-2814	141	7	been	be	AUX
easat-2814	141	8	no	no	DET
easat-2814	141	9	studies	study	NOUN
easat-2814	141	10	specifically	specifically	ADV
easat-2814	141	11	examining	examine	VERB
easat-2814	141	12	the	the	DET
easat-2814	141	13	effects	effect	NOUN
easat-2814	141	14	of	of	ADP
easat-2814	141	15	oral	oral	ADJ
easat-2814	141	16	melon	melon	NOUN
easat-2814	141	17	-	-	PUNCT
easat-2814	141	18	gliadin	gliadin	VERB
easat-2814	141	19	sod	sod	NOUN
easat-2814	141	20	supplementation	supplementation	NOUN
easat-2814	141	21	as	as	ADP
easat-2814	141	22	a	a	DET
easat-2814	141	23	therapy	therapy	NOUN
easat-2814	141	24	for	for	ADP
easat-2814	141	25	diabetic	diabetic	ADJ
easat-2814	141	26	retinopathy	retinopathy	NOUN
easat-2814	141	27	.	.	PUNCT
easat-2814	142	1	however	however	ADV
easat-2814	142	2	,	,	PUNCT
easat-2814	142	3	research	research	NOUN
easat-2814	142	4	by	by	ADP
easat-2814	142	5	lee	lee	PROPN
easat-2814	142	6	et	et	PROPN
easat-2814	142	7	al	al	PROPN
easat-2814	142	8	.	.	PROPN
easat-2814	142	9	supports	support	VERB
easat-2814	142	10	the	the	DET
easat-2814	142	11	utilization	utilization	NOUN
easat-2814	142	12	of	of	ADP
easat-2814	142	13	recombinant	recombinant	ADJ
easat-2814	142	14	extracellular	extracellular	ADJ
easat-2814	142	15	sod	sod	NOUN
easat-2814	142	16	(	(	PUNCT
easat-2814	142	17	sod3	sod3	PROPN
easat-2814	142	18	)	)	PUNCT
easat-2814	142	19	as	as	ADP
easat-2814	142	20	a	a	DET
easat-2814	142	21	preventative	preventative	ADJ
easat-2814	142	22	treatment	treatment	NOUN
easat-2814	142	23	for	for	ADP
easat-2814	142	24	diabetic	diabetic	ADJ
easat-2814	142	25	retinopathy	retinopathy	NOUN
easat-2814	142	26	.	.	PUNCT
easat-2814	143	1	their	their	PRON
easat-2814	143	2	study	study	NOUN
easat-2814	143	3	demonstrated	demonstrate	VERB
easat-2814	143	4	that	that	SCONJ
easat-2814	143	5	intravitreal	intravitreal	ADJ
easat-2814	143	6	sod3	sod3	NOUN
easat-2814	143	7	therapy	therapy	NOUN
easat-2814	143	8	improved	improve	VERB
easat-2814	143	9	the	the	DET
easat-2814	143	10	activation	activation	NOUN
easat-2814	143	11	of	of	ADP
easat-2814	143	12	retinal	retinal	ADJ
easat-2814	143	13	müller	müller	NOUN
easat-2814	143	14	cells	cell	NOUN
easat-2814	143	15	and	and	CCONJ
easat-2814	143	16	addressed	address	VERB
easat-2814	143	17	pericyte	pericyte	NOUN
easat-2814	143	18	dysfunction	dysfunction	NOUN
easat-2814	143	19	in	in	ADP
easat-2814	143	20	diabetic	diabetic	ADJ
easat-2814	143	21	mice	mouse	NOUN
easat-2814	143	22	.	.	PUNCT
easat-2814	144	1	these	these	DET
easat-2814	144	2	results	result	NOUN
easat-2814	144	3	suggest	suggest	VERB
easat-2814	144	4	that	that	SCONJ
easat-2814	144	5	sod3	sod3	PROPN
easat-2814	144	6	provides	provide	VERB
easat-2814	144	7	a	a	DET
easat-2814	144	8	protective	protective	ADJ
easat-2814	144	9	effect	effect	NOUN
easat-2814	144	10	against	against	ADP
easat-2814	144	11	the	the	DET
easat-2814	144	12	progression	progression	NOUN
easat-2814	144	13	of	of	ADP
easat-2814	144	14	diabetic	diabetic	ADJ
easat-2814	144	15	retinopathy.[22	retinopathy.[22	ADJ
easat-2814	144	16	-	-	PUNCT
easat-2814	144	17	25	25	NUM
easat-2814	144	18	]	]	SYM
easat-2814	144	19	3731	3731	NUM
easat-2814	144	20	edelweiss	edelweiss	PROPN
easat-2814	144	21	applied	apply	VERB
easat-2814	144	22	science	science	NOUN
easat-2814	144	23	and	and	CCONJ
easat-2814	144	24	technology	technology	NOUN
easat-2814	144	25	issn	issn	PROPN
easat-2814	144	26	:	:	PUNCT
easat-2814	144	27	2576	2576	NUM
easat-2814	144	28	-	-	SYM
easat-2814	144	29	8484	8484	NUM
easat-2814	144	30	vol	vol	NOUN
easat-2814	144	31	.	.	PROPN
easat-2814	144	32	8	8	NUM
easat-2814	144	33	,	,	PUNCT
easat-2814	144	34	no	no	INTJ
easat-2814	144	35	.	.	NOUN
easat-2814	145	1	6	6	NUM
easat-2814	145	2	:	:	SYM
easat-2814	145	3	3722	3722	NUM
easat-2814	145	4	-	-	SYM
easat-2814	145	5	3733	3733	NUM
easat-2814	145	6	,	,	PUNCT
easat-2814	145	7	2024	2024	NUM
easat-2814	145	8	doi	doi	NOUN
easat-2814	145	9	:	:	PUNCT
easat-2814	145	10	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	145	11	©	©	ADP
easat-2814	145	12	2024	2024	NUM
easat-2814	145	13	by	by	ADP
easat-2814	145	14	the	the	DET
easat-2814	145	15	authors	author	NOUN
easat-2814	145	16	;	;	PUNCT
easat-2814	145	17	licensee	licensee	PROPN
easat-2814	145	18	learning	learn	VERB
easat-2814	145	19	gate	gate	PROPN
easat-2814	145	20	figure	figure	NOUN
easat-2814	145	21	6	6	NUM
easat-2814	145	22	.	.	PUNCT
easat-2814	146	1	ros	ros	PROPN
easat-2814	146	2	and	and	CCONJ
easat-2814	146	3	antioxidant	antioxidant	ADJ
easat-2814	146	4	sod	sod	NOUN
easat-2814	146	5	in	in	ADP
easat-2814	146	6	the	the	DET
easat-2814	146	7	anterior	anterior	ADJ
easat-2814	146	8	and	and	CCONJ
easat-2814	146	9	posterior	posterior	ADJ
easat-2814	146	10	segments	segment	NOUN
easat-2814	146	11	of	of	ADP
easat-2814	146	12	the	the	DET
easat-2814	146	13	eye	eye	NOUN
easat-2814	146	14	[	[	X
easat-2814	146	15	24	24	NUM
easat-2814	146	16	]	]	PUNCT
easat-2814	146	17	.	.	PUNCT
easat-2814	147	1	table	table	NOUN
easat-2814	147	2	2	2	NUM
easat-2814	147	3	.	.	X
easat-2814	147	4	animal	animal	NOUN
easat-2814	147	5	research	research	NOUN
easat-2814	147	6	studies	study	NOUN
easat-2814	147	7	regarding	regard	VERB
easat-2814	147	8	the	the	DET
easat-2814	147	9	effects	effect	NOUN
easat-2814	147	10	of	of	ADP
easat-2814	147	11	administering	administer	VERB
easat-2814	147	12	sod	sod	NOUN
easat-2814	147	13	gliadin[25	gliadin[25	NOUN
easat-2814	147	14	]	]	PUNCT
easat-2814	147	15	.	.	PUNCT
easat-2814	148	1	2	2	X
easat-2814	148	2	.	.	X
easat-2814	148	3	conclusion	conclusion	NOUN
easat-2814	148	4	diabetic	diabetic	ADJ
easat-2814	148	5	retinopathy	retinopathy	ADJ
easat-2814	148	6	(	(	PUNCT
easat-2814	148	7	dr	dr	PROPN
easat-2814	148	8	)	)	PUNCT
easat-2814	148	9	is	be	AUX
easat-2814	148	10	a	a	DET
easat-2814	148	11	microvascular	microvascular	ADJ
easat-2814	148	12	complication	complication	NOUN
easat-2814	148	13	of	of	ADP
easat-2814	148	14	diabetes	diabetes	NOUN
easat-2814	148	15	mellitus	mellitus	NOUN
easat-2814	148	16	and	and	CCONJ
easat-2814	148	17	a	a	DET
easat-2814	148	18	leading	lead	VERB
easat-2814	148	19	cause	cause	NOUN
easat-2814	148	20	of	of	ADP
easat-2814	148	21	vision	vision	NOUN
easat-2814	148	22	impairment	impairment	NOUN
easat-2814	148	23	and	and	CCONJ
easat-2814	148	24	blindness	blindness	NOUN
easat-2814	148	25	when	when	SCONJ
easat-2814	148	26	left	leave	VERB
easat-2814	148	27	untreated	untreated	ADJ
easat-2814	148	28	.	.	PUNCT
easat-2814	149	1	one	one	NUM
easat-2814	149	2	of	of	ADP
easat-2814	149	3	the	the	DET
easat-2814	149	4	critical	critical	ADJ
easat-2814	149	5	pathological	pathological	ADJ
easat-2814	149	6	processes	process	NOUN
easat-2814	149	7	in	in	ADP
easat-2814	149	8	dr	dr	PROPN
easat-2814	149	9	is	be	AUX
easat-2814	149	10	the	the	DET
easat-2814	149	11	excessive	excessive	ADJ
easat-2814	149	12	accumulation	accumulation	NOUN
easat-2814	149	13	of	of	ADP
easat-2814	149	14	reactive	reactive	ADJ
easat-2814	149	15	oxygen	oxygen	NOUN
easat-2814	149	16	species	specie	NOUN
easat-2814	149	17	(	(	PUNCT
easat-2814	149	18	ros	ros	PROPN
easat-2814	149	19	)	)	PUNCT
easat-2814	149	20	,	,	PUNCT
easat-2814	149	21	which	which	PRON
easat-2814	149	22	can	can	AUX
easat-2814	149	23	damage	damage	VERB
easat-2814	149	24	tissues	tissue	NOUN
easat-2814	149	25	in	in	ADP
easat-2814	149	26	and	and	CCONJ
easat-2814	149	27	around	around	ADP
easat-2814	149	28	3732	3732	NUM
easat-2814	149	29	edelweiss	edelweiss	PROPN
easat-2814	149	30	applied	apply	VERB
easat-2814	149	31	science	science	NOUN
easat-2814	149	32	and	and	CCONJ
easat-2814	149	33	technology	technology	NOUN
easat-2814	149	34	issn	issn	PROPN
easat-2814	149	35	:	:	PUNCT
easat-2814	149	36	2576	2576	NUM
easat-2814	149	37	-	-	SYM
easat-2814	149	38	8484	8484	NUM
easat-2814	149	39	vol	vol	NOUN
easat-2814	149	40	.	.	PROPN
easat-2814	149	41	8	8	NUM
easat-2814	149	42	,	,	PUNCT
easat-2814	149	43	no	no	INTJ
easat-2814	149	44	.	.	NOUN
easat-2814	150	1	6	6	NUM
easat-2814	150	2	:	:	SYM
easat-2814	150	3	3722	3722	NUM
easat-2814	150	4	-	-	SYM
easat-2814	150	5	3733	3733	NUM
easat-2814	150	6	,	,	PUNCT
easat-2814	150	7	2024	2024	NUM
easat-2814	150	8	doi	doi	NOUN
easat-2814	150	9	:	:	PUNCT
easat-2814	150	10	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	150	11	©	©	ADP
easat-2814	150	12	2024	2024	NUM
easat-2814	150	13	by	by	ADP
easat-2814	150	14	the	the	DET
easat-2814	150	15	authors	author	NOUN
easat-2814	150	16	;	;	PUNCT
easat-2814	150	17	licensee	licensee	PROPN
easat-2814	150	18	learning	learning	NOUN
easat-2814	150	19	gate	gate	VERB
easat-2814	150	20	the	the	DET
easat-2814	150	21	retinal	retinal	ADJ
easat-2814	150	22	vasculature	vasculature	NOUN
easat-2814	150	23	.	.	PUNCT
easat-2814	151	1	increased	increase	VERB
easat-2814	151	2	ros	ros	PROPN
easat-2814	151	3	levels	level	NOUN
easat-2814	151	4	,	,	PUNCT
easat-2814	151	5	particularly	particularly	ADV
easat-2814	151	6	from	from	ADP
easat-2814	151	7	the	the	DET
easat-2814	151	8	protein	protein	NOUN
easat-2814	151	9	kinase	kinase	NOUN
easat-2814	151	10	c	c	PROPN
easat-2814	151	11	pathway	pathway	NOUN
easat-2814	151	12	,	,	PUNCT
easat-2814	151	13	are	be	AUX
easat-2814	151	14	associated	associate	VERB
easat-2814	151	15	with	with	ADP
easat-2814	151	16	elevated	elevated	ADJ
easat-2814	151	17	vascular	vascular	ADJ
easat-2814	151	18	endothelial	endothelial	NOUN
easat-2814	151	19	growth	growth	NOUN
easat-2814	151	20	factor	factor	NOUN
easat-2814	151	21	(	(	PUNCT
easat-2814	151	22	vegf	vegf	PROPN
easat-2814	151	23	)	)	PUNCT
easat-2814	151	24	levels	level	NOUN
easat-2814	151	25	,	,	PUNCT
easat-2814	151	26	which	which	PRON
easat-2814	151	27	contribute	contribute	VERB
easat-2814	151	28	significantly	significantly	ADV
easat-2814	151	29	to	to	ADP
easat-2814	151	30	blood	blood	NOUN
easat-2814	151	31	-	-	PUNCT
easat-2814	151	32	retinal	retinal	ADJ
easat-2814	151	33	barrier	barrier	NOUN
easat-2814	151	34	dysfunction	dysfunction	NOUN
easat-2814	151	35	and	and	CCONJ
easat-2814	151	36	increased	increase	VERB
easat-2814	151	37	vascular	vascular	ADJ
easat-2814	151	38	permeability	permeability	NOUN
easat-2814	151	39	,	,	PUNCT
easat-2814	151	40	leading	lead	VERB
easat-2814	151	41	to	to	ADP
easat-2814	151	42	angiogenesis	angiogenesis	NOUN
easat-2814	151	43	.	.	PUNCT
easat-2814	152	1	additionally	additionally	ADV
easat-2814	152	2	,	,	PUNCT
easat-2814	152	3	transforming	transform	VERB
easat-2814	152	4	growth	growth	NOUN
easat-2814	152	5	factor	factor	NOUN
easat-2814	152	6	beta	beta	NOUN
easat-2814	152	7	(	(	PUNCT
easat-2814	152	8	tgf	tgf	PROPN
easat-2814	152	9	-	-	PUNCT
easat-2814	152	10	β	β	NOUN
easat-2814	152	11	)	)	PUNCT
easat-2814	152	12	plays	play	VERB
easat-2814	152	13	a	a	DET
easat-2814	152	14	vital	vital	ADJ
easat-2814	152	15	role	role	NOUN
easat-2814	152	16	in	in	ADP
easat-2814	152	17	maintaining	maintain	VERB
easat-2814	152	18	ocular	ocular	ADJ
easat-2814	152	19	homeostasis	homeostasis	NOUN
easat-2814	152	20	and	and	CCONJ
easat-2814	152	21	capillary	capillary	ADJ
easat-2814	152	22	integrity	integrity	NOUN
easat-2814	152	23	.	.	PUNCT
easat-2814	153	1	sod	sod	NOUN
easat-2814	153	2	melon	melon	NOUN
easat-2814	153	3	gliadin	gliadin	NOUN
easat-2814	153	4	(	(	PUNCT
easat-2814	153	5	glisodin	glisodin	NOUN
easat-2814	153	6	®	®	NOUN
easat-2814	153	7	)	)	PUNCT
easat-2814	153	8	is	be	AUX
easat-2814	153	9	a	a	DET
easat-2814	153	10	type	type	NOUN
easat-2814	153	11	of	of	ADP
easat-2814	153	12	exogenous	exogenous	ADJ
easat-2814	153	13	superoxide	superoxide	NOUN
easat-2814	153	14	dismutase	dismutase	NOUN
easat-2814	153	15	(	(	PUNCT
easat-2814	153	16	sod	sod	NOUN
easat-2814	153	17	)	)	PUNCT
easat-2814	153	18	derived	derive	VERB
easat-2814	153	19	from	from	ADP
easat-2814	153	20	the	the	DET
easat-2814	153	21	melon	melon	NOUN
easat-2814	153	22	(	(	PUNCT
easat-2814	153	23	cucumis	cucumis	PROPN
easat-2814	153	24	melo	melo	PROPN
easat-2814	153	25	sp	sp	PROPN
easat-2814	153	26	.	.	PROPN
easat-2814	153	27	)	)	PUNCT
easat-2814	153	28	,	,	PUNCT
easat-2814	153	29	recognized	recognize	VERB
easat-2814	153	30	for	for	ADP
easat-2814	153	31	its	its	PRON
easat-2814	153	32	antioxidant	antioxidant	ADJ
easat-2814	153	33	properties	property	NOUN
easat-2814	153	34	.	.	PUNCT
easat-2814	154	1	it	it	PRON
easat-2814	154	2	is	be	AUX
easat-2814	154	3	known	know	VERB
easat-2814	154	4	to	to	PART
easat-2814	154	5	enhance	enhance	VERB
easat-2814	154	6	endogenous	endogenous	ADJ
easat-2814	154	7	sod	sod	NOUN
easat-2814	154	8	levels	level	NOUN
easat-2814	154	9	,	,	PUNCT
easat-2814	154	10	reduce	reduce	VERB
easat-2814	154	11	ros	ros	PROPN
easat-2814	154	12	,	,	PUNCT
easat-2814	154	13	and	and	CCONJ
easat-2814	154	14	mitigate	mitigate	VERB
easat-2814	154	15	damage	damage	NOUN
easat-2814	154	16	to	to	ADP
easat-2814	154	17	retinal	retinal	ADJ
easat-2814	154	18	vessels	vessel	NOUN
easat-2814	154	19	.	.	PUNCT
easat-2814	155	1	despite	despite	SCONJ
easat-2814	155	2	the	the	DET
easat-2814	155	3	potential	potential	ADJ
easat-2814	155	4	benefits	benefit	NOUN
easat-2814	155	5	of	of	ADP
easat-2814	155	6	glisodin	glisodin	NOUN
easat-2814	155	7	®	®	NOUN
easat-2814	155	8	in	in	ADP
easat-2814	155	9	ophthalmology	ophthalmology	NOUN
easat-2814	155	10	,	,	PUNCT
easat-2814	155	11	particularly	particularly	ADV
easat-2814	155	12	concerning	concern	VERB
easat-2814	155	13	complications	complication	NOUN
easat-2814	155	14	associated	associate	VERB
easat-2814	155	15	with	with	ADP
easat-2814	155	16	diabetic	diabetic	ADJ
easat-2814	155	17	retinopathy	retinopathy	NOUN
easat-2814	155	18	,	,	PUNCT
easat-2814	155	19	research	research	NOUN
easat-2814	155	20	in	in	ADP
easat-2814	155	21	this	this	DET
easat-2814	155	22	area	area	NOUN
easat-2814	155	23	remains	remain	VERB
easat-2814	155	24	limited	limited	ADJ
easat-2814	155	25	.	.	PUNCT
easat-2814	156	1	however	however	ADV
easat-2814	156	2	,	,	PUNCT
easat-2814	156	3	studies	study	NOUN
easat-2814	156	4	involving	involve	VERB
easat-2814	156	5	other	other	ADJ
easat-2814	156	6	sources	source	NOUN
easat-2814	156	7	of	of	ADP
easat-2814	156	8	exogenous	exogenous	ADJ
easat-2814	156	9	sod	sod	NOUN
easat-2814	156	10	suggest	suggest	VERB
easat-2814	156	11	that	that	SCONJ
easat-2814	156	12	sod	sod	NOUN
easat-2814	156	13	melon	melon	NOUN
easat-2814	156	14	gliadin	gliadin	NOUN
easat-2814	156	15	could	could	AUX
easat-2814	156	16	effectively	effectively	ADV
easat-2814	156	17	elevate	elevate	VERB
easat-2814	156	18	antioxidant	antioxidant	ADJ
easat-2814	156	19	levels	level	NOUN
easat-2814	156	20	in	in	ADP
easat-2814	156	21	vitreoretinal	vitreoretinal	ADJ
easat-2814	156	22	tissue	tissue	NOUN
easat-2814	156	23	and	and	CCONJ
easat-2814	156	24	serum	serum	NOUN
easat-2814	156	25	,	,	PUNCT
easat-2814	156	26	potentially	potentially	ADV
easat-2814	156	27	aiding	aid	VERB
easat-2814	156	28	in	in	ADP
easat-2814	156	29	the	the	DET
easat-2814	156	30	prevention	prevention	NOUN
easat-2814	156	31	of	of	ADP
easat-2814	156	32	diabetic	diabetic	ADJ
easat-2814	156	33	retinopathy	retinopathy	NOUN
easat-2814	156	34	in	in	ADP
easat-2814	156	35	the	the	DET
easat-2814	156	36	future	future	NOUN
easat-2814	156	37	.	.	PUNCT
easat-2814	157	1	acknowledgments	acknowledgment	NOUN
easat-2814	157	2	:	:	PUNCT
easat-2814	157	3	the	the	DET
easat-2814	157	4	author	author	NOUN
easat-2814	157	5	would	would	AUX
easat-2814	157	6	like	like	VERB
easat-2814	157	7	to	to	PART
easat-2814	157	8	thank	thank	VERB
easat-2814	157	9	all	all	DET
easat-2814	157	10	the	the	DET
easat-2814	157	11	staff	staff	NOUN
easat-2814	157	12	of	of	ADP
easat-2814	157	13	the	the	DET
easat-2814	157	14	division	division	NOUN
easat-2814	157	15	of	of	ADP
easat-2814	157	16	vitreoretina	vitreoretina	PROPN
easat-2814	157	17	and	and	CCONJ
easat-2814	157	18	all	all	DET
easat-2814	157	19	staff	staff	NOUN
easat-2814	157	20	at	at	ADP
easat-2814	157	21	department	department	NOUN
easat-2814	157	22	of	of	ADP
easat-2814	157	23	opthalmology	opthalmology	NOUN
easat-2814	157	24	at	at	ADP
easat-2814	157	25	the	the	DET
easat-2814	157	26	faculty	faculty	NOUN
easat-2814	157	27	of	of	ADP
easat-2814	157	28	medicine	medicine	NOUN
easat-2814	157	29	,	,	PUNCT
easat-2814	157	30	university	university	NOUN
easat-2814	157	31	of	of	ADP
easat-2814	157	32	airlangga	airlangga	PROPN
easat-2814	157	33	/dr	/dr	PROPN
easat-2814	157	34	.	.	PUNCT
easat-2814	158	1	soetomo	soetomo	PROPN
easat-2814	158	2	general	general	ADJ
easat-2814	158	3	academic	academic	ADJ
easat-2814	158	4	hospital	hospital	NOUN
easat-2814	158	5	,	,	PUNCT
easat-2814	158	6	surabaya	surabaya	PROPN
easat-2814	158	7	,	,	PUNCT
easat-2814	158	8	indonesia	indonesia	PROPN
easat-2814	158	9	.	.	PUNCT
easat-2814	159	1	copyright	copyright	NOUN
easat-2814	159	2	:	:	PUNCT
easat-2814	159	3	©	©	PROPN
easat-2814	159	4	2024	2024	NUM
easat-2814	159	5	by	by	ADP
easat-2814	159	6	the	the	DET
easat-2814	159	7	authors	author	NOUN
easat-2814	159	8	.	.	PUNCT
easat-2814	160	1	this	this	DET
easat-2814	160	2	article	article	NOUN
easat-2814	160	3	is	be	AUX
easat-2814	160	4	an	an	DET
easat-2814	160	5	open	open	ADJ
easat-2814	160	6	access	access	NOUN
easat-2814	160	7	article	article	NOUN
easat-2814	160	8	distributed	distribute	VERB
easat-2814	160	9	under	under	ADP
easat-2814	160	10	the	the	DET
easat-2814	160	11	terms	term	NOUN
easat-2814	160	12	and	and	CCONJ
easat-2814	160	13	conditions	condition	NOUN
easat-2814	160	14	of	of	ADP
easat-2814	160	15	the	the	DET
easat-2814	160	16	creative	creative	ADJ
easat-2814	160	17	commons	common	NOUN
easat-2814	160	18	attribution	attribution	NOUN
easat-2814	160	19	(	(	PUNCT
easat-2814	160	20	cc	cc	NOUN
easat-2814	160	21	by	by	ADP
easat-2814	160	22	)	)	PUNCT
easat-2814	160	23	license	license	NOUN
easat-2814	160	24	(	(	PUNCT
easat-2814	160	25	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-2814	160	26	)	)	PUNCT
easat-2814	160	27	.	.	PUNCT
easat-2814	161	1	references	reference	NOUN
easat-2814	161	2	[	[	X
easat-2814	161	3	1	1	X
easat-2814	161	4	]	]	SYM
easat-2814	161	5	ogurtsova	ogurtsova	PROPN
easat-2814	161	6	,	,	PUNCT
easat-2814	161	7	k.	k.	PROPN
easat-2814	161	8	,	,	PUNCT
easat-2814	161	9	da	da	PROPN
easat-2814	161	10	rocha	rocha	PROPN
easat-2814	161	11	fernandes	fernandes	PROPN
easat-2814	161	12	,	,	PUNCT
easat-2814	161	13	j.	j.	PROPN
easat-2814	161	14	d.	d.	PROPN
easat-2814	161	15	,	,	PUNCT
easat-2814	161	16	huang	huang	PROPN
easat-2814	161	17	,	,	PUNCT
easat-2814	161	18	y.	y.	PROPN
easat-2814	161	19	,	,	PUNCT
easat-2814	161	20	linnenkamp	linnenkamp	PROPN
easat-2814	161	21	,	,	PUNCT
easat-2814	161	22	u.	u.	PROPN
easat-2814	161	23	,	,	PUNCT
easat-2814	161	24	guariguata	guariguata	PROPN
easat-2814	161	25	,	,	PUNCT
easat-2814	161	26	l.	l.	PROPN
easat-2814	161	27	,	,	PUNCT
easat-2814	161	28	cho	cho	PROPN
easat-2814	161	29	,	,	PUNCT
easat-2814	161	30	n.	n.	PROPN
easat-2814	161	31	h.	h.	PROPN
easat-2814	161	32	,	,	PUNCT
easat-2814	161	33	makaroff	makaroff	PROPN
easat-2814	161	34	,	,	PUNCT
easat-2814	161	35	l.	l.	PROPN
easat-2814	161	36	e.	e.	PROPN
easat-2814	161	37	(	(	PUNCT
easat-2814	161	38	2017	2017	NUM
easat-2814	161	39	)	)	PUNCT
easat-2814	161	40	.	.	PUNCT
easat-2814	162	1	idf	idf	PROPN
easat-2814	162	2	diabetes	diabetes	PROPN
easat-2814	162	3	atlas	atlas	PROPN
easat-2814	162	4	:	:	PUNCT
easat-2814	162	5	global	global	ADJ
easat-2814	162	6	estimates	estimate	NOUN
easat-2814	162	7	for	for	ADP
easat-2814	162	8	the	the	DET
easat-2814	162	9	prevalence	prevalence	NOUN
easat-2814	162	10	of	of	ADP
easat-2814	162	11	diabetes	diabetes	NOUN
easat-2814	162	12	for	for	ADP
easat-2814	162	13	2015	2015	NUM
easat-2814	162	14	and	and	CCONJ
easat-2814	162	15	2040	2040	NUM
easat-2814	162	16	.	.	PUNCT
easat-2814	163	1	diabetes	diabetes	NOUN
easat-2814	163	2	research	research	NOUN
easat-2814	163	3	and	and	CCONJ
easat-2814	163	4	clinical	clinical	ADJ
easat-2814	163	5	practice	practice	NOUN
easat-2814	163	6	,	,	PUNCT
easat-2814	163	7	128	128	NUM
easat-2814	163	8	,	,	PUNCT
easat-2814	163	9	40–50	40–50	NUM
easat-2814	163	10	.	.	PUNCT
easat-2814	164	1	doi:10.1016	doi:10.1016	PROPN
easat-2814	164	2	/	/	SYM
easat-2814	164	3	j.diabres.2017.03.024	j.diabres.2017.03.024	NOUN
easat-2814	164	4	[	[	X
easat-2814	164	5	2	2	NUM
easat-2814	164	6	]	]	X
easat-2814	164	7	lee	lee	PROPN
easat-2814	164	8	,	,	PUNCT
easat-2814	164	9	r.	r.	PROPN
easat-2814	164	10	,	,	PUNCT
easat-2814	164	11	wong	wong	PROPN
easat-2814	164	12	,	,	PUNCT
easat-2814	164	13	t.y	t.y	PROPN
easat-2814	164	14	.	.	PROPN
easat-2814	164	15	&	&	CCONJ
easat-2814	164	16	sabanayagam	sabanayagam	PROPN
easat-2814	164	17	,	,	PUNCT
easat-2814	164	18	c.	c.	PROPN
easat-2814	164	19	epidemiology	epidemiology	NOUN
easat-2814	164	20	of	of	ADP
easat-2814	164	21	diabetic	diabetic	ADJ
easat-2814	164	22	retinopathy	retinopathy	NOUN
easat-2814	164	23	,	,	PUNCT
easat-2814	164	24	diabetic	diabetic	ADJ
easat-2814	164	25	macular	macular	ADJ
easat-2814	164	26	edema	edema	NOUN
easat-2814	164	27	and	and	CCONJ
easat-2814	164	28	related	related	ADJ
easat-2814	164	29	vision	vision	NOUN
easat-2814	164	30	loss	loss	NOUN
easat-2814	164	31	.	.	PUNCT
easat-2814	165	1	eye	eye	NOUN
easat-2814	165	2	and	and	CCONJ
easat-2814	165	3	vis	vis	X
easat-2814	165	4	2	2	NUM
easat-2814	165	5	,	,	PUNCT
easat-2814	165	6	17	17	NUM
easat-2814	165	7	(	(	PUNCT
easat-2814	165	8	2015	2015	NUM
easat-2814	165	9	)	)	PUNCT
easat-2814	165	10	.	.	PUNCT
easat-2814	166	1	https://doi.org/10.1186/s40662-015-0026-2	https://doi.org/10.1186/s40662-015-0026-2	NUM
easat-2814	167	1	[	[	X
easat-2814	167	2	3	3	NUM
easat-2814	167	3	]	]	X
easat-2814	167	4	suryathi	suryathi	NOUN
easat-2814	167	5	,	,	PUNCT
easat-2814	167	6	n.m.a	n.m.a	NOUN
easat-2814	167	7	.	.	PROPN
easat-2814	167	8	,	,	PUNCT
easat-2814	167	9	suastika	suastika	PROPN
easat-2814	167	10	,	,	PUNCT
easat-2814	167	11	k.	k.	PROPN
easat-2814	167	12	,	,	PUNCT
easat-2814	167	13	andayani	andayani	ADJ
easat-2814	167	14	,	,	PUNCT
easat-2814	167	15	a.	a.	NOUN
easat-2814	167	16	,	,	PUNCT
easat-2814	167	17	pantjawati	pantjawati	PROPN
easat-2814	167	18	,	,	PUNCT
easat-2814	167	19	n.l.d	n.l.d	NOUN
easat-2814	167	20	.	.	PROPN
easat-2814	167	21	,	,	PUNCT
easat-2814	167	22	surasmiati	surasmiati	PROPN
easat-2814	167	23	,	,	PUNCT
easat-2814	167	24	n.m.a	n.m.a	NOUN
easat-2814	167	25	.	.	PROPN
easat-2814	167	26	,	,	PUNCT
easat-2814	167	27	manuaba	manuaba	PROPN
easat-2814	167	28	,	,	PUNCT
easat-2814	167	29	i.b.p	i.b.p	X
easat-2814	167	30	.	.	PUNCT
easat-2814	167	31	(	(	PUNCT
easat-2814	167	32	2024	2024	NUM
easat-2814	167	33	)	)	PUNCT
easat-2814	167	34	.	.	PUNCT
easat-2814	168	1	high	high	ADJ
easat-2814	168	2	vitreous	vitreous	ADJ
easat-2814	168	3	tnf	tnf	PROPN
easat-2814	168	4	-	-	PUNCT
easat-2814	168	5	alpha	alpha	NOUN
easat-2814	168	6	and	and	CCONJ
easat-2814	168	7	vascular	vascular	ADJ
easat-2814	168	8	endothelial	endothelial	ADJ
easat-2814	168	9	growth	growth	NOUN
easat-2814	168	10	factor	factor	NOUN
easat-2814	168	11	levels	level	NOUN
easat-2814	168	12	as	as	ADP
easat-2814	168	13	a	a	DET
easat-2814	168	14	risk	risk	NOUN
easat-2814	168	15	factor	factor	NOUN
easat-2814	168	16	for	for	ADP
easat-2814	168	17	proliferative	proliferative	ADJ
easat-2814	168	18	diabetic	diabetic	ADJ
easat-2814	168	19	retinopathy	retinopathy	NOUN
easat-2814	168	20	in	in	ADP
easat-2814	168	21	type	type	NOUN
easat-2814	168	22	2	2	NUM
easat-2814	168	23	diabetes	diabetes	NOUN
easat-2814	168	24	mellitus	mellitus	NOUN
easat-2814	168	25	patients	patient	NOUN
easat-2814	168	26	.	.	PUNCT
easat-2814	169	1	bali	bali	PROPN
easat-2814	169	2	medical	medical	PROPN
easat-2814	169	3	journal	journal	PROPN
easat-2814	169	4	13(3	13(3	NUM
easat-2814	169	5	):	):	PUNCT
easat-2814	169	6	1307	1307	NUM
easat-2814	169	7	-	-	SYM
easat-2814	169	8	1311	1311	NUM
easat-2814	169	9	.	.	PUNCT
easat-2814	170	1	doi	doi	NOUN
easat-2814	170	2	:	:	PUNCT
easat-2814	170	3	10.15562	10.15562	NUM
easat-2814	170	4	/	/	SYM
easat-2814	170	5	bmj.v13i3.5298	bmj.v13i3.5298	PROPN
easat-2814	171	1	[	[	X
easat-2814	171	2	4	4	X
easat-2814	171	3	]	]	X
easat-2814	171	4	ervianti	ervianti	X
easat-2814	171	5	o	o	NOUN
easat-2814	171	6	,	,	PUNCT
easat-2814	171	7	sasono	sasono	PROPN
easat-2814	171	8	w	w	PROPN
easat-2814	171	9	,	,	PUNCT
easat-2814	171	10	prastyani	prastyani	PROPN
easat-2814	171	11	r.	r.	PROPN
easat-2814	171	12	the	the	DET
easat-2814	171	13	effects	effect	NOUN
easat-2814	171	14	of	of	ADP
easat-2814	171	15	melon	melon	NOUN
easat-2814	171	16	superoxide	superoxide	NOUN
easat-2814	171	17	dismutase	dismutase	NOUN
easat-2814	171	18	and	and	CCONJ
easat-2814	171	19	gliadin	gliadin	VERB
easat-2814	171	20	on	on	ADP
easat-2814	171	21	glutathione	glutathione	NOUN
easat-2814	171	22	reductase	reductase	NOUN
easat-2814	171	23	(	(	PUNCT
easat-2814	171	24	gsh	gsh	PROPN
easat-2814	171	25	)	)	PUNCT
easat-2814	171	26	and	and	CCONJ
easat-2814	171	27	superoxide	superoxide	NOUN
easat-2814	171	28	dismutase	dismutase	NOUN
easat-2814	171	29	(	(	PUNCT
easat-2814	171	30	sod	sod	NOUN
easat-2814	171	31	)	)	PUNCT
easat-2814	171	32	levels	level	NOUN
easat-2814	171	33	in	in	ADP
easat-2814	171	34	blood	blood	NOUN
easat-2814	171	35	plasma	plasma	NOUN
easat-2814	171	36	and	and	CCONJ
easat-2814	171	37	vitreoretina	vitreoretina	NOUN
easat-2814	171	38	in	in	ADP
easat-2814	171	39	diabetic	diabetic	ADJ
easat-2814	171	40	rat	rat	NOUN
easat-2814	171	41	model	model	NOUN
easat-2814	171	42	:	:	PUNCT
easat-2814	171	43	a	a	DET
easat-2814	171	44	literature	literature	NOUN
easat-2814	171	45	review	review	NOUN
easat-2814	171	46	.	.	PUNCT
easat-2814	172	1	pharmacogn	pharmacogn	PROPN
easat-2814	172	2	j.	j.	PROPN
easat-2814	172	3	2024;16(5	2024;16(5	PROPN
easat-2814	172	4	):	):	PUNCT
easat-2814	172	5	1202	1202	NUM
easat-2814	172	6	-	-	PUNCT
easat-2814	172	7	1208	1208	NUM
easat-2814	172	8	.	.	PUNCT
easat-2814	173	1	doi	doi	NOUN
easat-2814	173	2	:	:	PUNCT
easat-2814	173	3	doi	doi	NOUN
easat-2814	173	4	:	:	PUNCT
easat-2814	173	5	10.5530	10.5530	NUM
easat-2814	173	6	/	/	SYM
easat-2814	173	7	pj.2024.16.197	pj.2024.16.197	NOUN
easat-2814	174	1	[	[	X
easat-2814	174	2	5	5	NUM
easat-2814	174	3	]	]	PUNCT
easat-2814	174	4	brzović	brzović	NOUN
easat-2814	174	5	-	-	PUNCT
easat-2814	174	6	šarić	šarić	NOUN
easat-2814	174	7	,	,	PUNCT
easat-2814	174	8	v.	v.	PROPN
easat-2814	174	9	,	,	PUNCT
easat-2814	174	10	i.	i.	PROPN
easat-2814	174	11	landeka	landeka	PROPN
easat-2814	174	12	,	,	PUNCT
easat-2814	174	13	b.	b.	PROPN
easat-2814	174	14	šarić	šarić	PROPN
easat-2814	174	15	,	,	PUNCT
easat-2814	174	16	m.	m.	NOUN
easat-2814	174	17	barberić	barberić	PROPN
easat-2814	174	18	,	,	PUNCT
easat-2814	174	19	l.	l.	PROPN
easat-2814	174	20	andrijašević	andrijašević	PROPN
easat-2814	174	21	,	,	PUNCT
easat-2814	174	22	n.	n.	NOUN
easat-2814	174	23	oršolić	oršolić	NOUN
easat-2814	174	24	,	,	PUNCT
easat-2814	174	25	and	and	CCONJ
easat-2814	174	26	d.	d.	PROPN
easat-2814	174	27	đikić	đikić	PROPN
easat-2814	174	28	.	.	PUNCT
easat-2814	175	1	(	(	PUNCT
easat-2814	175	2	2015	2015	NUM
easat-2814	175	3	)	)	PUNCT
easat-2814	175	4	.	.	PUNCT
easat-2814	176	1	levels	level	NOUN
easat-2814	176	2	of	of	ADP
easat-2814	176	3	selected	select	VERB
easat-2814	176	4	oxidative	oxidative	ADJ
easat-2814	176	5	stress	stress	NOUN
easat-2814	176	6	markers	marker	NOUN
easat-2814	176	7	in	in	ADP
easat-2814	176	8	the	the	DET
easat-2814	176	9	vitreous	vitreous	ADJ
easat-2814	176	10	and	and	CCONJ
easat-2814	176	11	serum	serum	NOUN
easat-2814	176	12	of	of	ADP
easat-2814	176	13	diabetic	diabetic	ADJ
easat-2814	176	14	retinopathy	retinopathy	ADJ
easat-2814	176	15	patients	patient	NOUN
easat-2814	176	16	.	.	PUNCT
easat-2814	177	1	molecular	molecular	ADJ
easat-2814	177	2	vision	vision	NOUN
easat-2814	177	3	,	,	PUNCT
easat-2814	177	4	21:649–664	21:649–664	PROPN
easat-2814	177	5	,	,	PUNCT
easat-2814	177	6	.	.	PUNCT
easat-2814	178	1	http://www.molvis.org/molvis/v21/649	http://www.molvis.org/molvis/v21/649	PROPN
easat-2814	179	1	[	[	X
easat-2814	179	2	6	6	NUM
easat-2814	179	3	]	]	SYM
easat-2814	179	4	carillon	carillon	PROPN
easat-2814	179	5	,	,	PUNCT
easat-2814	179	6	j.	j.	PROPN
easat-2814	179	7	,	,	PUNCT
easat-2814	179	8	rouanet	rouanet	PROPN
easat-2814	179	9	,	,	PUNCT
easat-2814	179	10	j.-m	j.-m	PROPN
easat-2814	179	11	.	.	PUNCT
easat-2814	179	12	,	,	PUNCT
easat-2814	179	13	cristol	cristol	ADJ
easat-2814	179	14	,	,	PUNCT
easat-2814	179	15	j.-p	j.-p	PROPN
easat-2814	179	16	.	.	PROPN
easat-2814	179	17	,	,	PUNCT
easat-2814	179	18	&	&	CCONJ
easat-2814	179	19	brion	brion	PROPN
easat-2814	179	20	,	,	PUNCT
easat-2814	179	21	r.	r.	PROPN
easat-2814	179	22	(	(	PUNCT
easat-2814	179	23	2013	2013	NUM
easat-2814	179	24	)	)	PUNCT
easat-2814	179	25	.	.	PUNCT
easat-2814	180	1	superoxide	superoxide	NOUN
easat-2814	180	2	dismutase	dismutase	NOUN
easat-2814	180	3	administration	administration	NOUN
easat-2814	180	4	,	,	PUNCT
easat-2814	180	5	a	a	DET
easat-2814	180	6	potential	potential	ADJ
easat-2814	180	7	therapy	therapy	NOUN
easat-2814	180	8	against	against	ADP
easat-2814	180	9	oxidative	oxidative	ADJ
easat-2814	180	10	stress	stress	NOUN
easat-2814	180	11	related	relate	VERB
easat-2814	180	12	diseases	disease	NOUN
easat-2814	180	13	:	:	PUNCT
easat-2814	180	14	several	several	ADJ
easat-2814	180	15	routes	route	NOUN
easat-2814	180	16	of	of	ADP
easat-2814	180	17	supplementation	supplementation	NOUN
easat-2814	180	18	and	and	CCONJ
easat-2814	180	19	proposal	proposal	NOUN
easat-2814	180	20	of	of	ADP
easat-2814	180	21	an	an	DET
easat-2814	180	22	original	original	ADJ
easat-2814	180	23	mechanism	mechanism	NOUN
easat-2814	180	24	of	of	ADP
easat-2814	180	25	action	action	NOUN
easat-2814	180	26	.	.	PUNCT
easat-2814	181	1	pharmaceutical	pharmaceutical	ADJ
easat-2814	181	2	research	research	NOUN
easat-2814	181	3	,	,	PUNCT
easat-2814	181	4	30(11	30(11	NUM
easat-2814	181	5	)	)	PUNCT
easat-2814	181	6	,	,	PUNCT
easat-2814	181	7	2718–2728	2718–2728	NUM
easat-2814	181	8	.	.	PUNCT
easat-2814	182	1	doi:10.1007	doi:10.1007	VERB
easat-2814	182	2	/	/	SYM
easat-2814	182	3	s11095	s11095	NOUN
easat-2814	182	4	-	-	PUNCT
easat-2814	182	5	013	013	NUM
easat-2814	182	6	-	-	PUNCT
easat-2814	182	7	1113	1113	NUM
easat-2814	182	8	-	-	SYM
easat-2814	182	9	5	5	NUM
easat-2814	183	1	[	[	X
easat-2814	183	2	7	7	NUM
easat-2814	183	3	]	]	X
easat-2814	183	4	ahuja	ahuja	PROPN
easat-2814	183	5	,	,	PUNCT
easat-2814	183	6	s.	s.	PROPN
easat-2814	183	7	,	,	PUNCT
easat-2814	183	8	saxena	saxena	PROPN
easat-2814	183	9	,	,	PUNCT
easat-2814	183	10	s.	s.	PROPN
easat-2814	183	11	,	,	PUNCT
easat-2814	183	12	akduman	akduman	PROPN
easat-2814	183	13	,	,	PUNCT
easat-2814	183	14	l.	l.	PROPN
easat-2814	183	15	,	,	PUNCT
easat-2814	183	16	meyer	meyer	PROPN
easat-2814	183	17	,	,	PUNCT
easat-2814	183	18	c.h	c.h	PROPN
easat-2814	183	19	.	.	PROPN
easat-2814	183	20	,	,	PUNCT
easat-2814	183	21	kruzliak	kruzliak	PROPN
easat-2814	183	22	,	,	PUNCT
easat-2814	183	23	p.	p.	PROPN
easat-2814	183	24	,	,	PUNCT
easat-2814	183	25	khanna	khanna	PROPN
easat-2814	183	26	,	,	PUNCT
easat-2814	183	27	v.k	v.k	PROPN
easat-2814	183	28	.	.	PROPN
easat-2814	183	29	,	,	PUNCT
easat-2814	183	30	2019	2019	NUM
easat-2814	183	31	.	.	PUNCT
easat-2814	184	1	serum	serum	VERB
easat-2814	184	2	vascular	vascular	ADJ
easat-2814	184	3	endothelial	endothelial	ADJ
easat-2814	184	4	growth	growth	NOUN
easat-2814	184	5	factor	factor	NOUN
easat-2814	184	6	is	be	AUX
easat-2814	184	7	a	a	DET
easat-2814	184	8	biomolecular	biomolecular	ADJ
easat-2814	184	9	biomarker	biomarker	NOUN
easat-2814	184	10	of	of	ADP
easat-2814	184	11	severity	severity	NOUN
easat-2814	184	12	of	of	ADP
easat-2814	184	13	diabetic	diabetic	ADJ
easat-2814	184	14	retinopathy	retinopathy	NOUN
easat-2814	184	15	.	.	PUNCT
easat-2814	185	1	int	int	PROPN
easat-2814	186	1	j	j	PROPN
easat-2814	186	2	retin	retin	PROPN
easat-2814	186	3	vitr	vitr	PROPN
easat-2814	186	4	5	5	NUM
easat-2814	186	5	,	,	PUNCT
easat-2814	186	6	29	29	NUM
easat-2814	186	7	.	.	PUNCT
easat-2814	187	1	https://doi.org/10.1186/s40942-019-0179-6	https://doi.org/10.1186/s40942-019-0179-6	NUM
easat-2814	187	2	[	[	PUNCT
easat-2814	187	3	8	8	NUM
easat-2814	187	4	]	]	X
easat-2814	187	5	wong	wong	PROPN
easat-2814	187	6	,	,	PUNCT
easat-2814	187	7	t.	t.	PROPN
easat-2814	187	8	y.	y.	PROPN
easat-2814	187	9	,	,	PUNCT
easat-2814	187	10	cheung	cheung	PROPN
easat-2814	187	11	,	,	PUNCT
easat-2814	187	12	c.	c.	PROPN
easat-2814	187	13	m.	m.	PROPN
easat-2814	187	14	g.	g.	PROPN
easat-2814	187	15	,	,	PUNCT
easat-2814	187	16	larsen	larsen	PROPN
easat-2814	187	17	,	,	PUNCT
easat-2814	187	18	m.	m.	NOUN
easat-2814	187	19	,	,	PUNCT
easat-2814	187	20	sharma	sharma	PROPN
easat-2814	187	21	,	,	PUNCT
easat-2814	187	22	s.	s.	PROPN
easat-2814	187	23	,	,	PUNCT
easat-2814	187	24	&	&	CCONJ
easat-2814	187	25	simó	simó	PROPN
easat-2814	187	26	,	,	PUNCT
easat-2814	187	27	r.	r.	PROPN
easat-2814	187	28	(	(	PUNCT
easat-2814	187	29	2016	2016	NUM
easat-2814	187	30	)	)	PUNCT
easat-2814	187	31	.	.	PUNCT
easat-2814	188	1	diabetic	diabetic	ADJ
easat-2814	188	2	retinopathy	retinopathy	NOUN
easat-2814	188	3	.	.	PUNCT
easat-2814	189	1	nature	nature	NOUN
easat-2814	189	2	reviews	review	NOUN
easat-2814	189	3	disease	disease	NOUN
easat-2814	189	4	primers	primer	NOUN
easat-2814	189	5	,	,	PUNCT
easat-2814	189	6	2	2	NUM
easat-2814	189	7	,	,	PUNCT
easat-2814	189	8	16012	16012	NUM
easat-2814	189	9	.	.	PUNCT
easat-2814	190	1	doi:10.1038	doi:10.1038	NOUN
easat-2814	190	2	/	/	SYM
easat-2814	190	3	nrdp.2016.12	nrdp.2016.12	NOUN
easat-2814	190	4	[	[	X
easat-2814	190	5	9	9	NUM
easat-2814	190	6	]	]	SYM
easat-2814	190	7	kowluru	kowluru	PROPN
easat-2814	190	8	,	,	PUNCT
easat-2814	190	9	r.	r.	PROPN
easat-2814	190	10	a.	a.	PROPN
easat-2814	190	11	,	,	PUNCT
easat-2814	190	12	and	and	CCONJ
easat-2814	190	13	m.	m.	PROPN
easat-2814	190	14	mishra	mishra	PROPN
easat-2814	190	15	.	.	PROPN
easat-2814	190	16	(	(	PUNCT
easat-2814	190	17	2015	2015	NUM
easat-2814	190	18	)	)	PUNCT
easat-2814	190	19	.	.	PUNCT
easat-2814	191	1	oxidative	oxidative	ADJ
easat-2814	191	2	stress	stress	NOUN
easat-2814	191	3	,	,	PUNCT
easat-2814	191	4	mitochondrial	mitochondrial	ADJ
easat-2814	191	5	damage	damage	NOUN
easat-2814	191	6	and	and	CCONJ
easat-2814	191	7	diabetic	diabetic	ADJ
easat-2814	191	8	retinopathy	retinopathy	NOUN
easat-2814	191	9	.	.	PUNCT
easat-2814	192	1	biochimica	biochimica	PROPN
easat-2814	192	2	et	et	PROPN
easat-2814	192	3	biophysica	biophysica	PROPN
easat-2814	192	4	acta	acta	PROPN
easat-2814	192	5	(	(	PUNCT
easat-2814	192	6	bba	bba	NOUN
easat-2814	192	7	)	)	PUNCT
easat-2814	192	8	molecular	molecular	ADJ
easat-2814	192	9	basis	basis	NOUN
easat-2814	192	10	of	of	ADP
easat-2814	192	11	disease	disease	NOUN
easat-2814	192	12	,	,	PUNCT
easat-2814	192	13	1852(11):2474–2483	1852(11):2474–2483	NUM
easat-2814	192	14	,	,	PUNCT
easat-2814	192	15	https://doi.org/10.1016/j.bbadis.2015.08.001	https://doi.org/10.1016/j.bbadis.2015.08.001	NOUN
easat-2814	192	16	.	.	PUNCT
easat-2814	193	1	[	[	X
easat-2814	193	2	10	10	NUM
easat-2814	193	3	]	]	X
easat-2814	193	4	brownlee	brownlee	PROPN
easat-2814	193	5	,	,	PUNCT
easat-2814	193	6	m.	m.	NOUN
easat-2814	193	7	2001	2001	NUM
easat-2814	193	8	.	.	PUNCT
easat-2814	194	1	biochemistry	biochemistry	NOUN
easat-2814	194	2	and	and	CCONJ
easat-2814	194	3	molecular	molecular	ADJ
easat-2814	194	4	cell	cell	NOUN
easat-2814	194	5	biology	biology	NOUN
easat-2814	194	6	of	of	ADP
easat-2814	194	7	diabetic	diabetic	ADJ
easat-2814	194	8	complications	complication	NOUN
easat-2814	194	9	.	.	PUNCT
easat-2814	195	1	nature	nature	NOUN
easat-2814	195	2	,	,	PUNCT
easat-2814	195	3	414(6865):813–820	414(6865):813–820	ADV
easat-2814	195	4	,	,	PUNCT
easat-2814	195	5	https://doi.org/10.1038/414813a	https://doi.org/10.1038/414813a	PUNCT
easat-2814	196	1	[	[	X
easat-2814	196	2	11	11	NUM
easat-2814	196	3	]	]	X
easat-2814	196	4	kang	kang	PROPN
easat-2814	196	5	,	,	PUNCT
easat-2814	196	6	q.	q.	PROPN
easat-2814	196	7	,	,	PUNCT
easat-2814	196	8	and	and	CCONJ
easat-2814	196	9	c.	c.	PROPN
easat-2814	196	10	yang	yang	PROPN
easat-2814	196	11	.	.	PUNCT
easat-2814	197	1	(	(	PUNCT
easat-2814	197	2	2020	2020	NUM
easat-2814	197	3	)	)	PUNCT
easat-2814	197	4	.	.	PUNCT
easat-2814	198	1	oxidative	oxidative	ADJ
easat-2814	198	2	stress	stress	NOUN
easat-2814	198	3	and	and	CCONJ
easat-2814	198	4	diabetic	diabetic	ADJ
easat-2814	198	5	retinopathy	retinopathy	NOUN
easat-2814	198	6	:	:	PUNCT
easat-2814	198	7	molecular	molecular	ADJ
easat-2814	198	8	mechanisms	mechanism	NOUN
easat-2814	198	9	,	,	PUNCT
easat-2814	198	10	pathogenetic	pathogenetic	ADJ
easat-2814	198	11	role	role	NOUN
easat-2814	198	12	and	and	CCONJ
easat-2814	198	13	therapeutic	therapeutic	ADJ
easat-2814	198	14	implications	implication	NOUN
easat-2814	198	15	.	.	PUNCT
easat-2814	199	1	redox	redox	ADJ
easat-2814	199	2	biology	biology	NOUN
easat-2814	199	3	,	,	PUNCT
easat-2814	199	4	37:101799	37:101799	NUM
easat-2814	199	5	,	,	PUNCT
easat-2814	199	6	https://doi.org/10.1016/j.redox.2020.101799	https://doi.org/10.1016/j.redox.2020.101799	PROPN
easat-2814	199	7	.	.	PUNCT
easat-2814	200	1	[	[	X
easat-2814	200	2	12	12	NUM
easat-2814	200	3	]	]	SYM
easat-2814	200	4	li	li	PROPN
easat-2814	200	5	,	,	PUNCT
easat-2814	200	6	c.	c.	PROPN
easat-2814	200	7	,	,	PUNCT
easat-2814	200	8	x.	x.	NOUN
easat-2814	200	9	miao	miao	PROPN
easat-2814	200	10	,	,	PUNCT
easat-2814	200	11	f.	f.	PROPN
easat-2814	200	12	li	li	PROPN
easat-2814	200	13	,	,	PUNCT
easat-2814	200	14	s.	s.	PROPN
easat-2814	200	15	wang	wang	PROPN
easat-2814	200	16	,	,	PUNCT
easat-2814	200	17	q.	q.	PROPN
easat-2814	200	18	liu	liu	PROPN
easat-2814	200	19	,	,	PUNCT
easat-2814	200	20	y.	y.	PROPN
easat-2814	200	21	wang	wang	PROPN
easat-2814	200	22	,	,	PUNCT
easat-2814	200	23	and	and	CCONJ
easat-2814	200	24	j.	j.	PROPN
easat-2814	200	25	sun	sun	PROPN
easat-2814	200	26	.	.	PUNCT
easat-2814	200	27	(	(	PUNCT
easat-2814	200	28	2017	2017	NUM
easat-2814	200	29	)	)	PUNCT
easat-2814	200	30	.	.	PUNCT
easat-2814	201	1	oxidative	oxidative	ADJ
easat-2814	201	2	stress	stress	NOUN
easat-2814	201	3	related	relate	VERB
easat-2814	201	4	mechanisms	mechanism	NOUN
easat-2814	201	5	and	and	CCONJ
easat-2814	201	6	antioxidant	antioxidant	ADJ
easat-2814	201	7	therapy	therapy	NOUN
easat-2814	201	8	in	in	ADP
easat-2814	201	9	diabetic	diabetic	ADJ
easat-2814	201	10	retinopathy	retinopathy	NOUN
easat-2814	201	11	.	.	PUNCT
easat-2814	202	1	oxidative	oxidative	ADJ
easat-2814	202	2	medicine	medicine	NOUN
easat-2814	202	3	and	and	CCONJ
easat-2814	202	4	cellular	cellular	ADJ
easat-2814	202	5	longevity	longevity	NOUN
easat-2814	202	6	,	,	PUNCT
easat-2814	202	7	2017:1–15	2017:1–15	NUM
easat-2814	202	8	,	,	PUNCT
easat-2814	202	9	https://doi.org/10.1155/2017/9702820	https://doi.org/10.1155/2017/9702820	NOUN
easat-2814	202	10	[	[	X
easat-2814	202	11	13	13	NUM
easat-2814	202	12	]	]	SYM
easat-2814	202	13	panahi	panahi	NOUN
easat-2814	202	14	,	,	PUNCT
easat-2814	202	15	f.	f.	PROPN
easat-2814	202	16	,	,	PUNCT
easat-2814	202	17	baharivand	baharivand	NOUN
easat-2814	202	18	,	,	PUNCT
easat-2814	202	19	n.	n.	NOUN
easat-2814	202	20	,	,	PUNCT
easat-2814	202	21	zarghami	zarghami	NOUN
easat-2814	202	22	,	,	PUNCT
easat-2814	202	23	dokht	dokht	ADJ
easat-2814	202	24	ghafari	ghafari	PROPN
easat-2814	202	25	m.	m.	PROPN
easat-2814	202	26	yazdan	yazdan	PROPN
easat-2814	202	27	,	,	PUNCT
easat-2814	202	28	mahdavi	mahdavi	VERB
easat-2814	202	29	fard	fard	NOUN
easat-2814	202	30	,	,	PUNCT
easat-2814	202	31	a.	a.	PROPN
easat-2814	202	32	,	,	PUNCT
easat-2814	202	33	mohajeri	mohajeri	PROPN
easat-2814	202	34	abas	abas	PROPN
easat-2814	202	35	,	,	PUNCT
easat-2814	202	36	2012	2012	NUM
easat-2814	202	37	.	.	PUNCT
easat-2814	203	1	relationship	relationship	NOUN
easat-2814	203	2	between	between	ADP
easat-2814	203	3	vitreous	vitreous	ADJ
easat-2814	203	4	and	and	CCONJ
easat-2814	203	5	serum	serum	VERB
easat-2814	203	6	vascular	vascular	ADJ
easat-2814	203	7	endothelial	endothelial	ADJ
easat-2814	203	8	growth	growth	NOUN
easat-2814	203	9	factor	factor	NOUN
easat-2814	203	10	levels	level	NOUN
easat-2814	203	11	,	,	PUNCT
easat-2814	203	12	control	control	NOUN
easat-2814	203	13	of	of	ADP
easat-2814	203	14	diabetes	diabetes	NOUN
easat-2814	203	15	and	and	CCONJ
easat-2814	203	16	microalbuminuria	microalbuminuria	PROPN
easat-2814	203	17	in	in	ADP
easat-2814	203	18	proliferative	proliferative	ADJ
easat-2814	203	19	diabetic	diabetic	ADJ
easat-2814	203	20	retinopathy	retinopathy	NOUN
easat-2814	203	21	.	.	PUNCT
easat-2814	204	1	opth	opth	NOUN
easat-2814	204	2	185	185	NUM
easat-2814	204	3	.	.	PUNCT
easat-2814	205	1	https://doi.org/10.2147/opth.s27423	https://doi.org/10.2147/opth.s27423	PROPN
easat-2814	205	2	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-2814	205	3	3733	3733	NUM
easat-2814	205	4	edelweiss	edelweiss	PROPN
easat-2814	205	5	applied	apply	VERB
easat-2814	205	6	science	science	NOUN
easat-2814	205	7	and	and	CCONJ
easat-2814	205	8	technology	technology	NOUN
easat-2814	205	9	issn	issn	PROPN
easat-2814	205	10	:	:	PUNCT
easat-2814	205	11	2576	2576	NUM
easat-2814	205	12	-	-	SYM
easat-2814	205	13	8484	8484	NUM
easat-2814	205	14	vol	vol	NOUN
easat-2814	205	15	.	.	PROPN
easat-2814	205	16	8	8	NUM
easat-2814	205	17	,	,	PUNCT
easat-2814	205	18	no	no	INTJ
easat-2814	205	19	.	.	NOUN
easat-2814	205	20	6	6	NUM
easat-2814	205	21	:	:	SYM
easat-2814	205	22	3722	3722	NUM
easat-2814	205	23	-	-	SYM
easat-2814	205	24	3733	3733	NUM
easat-2814	205	25	,	,	PUNCT
easat-2814	205	26	2024	2024	NUM
easat-2814	205	27	doi	doi	NOUN
easat-2814	205	28	:	:	PUNCT
easat-2814	205	29	10.55214/25768484.v8i6.2814	10.55214/25768484.v8i6.2814	NUM
easat-2814	205	30	©	©	ADP
easat-2814	205	31	2024	2024	NUM
easat-2814	205	32	by	by	ADP
easat-2814	205	33	the	the	DET
easat-2814	205	34	authors	author	NOUN
easat-2814	205	35	;	;	PUNCT
easat-2814	205	36	licensee	licensee	PROPN
easat-2814	205	37	learning	learning	NOUN
easat-2814	205	38	gate	gate	NOUN
easat-2814	206	1	[	[	X
easat-2814	206	2	14	14	NUM
easat-2814	206	3	]	]	SYM
easat-2814	206	4	wu	wu	PROPN
easat-2814	206	5	,	,	PUNCT
easat-2814	206	6	m.-y	m.-y	PROPN
easat-2814	206	7	.	.	PUNCT
easat-2814	206	8	,	,	PUNCT
easat-2814	206	9	yiang	yiang	PROPN
easat-2814	206	10	,	,	PUNCT
easat-2814	206	11	g.-t	g.-t	PROPN
easat-2814	206	12	.	.	PUNCT
easat-2814	206	13	,	,	PUNCT
easat-2814	206	14	lai	lai	PROPN
easat-2814	206	15	,	,	PUNCT
easat-2814	206	16	t.-t	t.-t	PROPN
easat-2814	206	17	.	.	PUNCT
easat-2814	206	18	,	,	PUNCT
easat-2814	206	19	li	li	PROPN
easat-2814	206	20	,	,	PUNCT
easat-2814	206	21	c.-j	c.-j	PROPN
easat-2814	206	22	.	.	PROPN
easat-2814	206	23	,	,	PUNCT
easat-2814	206	24	2018	2018	NUM
easat-2814	206	25	.	.	PUNCT
easat-2814	207	1	the	the	DET
easat-2814	207	2	oxidative	oxidative	ADJ
easat-2814	207	3	stress	stress	NOUN
easat-2814	207	4	and	and	CCONJ
easat-2814	207	5	mitochondrial	mitochondrial	ADJ
easat-2814	207	6	dysfunction	dysfunction	NOUN
easat-2814	207	7	during	during	ADP
easat-2814	207	8	the	the	DET
easat-2814	207	9	pathogenesis	pathogenesis	NOUN
easat-2814	207	10	of	of	ADP
easat-2814	207	11	diabetic	diabetic	ADJ
easat-2814	207	12	retinopathy	retinopathy	NOUN
easat-2814	207	13	.	.	PUNCT
easat-2814	208	1	oxidative	oxidative	ADJ
easat-2814	208	2	medicine	medicine	NOUN
easat-2814	208	3	and	and	CCONJ
easat-2814	208	4	cellular	cellular	ADJ
easat-2814	208	5	longevity	longevity	NOUN
easat-2814	208	6	2018	2018	NUM
easat-2814	208	7	,	,	PUNCT
easat-2814	208	8	1–12	1–12	NOUN
easat-2814	208	9	.	.	PUNCT
easat-2814	209	1	https://doi.org/10.1155/2018/3420187	https://doi.org/10.1155/2018/3420187	PROPN
easat-2814	210	1	[	[	X
easat-2814	210	2	15	15	NUM
easat-2814	210	3	]	]	X
easat-2814	210	4	bonfiglio	bonfiglio	PROPN
easat-2814	210	5	,	,	PUNCT
easat-2814	210	6	v.	v.	PROPN
easat-2814	210	7	,	,	PUNCT
easat-2814	210	8	platania	platania	NOUN
easat-2814	210	9	,	,	PUNCT
easat-2814	210	10	c.b.m	c.b.m	ADJ
easat-2814	210	11	.	.	PROPN
easat-2814	210	12	,	,	PUNCT
easat-2814	210	13	lazzara	lazzara	PROPN
easat-2814	210	14	,	,	PUNCT
easat-2814	210	15	f.	f.	PROPN
easat-2814	210	16	,	,	PUNCT
easat-2814	210	17	conti	conti	PROPN
easat-2814	210	18	,	,	PUNCT
easat-2814	210	19	f.	f.	PROPN
easat-2814	210	20	,	,	PUNCT
easat-2814	210	21	pizzo	pizzo	PROPN
easat-2814	210	22	,	,	PUNCT
easat-2814	210	23	c.	c.	PROPN
easat-2814	210	24	,	,	PUNCT
easat-2814	210	25	reibaldi	reibaldi	NOUN
easat-2814	210	26	,	,	PUNCT
easat-2814	210	27	m.	m.	NOUN
easat-2814	210	28	,	,	PUNCT
easat-2814	210	29	russo	russo	PROPN
easat-2814	210	30	,	,	PUNCT
easat-2814	210	31	a.	a.	NOUN
easat-2814	210	32	,	,	PUNCT
easat-2814	210	33	fallico	fallico	PROPN
easat-2814	210	34	,	,	PUNCT
easat-2814	210	35	m.	m.	NOUN
easat-2814	210	36	,	,	PUNCT
easat-2814	210	37	ortisi	ortisi	VERB
easat-2814	210	38	,	,	PUNCT
easat-2814	210	39	e.	e.	PROPN
easat-2814	210	40	,	,	PUNCT
easat-2814	210	41	pignatelli	pignatelli	PROPN
easat-2814	210	42	,	,	PUNCT
easat-2814	210	43	f.	f.	PROPN
easat-2814	210	44	,	,	PUNCT
easat-2814	210	45	longo	longo	PROPN
easat-2814	210	46	,	,	PUNCT
easat-2814	210	47	a.	a.	NOUN
easat-2814	210	48	,	,	PUNCT
easat-2814	210	49	avitabile	avitabile	NOUN
easat-2814	210	50	,	,	PUNCT
easat-2814	210	51	t.	t.	PROPN
easat-2814	210	52	,	,	PUNCT
easat-2814	210	53	drago	drago	PROPN
easat-2814	210	54	,	,	PUNCT
easat-2814	210	55	f.	f.	PROPN
easat-2814	210	56	,	,	PUNCT
easat-2814	210	57	bucolo	bucolo	PROPN
easat-2814	210	58	,	,	PUNCT
easat-2814	210	59	c.	c.	PROPN
easat-2814	210	60	,	,	PUNCT
easat-2814	210	61	2020	2020	NUM
easat-2814	210	62	.	.	PUNCT
easat-2814	211	1	tgf	tgf	PROPN
easat-2814	211	2	-	-	PUNCT
easat-2814	211	3	β	β	PROPN
easat-2814	211	4	serum	serum	NOUN
easat-2814	211	5	levels	level	NOUN
easat-2814	211	6	in	in	ADP
easat-2814	211	7	diabetic	diabetic	ADJ
easat-2814	211	8	retinopathy	retinopathy	ADJ
easat-2814	211	9	patients	patient	NOUN
easat-2814	211	10	and	and	CCONJ
easat-2814	211	11	the	the	DET
easat-2814	211	12	role	role	NOUN
easat-2814	211	13	of	of	ADP
easat-2814	211	14	anti	anti	ADJ
easat-2814	211	15	-	-	ADJ
easat-2814	211	16	vegf	vegf	ADJ
easat-2814	211	17	therapy	therapy	NOUN
easat-2814	211	18	.	.	PUNCT
easat-2814	212	1	ijms	ijm	VERB
easat-2814	212	2	21	21	NUM
easat-2814	212	3	,	,	PUNCT
easat-2814	212	4	9558	9558	NUM
easat-2814	212	5	.	.	PUNCT
easat-2814	213	1	https://doi.org/10.3390/ijms21249558	https://doi.org/10.3390/ijms21249558	PROPN
easat-2814	213	2	[	[	X
easat-2814	213	3	16	16	NUM
easat-2814	213	4	]	]	PUNCT
easat-2814	213	5	ighodaro	ighodaro	NOUN
easat-2814	213	6	,	,	PUNCT
easat-2814	213	7	o.m	o.m	PROPN
easat-2814	213	8	.	.	PROPN
easat-2814	213	9	,	,	PUNCT
easat-2814	213	10	akinloye	akinloye	PROPN
easat-2814	213	11	,	,	PUNCT
easat-2814	213	12	o.a	o.a	PROPN
easat-2814	213	13	.	.	PROPN
easat-2814	213	14	,	,	PUNCT
easat-2814	213	15	2018	2018	NUM
easat-2814	213	16	.	.	PUNCT
easat-2814	214	1	first	first	ADJ
easat-2814	214	2	line	line	NOUN
easat-2814	214	3	defence	defence	NOUN
easat-2814	214	4	antioxidants	antioxidant	NOUN
easat-2814	214	5	-	-	PUNCT
easat-2814	214	6	superoxide	superoxide	NOUN
easat-2814	214	7	dismutase	dismutase	NOUN
easat-2814	214	8	(	(	PUNCT
easat-2814	214	9	sod	sod	NOUN
easat-2814	214	10	)	)	PUNCT
easat-2814	214	11	,	,	PUNCT
easat-2814	214	12	catalase	catalase	NOUN
easat-2814	214	13	(	(	PUNCT
easat-2814	214	14	cat	cat	NOUN
easat-2814	214	15	)	)	PUNCT
easat-2814	214	16	and	and	CCONJ
easat-2814	214	17	glutathione	glutathione	NOUN
easat-2814	214	18	peroxidase	peroxidase	NOUN
easat-2814	214	19	(	(	PUNCT
easat-2814	214	20	gpx	gpx	PROPN
easat-2814	214	21	):	):	PUNCT
easat-2814	214	22	their	their	PRON
easat-2814	214	23	fundamental	fundamental	ADJ
easat-2814	214	24	role	role	NOUN
easat-2814	214	25	in	in	ADP
easat-2814	214	26	the	the	DET
easat-2814	214	27	entire	entire	ADJ
easat-2814	214	28	antioxidant	antioxidant	ADJ
easat-2814	214	29	defence	defence	NOUN
easat-2814	214	30	grid	grid	NOUN
easat-2814	214	31	.	.	PUNCT
easat-2814	215	1	alexandria	alexandria	PROPN
easat-2814	215	2	journal	journal	PROPN
easat-2814	215	3	of	of	ADP
easat-2814	215	4	medicine	medicine	NOUN
easat-2814	215	5	54	54	NUM
easat-2814	215	6	,	,	PUNCT
easat-2814	215	7	287–293	287–293	NUM
easat-2814	215	8	.	.	PUNCT
easat-2814	216	1	https://doi.org/10.1016/j.ajme.2017.09.001	https://doi.org/10.1016/j.ajme.2017.09.001	VERB
easat-2814	216	2	[	[	X
easat-2814	216	3	17	17	NUM
easat-2814	216	4	]	]	X
easat-2814	216	5	lee	lee	PROPN
easat-2814	216	6	,	,	PUNCT
easat-2814	216	7	j.-y	j.-y	PROPN
easat-2814	216	8	.	.	PUNCT
easat-2814	216	9	,	,	PUNCT
easat-2814	216	10	kim	kim	PROPN
easat-2814	216	11	,	,	PUNCT
easat-2814	216	12	m.	m.	NOUN
easat-2814	216	13	,	,	PUNCT
easat-2814	216	14	oh	oh	INTJ
easat-2814	216	15	,	,	PUNCT
easat-2814	216	16	s.b	s.b	PROPN
easat-2814	216	17	.	.	PROPN
easat-2814	216	18	,	,	PUNCT
easat-2814	216	19	kim	kim	PROPN
easat-2814	216	20	,	,	PUNCT
easat-2814	216	21	h.-y	h.-y	NOUN
easat-2814	216	22	.	.	PUNCT
easat-2814	216	23	,	,	PUNCT
easat-2814	216	24	kim	kim	PROPN
easat-2814	216	25	,	,	PUNCT
easat-2814	216	26	c.	c.	PROPN
easat-2814	216	27	,	,	PUNCT
easat-2814	216	28	kim	kim	PROPN
easat-2814	216	29	,	,	PUNCT
easat-2814	216	30	t.-y	t.-y	NOUN
easat-2814	216	31	.	.	PROPN
easat-2814	216	32	,	,	PUNCT
easat-2814	216	33	park	park	NOUN
easat-2814	216	34	,	,	PUNCT
easat-2814	216	35	y.-h	y.-h	PROPN
easat-2814	216	36	.	.	PROPN
easat-2814	216	37	,	,	PUNCT
easat-2814	216	38	2022	2022	NUM
easat-2814	216	39	.	.	PUNCT
easat-2814	216	40	superoxide	superoxide	NOUN
easat-2814	216	41	dismutase	dismutase	NOUN
easat-2814	216	42	3	3	NUM
easat-2814	216	43	prevents	prevent	VERB
easat-2814	216	44	early	early	ADJ
easat-2814	216	45	stage	stage	NOUN
easat-2814	216	46	diabetic	diabetic	ADJ
easat-2814	216	47	retinopathy	retinopathy	NOUN
easat-2814	216	48	in	in	ADP
easat-2814	216	49	streptozotocin	streptozotocin	NOUN
easat-2814	216	50	-	-	PUNCT
easat-2814	216	51	induced	induce	VERB
easat-2814	216	52	diabetic	diabetic	ADJ
easat-2814	216	53	rat	rat	NOUN
easat-2814	216	54	model	model	NOUN
easat-2814	216	55	.	.	PUNCT
easat-2814	217	1	plos	plos	PROPN
easat-2814	217	2	one	one	NUM
easat-2814	217	3	17	17	NUM
easat-2814	217	4	,	,	PUNCT
easat-2814	217	5	e0262396	e0262396	PROPN
easat-2814	217	6	.	.	PUNCT
easat-2814	218	1	https://doi.org/10.1371/journal.pone.0262396	https://doi.org/10.1371/journal.pone.0262396	PROPN
easat-2814	219	1	[	[	X
easat-2814	219	2	18	18	NUM
easat-2814	219	3	]	]	X
easat-2814	219	4	zhang	zhang	PROPN
easat-2814	219	5	,	,	PUNCT
easat-2814	219	6	y.	y.	PROPN
easat-2814	219	7	,	,	PUNCT
easat-2814	219	8	zhang	zhang	PROPN
easat-2814	219	9	,	,	PUNCT
easat-2814	219	10	g.	g.	PROPN
easat-2814	219	11	,	,	PUNCT
easat-2814	219	12	song	song	NOUN
easat-2814	219	13	,	,	PUNCT
easat-2814	219	14	d.	d.	PROPN
easat-2814	219	15	,	,	PUNCT
easat-2814	219	16	2014	2014	NUM
easat-2814	219	17	.	.	PUNCT
easat-2814	220	1	study	study	NOUN
easat-2814	220	2	on	on	ADP
easat-2814	220	3	vascular	vascular	ADJ
easat-2814	220	4	endothelial	endothelial	ADJ
easat-2814	220	5	growth	growth	NOUN
easat-2814	220	6	factor	factor	NOUN
easat-2814	220	7	and	and	CCONJ
easat-2814	220	8	its	its	PRON
easat-2814	220	9	receptor	receptor	NOUN
easat-2814	220	10	in	in	ADP
easat-2814	220	11	the	the	DET
easat-2814	220	12	vitreous	vitreous	NOUN
easat-2814	220	13	of	of	ADP
easat-2814	220	14	diabetic	diabetic	ADJ
easat-2814	220	15	rats	rat	NOUN
easat-2814	220	16	.	.	PUNCT
easat-2814	221	1	wimj	wimj	ADJ
easat-2814	221	2	61	61	NUM
easat-2814	221	3	.	.	PUNCT
easat-2814	222	1	https://doi.org/10.7727/wimj.2013.144	https://doi.org/10.7727/wimj.2013.144	PROPN
easat-2814	222	2	[	[	X
easat-2814	222	3	19	19	NUM
easat-2814	222	4	]	]	PUNCT
easat-2814	222	5	hachana	hachana	PROPN
easat-2814	222	6	,	,	PUNCT
easat-2814	222	7	s.	s.	PROPN
easat-2814	222	8	,	,	PUNCT
easat-2814	222	9	larrivée	larrivée	PROPN
easat-2814	222	10	,	,	PUNCT
easat-2814	222	11	b.	b.	PROPN
easat-2814	222	12	,	,	PUNCT
easat-2814	222	13	2022	2022	NUM
easat-2814	222	14	.	.	PUNCT
easat-2814	223	1	tgf	tgf	PROPN
easat-2814	223	2	-	-	PUNCT
easat-2814	223	3	β	β	X
easat-2814	223	4	superfamily	superfamily	ADV
easat-2814	223	5	signaling	signal	VERB
easat-2814	223	6	in	in	ADP
easat-2814	223	7	the	the	DET
easat-2814	223	8	eye	eye	NOUN
easat-2814	223	9	:	:	PUNCT
easat-2814	223	10	implications	implication	NOUN
easat-2814	223	11	for	for	ADP
easat-2814	223	12	ocular	ocular	ADJ
easat-2814	223	13	pathologies	pathology	NOUN
easat-2814	223	14	.	.	PUNCT
easat-2814	224	1	cells	cell	NOUN
easat-2814	224	2	11	11	NUM
easat-2814	224	3	,	,	PUNCT
easat-2814	224	4	2336	2336	NUM
easat-2814	224	5	.	.	PUNCT
easat-2814	225	1	https://doi.org/10.3390/cells11152336	https://doi.org/10.3390/cells11152336	PROPN
easat-2814	226	1	[	[	X
easat-2814	226	2	20	20	NUM
easat-2814	226	3	]	]	X
easat-2814	226	4	rosa	rosa	PROPN
easat-2814	226	5	,	,	PUNCT
easat-2814	226	6	a.	a.	PROPN
easat-2814	226	7	c.	c.	PROPN
easat-2814	226	8	,	,	PUNCT
easat-2814	226	9	d.	d.	PROPN
easat-2814	226	10	corsi	corsi	PROPN
easat-2814	226	11	.	.	PROPN
easat-2814	226	12	,	,	PUNCT
easat-2814	226	13	n.	n.	PROPN
easat-2814	226	14	cavi	cavi	PROPN
easat-2814	226	15	.	.	PROPN
easat-2814	226	16	,	,	PUNCT
easat-2814	226	17	n.	n.	PROPN
easat-2814	226	18	bruni	bruni	PROPN
easat-2814	226	19	.	.	PROPN
easat-2814	226	20	,	,	PUNCT
easat-2814	226	21	and	and	CCONJ
easat-2814	226	22	f.	f.	PROPN
easat-2814	226	23	dosio	dosio	PROPN
easat-2814	226	24	.	.	PUNCT
easat-2814	227	1	(	(	PUNCT
easat-2814	227	2	2021	2021	NUM
easat-2814	227	3	)	)	PUNCT
easat-2814	227	4	.	.	PUNCT
easat-2814	228	1	superoxide	superoxide	NOUN
easat-2814	228	2	dismutase	dismutase	NOUN
easat-2814	228	3	administration	administration	NOUN
easat-2814	228	4	:	:	PUNCT
easat-2814	228	5	a	a	DET
easat-2814	228	6	review	review	NOUN
easat-2814	228	7	of	of	ADP
easat-2814	228	8	proposed	propose	VERB
easat-2814	228	9	human	human	ADJ
easat-2814	228	10	uses	use	NOUN
easat-2814	228	11	.	.	PUNCT
easat-2814	229	1	molecules	molecule	NOUN
easat-2814	229	2	,	,	PUNCT
easat-2814	229	3	26(7):1844	26(7):1844	NUM
easat-2814	229	4	-	-	SYM
easat-2814	229	5	1884	1884	NUM
easat-2814	229	6	,	,	PUNCT
easat-2814	229	7	https://doi.org/10.3390/molecules26071844	https://doi.org/10.3390/molecules26071844	PROPN
easat-2814	229	8	.	.	PUNCT
easat-2814	230	1	[	[	X
easat-2814	230	2	21	21	NUM
easat-2814	230	3	]	]	X
easat-2814	230	4	vouldoukis	vouldoukis	PROPN
easat-2814	230	5	,	,	PUNCT
easat-2814	230	6	i.	i.	PROPN
easat-2814	230	7	,	,	PUNCT
easat-2814	230	8	d.	d.	PROPN
easat-2814	230	9	lacan	lacan	PROPN
easat-2814	230	10	.	.	PROPN
easat-2814	230	11	,	,	PUNCT
easat-2814	230	12	c.	c.	PROPN
easat-2814	230	13	kamate	kamate	PROPN
easat-2814	230	14	.	.	PUNCT
easat-2814	230	15	,	,	PUNCT
easat-2814	230	16	p.	p.	NOUN
easat-2814	230	17	coste	coste	NOUN
easat-2814	230	18	.	.	PUNCT
easat-2814	230	19	,	,	PUNCT
easat-2814	230	20	a.	a.	PROPN
easat-2814	230	21	calenda	calenda	PROPN
easat-2814	230	22	.	.	PUNCT
easat-2814	230	23	,	,	PUNCT
easat-2814	230	24	d.	d.	PROPN
easat-2814	230	25	mazier	mazier	PROPN
easat-2814	230	26	,	,	PUNCT
easat-2814	230	27	and	and	CCONJ
easat-2814	230	28	m.	m.	PROPN
easat-2814	230	29	conti	conti	PROPN
easat-2814	230	30	,	,	PUNCT
easat-2814	230	31	et	et	PROPN
easat-2814	230	32	al	al	PROPN
easat-2814	230	33	.	.	PROPN
easat-2814	230	34	(	(	PUNCT
easat-2814	230	35	2004	2004	NUM
easat-2814	230	36	)	)	PUNCT
easat-2814	230	37	.	.	PUNCT
easat-2814	231	1	antioxidant	antioxidant	NOUN
easat-2814	231	2	and	and	CCONJ
easat-2814	231	3	anti	anti	ADJ
easat-2814	231	4	-	-	ADJ
easat-2814	231	5	inflammatory	inflammatory	ADJ
easat-2814	231	6	properties	property	NOUN
easat-2814	231	7	of	of	ADP
easat-2814	231	8	a	a	DET
easat-2814	231	9	cucumis	cucumis	PROPN
easat-2814	231	10	melo	melo	PROPN
easat-2814	231	11	lc	lc	PROPN
easat-2814	231	12	.	.	PROPN
easat-2814	231	13	extract	extract	VERB
easat-2814	231	14	rich	rich	ADJ
easat-2814	231	15	in	in	ADP
easat-2814	231	16	superoxide	superoxide	NOUN
easat-2814	231	17	dismutase	dismutase	NOUN
easat-2814	231	18	activity	activity	NOUN
easat-2814	231	19	.	.	PUNCT
easat-2814	232	1	journal	journal	NOUN
easat-2814	232	2	of	of	ADP
easat-2814	232	3	ethnopharmacology	ethnopharmacology	NOUN
easat-2814	232	4	94(1):67–75	94(1):67–75	NUM
easat-2814	232	5	,	,	PUNCT
easat-2814	232	6	https://doi.org/10.1016/j.jep.2004.04.023	https://doi.org/10.1016/j.jep.2004.04.023	NOUN
easat-2814	232	7	.	.	PUNCT
easat-2814	233	1	[	[	X
easat-2814	233	2	22	22	NUM
easat-2814	233	3	]	]	PUNCT
easat-2814	233	4	sicard	sicard	NOUN
easat-2814	233	5	p	p	X
easat-2814	233	6	,	,	PUNCT
easat-2814	233	7	amoureux	amoureux	PROPN
easat-2814	233	8	s	s	PART
easat-2814	233	9	,	,	PUNCT
easat-2814	233	10	acar	acar	NOUN
easat-2814	233	11	n	n	CCONJ
easat-2814	233	12	,	,	PUNCT
easat-2814	233	13	joffre	joffre	ADJ
easat-2814	233	14	c	c	PROPN
easat-2814	233	15	,	,	PUNCT
easat-2814	233	16	bron	bron	PROPN
easat-2814	233	17	a	a	X
easat-2814	233	18	,	,	PUNCT
easat-2814	233	19	maire	maire	PROPN
easat-2814	233	20	ma	ma	PROPN
easat-2814	233	21	,	,	PUNCT
easat-2814	233	22	et	et	PROPN
easat-2814	233	23	al	al	PROPN
easat-2814	233	24	.	.	PUNCT
easat-2814	234	1	(	(	PUNCT
easat-2814	234	2	2006	2006	NUM
easat-2814	234	3	)	)	PUNCT
easat-2814	234	4	.	.	PUNCT
easat-2814	235	1	dietary	dietary	ADJ
easat-2814	235	2	superoxide	superoxide	NOUN
easat-2814	235	3	dismutase	dismutase	NOUN
easat-2814	235	4	protects	protect	VERB
easat-2814	235	5	against	against	ADP
easat-2814	235	6	light	light	ADJ
easat-2814	235	7	–	–	PUNCT
easat-2814	235	8	induced	induce	VERB
easat-2814	235	9	retinal	retinal	ADJ
easat-2814	235	10	oxidative	oxidative	ADJ
easat-2814	235	11	stress	stress	NOUN
easat-2814	235	12	in	in	ADP
easat-2814	235	13	young	young	ADJ
easat-2814	235	14	senescence	senescence	NOUN
easat-2814	235	15	accelerated	accelerate	VERB
easat-2814	235	16	mice	mouse	NOUN
easat-2814	235	17	(	(	PUNCT
easat-2814	235	18	sam	sam	PROPN
easat-2814	235	19	)	)	PUNCT
easat-2814	235	20	.	.	PUNCT
easat-2814	236	1	invest	invest	VERB
easat-2814	236	2	ophthalmol	ophthalmol	PROPN
easat-2814	236	3	visual	visual	PROPN
easat-2814	236	4	sci	sci	PROPN
easat-2814	236	5	.	.	PUNCT
easat-2814	237	1	2006;47:2089	2006;47:2089	NUM
easat-2814	237	2	-	-	SYM
easat-2814	237	3	2089	2089	NUM
easat-2814	237	4	.	.	PUNCT
easat-2814	238	1	https://iovs.arvojournals.org/article.aspx?articleid=2391946	https://iovs.arvojournals.org/article.aspx?articleid=2391946	NOUN
easat-2814	238	2	[	[	X
easat-2814	238	3	23	23	NUM
easat-2814	238	4	]	]	X
easat-2814	238	5	eric	eric	PROPN
easat-2814	238	6	,	,	PUNCT
easat-2814	238	7	p.	p.	NOUN
easat-2814	238	8	,	,	PUNCT
easat-2814	238	9	laurent	laurent	PROPN
easat-2814	238	10	,	,	PUNCT
easat-2814	238	11	i.	i.	PROPN
easat-2814	238	12	,	,	PUNCT
easat-2814	238	13	françois	françois	PROPN
easat-2814	238	14	,	,	PUNCT
easat-2814	238	15	v.	v.	PROPN
easat-2814	238	16	,	,	PUNCT
easat-2814	238	17	(	(	PUNCT
easat-2814	238	18	2022	2022	NUM
easat-2814	238	19	)	)	PUNCT
easat-2814	238	20	.	.	PUNCT
easat-2814	239	1	immunomodulatory	immunomodulatory	ADJ
easat-2814	239	2	and	and	CCONJ
easat-2814	239	3	anti	anti	ADJ
easat-2814	239	4	-	-	ADJ
easat-2814	239	5	inflammatory	inflammatory	ADJ
easat-2814	239	6	properties	property	NOUN
easat-2814	239	7	of	of	ADP
easat-2814	239	8	an	an	DET
easat-2814	239	9	orally	orally	ADV
easat-2814	239	10	bioavailable	bioavailable	ADJ
easat-2814	239	11	sod	sod	NOUN
easat-2814	239	12	-	-	PUNCT
easat-2814	239	13	gliadin	gliadin	NOUN
easat-2814	239	14	complex	complex	NOUN
easat-2814	239	15	.	.	PUNCT
easat-2814	240	1	j	j	PROPN
easat-2814	240	2	pharm	pharm	PROPN
easat-2814	240	3	med	med	PROPN
easat-2814	240	4	h	h	PROPN
easat-2814	240	5	sci	sci	PROPN
easat-2814	240	6	68–74	68–74	PROPN
easat-2814	240	7	.	.	PUNCT
easat-2814	241	1	https://doi.org/10.37022/jpmhs.v5i4.84	https://doi.org/10.37022/jpmhs.v5i4.84	X
easat-2814	242	1	[	[	X
easat-2814	242	2	24	24	NUM
easat-2814	242	3	]	]	X
easat-2814	242	4	lópez	lópez	NOUN
easat-2814	242	5	-	-	PUNCT
easat-2814	242	6	contreras	contreras	PROPN
easat-2814	242	7	,	,	PUNCT
easat-2814	242	8	a.	a.	NOUN
easat-2814	242	9	,	,	PUNCT
easat-2814	242	10	m.	m.	NOUN
easat-2814	242	11	martínez	martínez	PROPN
easat-2814	242	12	-	-	PUNCT
easat-2814	242	13	ruiz	ruiz	NOUN
easat-2814	242	14	.	.	PUNCT
easat-2814	242	15	,	,	PUNCT
easat-2814	242	16	c.	c.	PROPN
easat-2814	242	17	olvera	olvera	PROPN
easat-2814	242	18	-	-	PUNCT
easat-2814	242	19	montaño	montaño	PROPN
easat-2814	242	20	.	.	PUNCT
easat-2814	242	21	,	,	PUNCT
easat-2814	242	22	r.	r.	PROPN
easat-2814	242	23	robles	robles	PROPN
easat-2814	242	24	-	-	PUNCT
easat-2814	242	25	rivera	rivera	PROPN
easat-2814	242	26	.	.	PUNCT
easat-2814	242	27	,	,	PUNCT
easat-2814	242	28	d.	d.	PROPN
easat-2814	242	29	arévalo	arévalo	PROPN
easat-2814	242	30	-	-	PUNCT
easat-2814	242	31	simental	simental	NOUN
easat-2814	242	32	.	.	PUNCT
easat-2814	242	33	,	,	PUNCT
easat-2814	242	34	j.	j.	PROPN
easat-2814	242	35	castellanos	castellanos	PROPN
easat-2814	242	36	-	-	PUNCT
easat-2814	242	37	gonzález	gonzález	PROPN
easat-2814	242	38	.	.	PUNCT
easat-2814	242	39	,	,	PUNCT
easat-2814	242	40	and	and	CCONJ
easat-2814	242	41	a.	a.	PROPN
easat-2814	242	42	hernándezchávez	hernándezchávez	PROPN
easat-2814	242	43	,	,	PUNCT
easat-2814	242	44	et	et	PROPN
easat-2814	242	45	al	al	PROPN
easat-2814	242	46	.	.	PROPN
easat-2814	242	47	(	(	PUNCT
easat-2814	242	48	2020	2020	NUM
easat-2814	242	49	)	)	PUNCT
easat-2814	242	50	.	.	PUNCT
easat-2814	243	1	importance	importance	NOUN
easat-2814	243	2	of	of	ADP
easat-2814	243	3	the	the	DET
easat-2814	243	4	use	use	NOUN
easat-2814	243	5	of	of	ADP
easat-2814	243	6	oxidative	oxidative	ADJ
easat-2814	243	7	stress	stress	NOUN
easat-2814	243	8	biomarkers	biomarker	NOUN
easat-2814	243	9	and	and	CCONJ
easat-2814	243	10	inflammatory	inflammatory	ADJ
easat-2814	243	11	profile	profile	NOUN
easat-2814	243	12	in	in	ADP
easat-2814	243	13	aqueous	aqueous	ADJ
easat-2814	243	14	and	and	CCONJ
easat-2814	243	15	vitreous	vitreous	ADJ
easat-2814	243	16	humor	humor	NOUN
easat-2814	243	17	in	in	ADP
easat-2814	243	18	diabetic	diabetic	ADJ
easat-2814	243	19	retinopathy	retinopathy	NOUN
easat-2814	243	20	.	.	PUNCT
easat-2814	244	1	antioxidants	antioxidant	NOUN
easat-2814	244	2	,	,	PUNCT
easat-2814	244	3	9(9):891	9(9):891	NUM
easat-2814	244	4	-	-	SYM
easat-2814	244	5	927	927	NUM
easat-2814	244	6	,	,	PUNCT
easat-2814	244	7	https://doi.org/10.3390/antiox9090891	https://doi.org/10.3390/antiox9090891	NOUN
easat-2814	244	8	[	[	X
easat-2814	244	9	25	25	NUM
easat-2814	244	10	]	]	X
easat-2814	244	11	romao	romao	ADJ
easat-2814	244	12	,	,	PUNCT
easat-2814	244	13	s.	s.	PROPN
easat-2814	244	14	(	(	PUNCT
easat-2814	244	15	2015	2015	NUM
easat-2814	244	16	)	)	PUNCT
easat-2814	244	17	.	.	PUNCT
easat-2814	245	1	therapeutic	therapeutic	ADJ
easat-2814	245	2	value	value	NOUN
easat-2814	245	3	of	of	ADP
easat-2814	245	4	oral	oral	ADJ
easat-2814	245	5	supplementation	supplementation	NOUN
easat-2814	245	6	with	with	ADP
easat-2814	245	7	melon	melon	NOUN
easat-2814	245	8	superoxide	superoxide	NOUN
easat-2814	245	9	dismutase	dismutase	NOUN
easat-2814	245	10	and	and	CCONJ
easat-2814	245	11	wheat	wheat	NOUN
easat-2814	245	12	gliadin	gliadin	NOUN
easat-2814	245	13	combination	combination	NOUN
easat-2814	245	14	.	.	PUNCT
easat-2814	246	1	nutrition	nutrition	NOUN
easat-2814	246	2	,	,	PUNCT
easat-2814	246	3	31(3):430–436	31(3):430–436	NUM
easat-2814	246	4	,	,	PUNCT
easat-2814	246	5	https://doi.org/10.1016/j.nut.2014.10.006	https://doi.org/10.1016/j.nut.2014.10.006	NOUN
easat-2814	246	6	.	.	PUNCT